Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
AC008695.1		ENSG00000273217			5	131425891-131796983	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 11.1"	"Lineage enriched"	"Detected in many"	5	"T-cells: 11.1"	"Cell line enhanced"	"Detected in some"		"A549: 7.0;HeLa: 1.3;HL-60: 1.4;HMC-1: 2.8;U-937: 1.7"									"HPA037982, HPA037983"	Uncertain		Approved	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA037982: AB_10670535, HPA037983: AB_2675769"																		4.0	2.5	3.6	2.4	4.3	3.8	2.9	3.4	4.1	2.7	2.7	3.8	2.1	2.4	3.5	2.4	2.5	2.5	2.4	2.6	2.5	2.5	2.5	2.5	2.6	3.5	5.8	2.6	4.0	2.5	2.4	6.1	4.5	3.5	2.5	2.4	1.4	2.5	2.4	4.2	2.5	2.5	3.0	3.3	2.5	2.5	4.2	5.2	2.4	2.5	1.1	2.4	3.0	4.0	2.0	0.3	2.3	0.9	2.4	11.1	2.8	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.7	1.3	0.0	0.0	1.4	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	1.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.2	0.0	0.0	1.7	0.0	0.6	0.9	2.3	3.3	0.4	5.7	1.4	3.6	3.8	0.3	2.0	11.1	5.0	0.6	2.4	0.9	0.0	2.8	2.8	3.6	4.3	3.4	4.1	2.5	2.5	5.8	2.6	3.5	5.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACTR8	INO80N	ENSG00000113812	"ARP8 actin related protein 8 homolog"	Q9H981	3	53867066-53882202	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 71.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 28.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065236			Supported	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA065236: AB_2685442"	"unprognostic (9.05e-2)"	"unprognostic (2.06e-1)"	"prognostic favorable (2.21e-4)"	"unprognostic (2.97e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (5.11e-6)"	"unprognostic (2.24e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.68e-2)"	"prognostic favorable (7.88e-9)"	"unprognostic (3.68e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.15e-1)"	13.2	11.2	19.8	12.6	20.0	11.3	12.9	25.6	24.5	13.7	12.4	13.9	10.5	9.9	14.1	14.3	14.1	12.8	11.3	24.3	18.2	13.7	17.9	11.8	12.4	17.0	17.7	15.5	15.0	15.8	21.9	22.0	14.8	16.0	13.0	16.8	12.5	14.2	12.6	20.1	14.5	11.9	15.3	16.1	14.4	12.6	27.5	19.9	19.9	16.8	10.5	19.2	16.1	11.8	6.1	6.3	28.8	7.1	8.6	8.5	4.4	6.5	8.1	15.9	13.1	13.1	16.5	11.9	15.5	19.8	21.0	16.8	12.6	8.0	20.0	4.6	21.3	15.5	5.6	11.9	10.7	20.0	8.1	4.9	19.9	12.6	13.4	15.5	21.1	17.9	12.9	11.0	21.7	13.7	16.3	16.2	10.7	8.9	7.0	21.1	7.6	7.0	12.6	14.8	9.5	12.9	9.3	9.9	12.0	15.9	18.4	4.7	13.7	10.1	8.8	8.9	15.7	5.7	11.8	11.0	16.1	10.5	14.7	14.0	19.6	24.9	20.5	11.9	15.5	10.0	28.8	4.7	5.8	5.8	7.1	5.8	6.1	5.4	5.5	6.3	3.8	5.7	6.1	2.4	8.6	4.2	4.6	8.5	4.4	19.8	20.0	25.6	24.5	18.2	13.7	17.7	15.5	16.0	19.9	3.0	7.7	7.8	6.1	6.9	6.5	17.8	10.2	2.7	4.5	3.5	3.9	10.4	18.3	13.2	35.7	7.7	5.2	0.0	13.7	9.4	7.1	5.7	5.7	4.7	10.2	1.6	10.4	7.4	6.3	71.4	10.0	8.2	5.0	13.6	9.0	7.0	11.6	2.9	9.2	15.9	4.7	0.0	9.2	17.6	15.4	5.6	8.6	12.2	5.7	5.4
ADCK2	MGC20727	ENSG00000133597	"AarF domain containing kinase 2"	Q7Z695	7	140673153-140696261	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA036036	Approved		Uncertain	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"HPA036036: AB_10672078"	"unprognostic (2.76e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.72e-2)"	"unprognostic (5.30e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.05e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.10e-3)"	"unprognostic (6.81e-3)"	"unprognostic (9.36e-3)"	"prognostic favorable (9.75e-5)"	"unprognostic (1.89e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.13e-1)"	"unprognostic (2.13e-1)"	12.3	10.6	15.3	11.3	16.6	8.8	13.4	15.4	27.0	12.3	15.1	26.3	13.2	8.8	10.3	11.4	18.0	20.0	10.3	10.2	16.6	18.2	12.3	12.5	12.8	15.6	19.5	13.1	14.5	22.8	21.4	12.7	19.9	18.2	14.4	13.2	10.7	16.8	14.0	12.5	25.8	13.0	10.9	24.0	13.6	13.0	7.6	13.3	20.6	25.1	9.9	16.2	13.4	18.9	8.2	12.0	3.2	5.0	5.1	7.3	2.2	16.0	11.6	2.7	12.7	10.0	11.4	16.5	8.3	10.2	8.7	5.8	10.5	11.4	21.6	12.6	5.8	20.4	13.3	13.9	9.5	2.6	15.9	14.2	4.5	4.5	5.1	13.9	3.0	11.3	9.5	29.1	5.0	6.9	9.0	7.5	15.4	7.9	10.6	3.1	20.0	22.5	7.5	4.0	12.8	12.6	17.8	0.1	10.4	4.7	16.1	10.8	7.6	11.4	16.7	11.4	5.5	14.8	6.1	7.9	10.9	3.8	18.1	16.0	7.4	11.2	15.8	16.1	12.1	12.9	0.0	3.7	3.2	5.4	5.0	4.9	8.2	4.8	5.3	5.7	4.2	7.3	4.7	0.1	5.1	3.0	12.0	6.0	2.2	15.3	16.6	15.4	27.0	16.6	18.2	19.5	13.1	18.2	13.3	8.9	5.1	8.2	18.5	11.0	11.4	5.8	5.1	2.7	1.2	8.7	0.0	25.4	5.0	5.3	16.9	9.0	8.5	0.0	6.4	18.4	7.1	15.5	11.5	8.6	27.9	11.1	16.1	6.7	7.9	12.5	3.1	11.8	3.3	7.2	13.8	11.6	5.9	14.4	12.7	4.8	4.8	0.0	6.9	5.9	3.1	12.2	28.3	7.7	11.3	16.1
AKNA	KIAA1968	ENSG00000106948	"AT-hook transcription factor"	Q7Z591	9	114334156-114394405	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 71.2"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 139.4;Rod photoreceptor cells: 137.4;T-cells: 94.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 32.0;MOLT-4: 30.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA052367, HPA063993"			Supported	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"HPA052367: AB_2681801, HPA063993: AB_2685169"	"unprognostic (5.19e-3)"	"prognostic favorable (1.22e-4)"	"unprognostic (5.38e-3)"	"prognostic favorable (2.14e-5)"	"unprognostic (3.12e-1)"	"prognostic favorable (1.25e-4)"	"unprognostic (1.88e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.13e-2)"	"unprognostic (6.62e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.55e-5)"	"unprognostic (1.19e-2)"	"unprognostic (6.61e-3)"	"unprognostic (2.93e-1)"	"prognostic favorable (2.29e-4)"	7.2	2.8	4.6	41.8	4.9	17.5	6.1	2.0	4.5	13.9	7.3	5.9	2.4	5.7	13.4	4.5	3.3	11.4	12.9	2.8	4.9	3.8	3.9	5.6	11.2	30.4	4.9	3.3	9.9	3.4	0.8	3.6	2.8	4.9	5.3	4.7	7.1	10.2	4.2	1.6	2.5	18.4	8.8	3.6	43.1	7.3	3.9	4.8	71.2	4.0	4.5	42.9	6.1	6.4	7.2	8.8	16.6	6.1	11.9	16.6	6.4	1.4	1.5	1.8	1.3	12.8	1.5	8.0	1.6	1.9	1.5	1.2	2.7	1.6	17.5	1.6	1.4	2.8	3.4	1.2	0.4	0.5	32.0	0.7	1.8	0.7	1.8	15.4	16.9	19.2	2.6	2.8	1.3	1.4	2.2	2.7	15.8	1.7	21.2	0.6	2.5	30.4	22.0	6.9	3.4	1.8	18.9	0.3	4.0	14.6	0.8	0.9	1.7	0.4	1.4	4.7	2.4	4.0	9.3	4.4	0.8	1.7	0.3	1.4	4.4	4.9	14.8	1.0	8.6	0.7	8.0	6.1	9.6	16.6	4.6	13.1	6.5	8.9	14.1	4.1	7.2	7.9	10.6	16.6	11.9	4.1	8.8	7.0	6.4	4.6	4.9	2.0	4.5	4.9	3.8	4.9	3.3	4.9	4.8	11.9	28.1	43.3	5.9	4.6	25.8	3.1	0.0	29.4	12.5	22.7	139.4	7.7	0.0	3.4	16.1	6.3	6.7	0.0	7.0	5.7	8.0	6.2	31.3	8.5	16.0	4.8	12.2	13.5	41.0	20.2	13.6	31.2	5.0	26.2	19.5	6.5	5.0	10.5	6.3	0.9	137.4	0.0	10.8	0.6	0.7	3.0	2.9	94.4	12.9	7.5
ALDH8A1	ALDH12	ENSG00000118514	"Aldehyde dehydrogenase 8 family member A1"	Q9H2A2	6	134917390-134950122	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"kidney: 26.2;liver: 90.1"	"Cell type enhanced"	"Detected in some"	22	"Collecting duct cells: 29.6;Hepatocytes: 129.5;Proximal tubular cells: 94.1"	"Group enriched"	"Detected in some"	7	"liver cancer: 26.3;renal cancer: 17.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 5.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 5.6;RPTEC TERT1: 6.4;U-266/70: 5.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA026292, HPA055414"	Enhanced		Approved	Nucleoplasm,Centrosome		NA	NA		24000	Centrosome	Nucleoplasm	"HPA026292: AB_1844741, HPA055414: AB_2682810"	"unprognostic (1.12e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.32e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.99e-2)"	"prognostic favorable (9.87e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.86e-5)"	0.3	0.3	0.8	0.3	1.0	0.6	0.3	1.9	0.9	0.3	0.6	0.3	0.3	0.2	0.3	0.6	0.3	0.1	0.3	0.3	1.4	0.6	26.2	90.1	0.3	0.3	1.1	0.4	0.3	0.3	0.2	0.3	0.4	0.3	0.3	0.2	0.3	0.3	0.3	1.0	0.5	0.3	0.3	0.8	0.3	0.1	0.3	0.3	0.4	0.4	0.3	0.3	0.3	0.3	1.5	1.1	5.9	0.9	2.3	1.3	0.6	0.2	1.1	1.6	0.8	0.5	0.2	1.4	0.4	0.5	0.1	1.0	0.5	0.7	0.4	0.6	0.0	0.4	1.1	1.1	0.1	0.9	1.2	5.6	3.7	3.9	5.3	0.6	1.5	2.0	1.6	1.8	0.4	0.9	1.2	0.4	1.8	5.4	2.2	0.2	0.1	1.8	2.4	0.3	0.4	1.1	0.1	0.5	0.5	6.4	0.8	1.7	0.6	0.3	0.1	1.3	0.5	0.9	0.3	0.4	0.8	3.2	1.3	1.5	5.6	1.7	0.9	0.7	1.4	0.5	5.9	0.9	0.9	1.3	0.3	0.5	1.0	1.2	0.7	0.1	1.5	1.1	0.9	2.4	2.3	0.4	1.1	1.2	0.6	0.8	1.0	1.9	0.9	1.4	0.6	1.1	0.4	0.3	0.3	3.0	1.1	2.2	0.2	0.0	1.8	0.3	2.5	0.0	1.2	29.6	0.0	0.2	16.6	0.1	0.0	0.2	0.0	0.0	0.0	1.2	0.4	0.1	0.0	129.5	0.1	3.2	0.0	3.1	1.3	0.0	0.0	0.1	0.0	1.0	0.0	0.3	0.0	0.0	0.0	94.1	1.6	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0
APPL1	APPL	ENSG00000157500	"Adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1"	Q9UKG1	3	57227737-57273468	"Disease related genes, Predicted intracellular proteins"	"Cell cycle"		"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"naive B-cell: 20.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011138, HPA073477"	Approved		Uncertain	"Mitotic spindle,Centrosome"		Yes	No		28000	"Mitotic spindle, Centrosome"		"HPA011138: AB_1844959, HPA073477: AB_2797272"	"unprognostic (1.39e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.36e-2)"	"unprognostic (9.05e-3)"	"unprognostic (5.55e-2)"	"prognostic favorable (7.26e-5)"	"unprognostic (3.99e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.55e-1)"	18.3	14.0	20.9	15.3	17.9	13.7	22.5	25.2	23.7	18.5	15.7	12.8	16.8	12.6	19.2	14.5	21.0	16.0	13.2	23.7	15.8	15.4	17.0	14.3	15.3	24.3	15.4	18.8	24.0	38.2	28.4	20.4	14.1	18.8	15.7	14.4	11.0	18.0	22.2	40.5	19.9	14.5	20.5	16.7	15.0	16.3	10.5	15.7	20.9	20.0	15.2	18.9	17.7	20.8	20.7	12.0	2.5	3.9	4.7	3.5	1.7	14.9	6.5	6.4	23.2	11.0	15.5	13.5	7.9	4.9	8.0	9.2	7.6	9.0	24.3	3.3	12.2	12.6	3.0	17.1	13.7	13.8	18.3	7.6	13.7	10.4	8.0	11.9	30.4	10.1	11.4	12.5	10.2	11.1	16.1	12.7	15.3	4.6	15.3	9.0	5.1	23.9	7.5	10.0	10.6	11.2	0.8	26.0	13.0	14.1	8.4	6.5	13.8	10.9	16.4	10.4	9.0	8.0	19.8	12.0	13.3	9.4	19.3	15.3	14.1	20.6	17.1	14.4	14.7	8.6	1.6	3.9	2.5	2.6	3.0	3.5	11.3	2.8	2.4	7.2	20.7	2.6	1.9	1.0	4.7	2.5	12.0	1.1	1.7	20.9	17.9	25.2	23.7	15.8	15.4	15.4	18.8	18.8	15.7	47.6	39.2	44.5	41.0	47.1	39.5	88.3	45.9	20.1	55.7	40.1	29.5	40.0	49.7	52.3	22.7	58.0	26.9	0.0	52.6	38.3	45.7	34.4	22.0	37.6	46.6	49.3	43.8	35.6	50.8	15.5	67.6	54.0	18.6	85.6	35.9	55.2	46.8	11.5	71.5	43.7	52.2	51.8	38.7	40.0	39.4	60.9	23.5	30.5	44.7	23.4
ARHGEF38	FLJ20184	ENSG00000236699	"Rho guanine nucleotide exchange factor 38"	Q9NXL2	4	105552620-105708093	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 35.5"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 2: 33.6;Ciliated cells: 45.5;Club cells: 18.2"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 3.0;RPTEC TERT1: 16.4;SK-BR-3: 9.0;T-47d: 9.3"					"Low region specificity"	"Detected in all"			"HPA036510, HPA045484"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA036510: AB_10672357, HPA045484: AB_2679345"	"unprognostic (1.49e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.47e-3)"	"unprognostic (2.79e-1)"	"unprognostic (6.14e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.53e-3)"	"unprognostic (3.16e-8)"	"unprognostic (2.33e-3)"	"unprognostic (6.16e-2)"	"unprognostic (3.19e-3)"	"unprognostic (6.45e-3)"	0.2	0.2	0.2	3.2	0.2	0.0	10.8	0.2	0.2	3.5	7.6	0.0	1.6	2.3	1.4	15.7	0.4	1.1	11.7	0.2	0.2	0.2	13.8	0.4	16.1	0.0	0.2	0.0	1.3	12.9	0.0	35.5	0.4	0.0	14.6	5.6	0.2	13.9	0.5	0.2	1.0	9.6	0.0	0.2	0.2	4.1	0.6	0.0	0.0	8.0	0.7	2.0	0.5	0.4	0.0	0.0	0.1	0.2	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	3.0	0.3	0.0	0.0	0.1	16.4	0.0	0.0	0.0	0.0	9.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.1	0.2	0.1	0.0	0.3	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	6.0	33.6	0.0	0.9	0.0	0.0	1.4	2.5	45.5	18.2	12.2	0.0	0.1	8.3	4.2	1.2	0.0	4.1	0.0	5.0	0.1	0.0	13.9	0.0	0.0	0.1	0.0	8.1	0.0	0.0	0.0	0.0	0.0	3.3	0.0	7.7	0.0	3.3	5.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	7.0	0.4
ARL3	ARFL3	ENSG00000138175	"ADP ribosylation factor like GTPase 3"	P36405	10	102673731-102714407	"Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"		"Ciliopathy, Disease mutation, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036292, HPA063596"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA		17000	Centrosome	Nucleoplasm	"HPA036292: AB_10673618, HPA063596: AB_2685053"	"unprognostic (1.36e-1)"	"unprognostic (2.89e-3)"	"unprognostic (4.19e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.45e-2)"	"unprognostic (7.69e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.99e-3)"	"unprognostic (5.58e-2)"	"prognostic favorable (1.71e-6)"	"unprognostic (5.62e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.03e-1)"	8.8	13.8	24.8	6.6	29.4	2.9	11.4	24.1	32.9	14.1	8.9	9.6	8.2	6.8	17.1	16.7	10.2	23.0	8.3	29.9	19.9	21.4	22.7	8.1	9.6	5.5	20.2	16.0	25.2	9.9	18.9	21.0	7.7	17.6	12.1	7.7	21.5	8.8	14.5	7.9	7.9	6.4	13.4	14.2	5.3	9.0	13.6	9.3	4.1	17.3	5.5	7.2	16.0	13.8	5.0	7.8	14.9	8.1	4.5	11.1	5.8	8.4	14.6	20.1	14.7	9.4	14.0	3.5	6.7	10.3	8.2	9.0	5.0	4.4	3.5	6.5	10.8	9.9	6.3	7.6	9.0	10.3	9.2	7.9	5.7	10.4	4.7	10.1	2.6	5.8	7.1	7.6	11.3	6.7	21.9	9.3	7.1	2.5	3.6	13.6	8.7	5.4	4.2	7.7	5.4	5.8	4.5	14.9	3.1	10.9	4.5	7.1	15.5	5.1	1.1	7.9	11.6	26.8	2.6	5.3	5.6	7.9	11.3	9.2	2.5	5.0	6.5	14.8	7.9	4.8	2.3	8.1	2.7	4.5	6.5	11.1	5.0	7.8	6.5	7.8	3.5	4.8	5.7	14.9	4.5	5.5	5.7	5.2	5.8	24.8	29.4	24.1	25.6	19.9	21.4	20.2	16.0	17.6	9.3	50.6	35.3	24.6	62.4	28.5	163.4	124.2	25.5	234.2	69.4	59.3	110.0	37.6	198.9	63.3	31.0	37.3	8.7	0.0	38.5	31.6	63.5	46.4	32.3	23.7	54.8	92.2	71.9	38.1	15.3	15.4	56.1	32.0	72.6	102.8	28.8	161.1	29.6	11.5	97.9	174.9	241.8	25.8	102.0	184.2	20.1	27.7	27.0	20.1	26.6	42.6
BCAS2	"DAM1, Snt309, SPF27"	ENSG00000116752	"BCAS2, pre-mRNA processing factor"	O75934	1	114567557-114581639	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 118.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067881	Supported		Supported	"Nuclear speckles,Centrosome"		NA	NA			"Nuclear speckles, Centrosome"		"HPA067881: AB_2685915"	"unprognostic (6.93e-2)"	"unprognostic (1.88e-2)"	"unprognostic (8.58e-3)"	"unprognostic (4.74e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.99e-3)"	"prognostic unfavorable (8.23e-7)"	"unprognostic (1.16e-1)"	"unprognostic (8.51e-3)"	"prognostic favorable (7.96e-4)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (4.27e-4)"	"prognostic favorable (6.49e-4)"	"unprognostic (2.25e-3)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (5.24e-4)"	"unprognostic (1.87e-1)"	23.2	28.0	36.7	17.6	34.1	43.0	25.0	30.4	40.6	21.3	19.7	16.5	17.3	16.7	22.9	33.2	26.0	16.6	20.7	24.5	31.6	41.8	28.7	32.9	17.5	22.4	37.0	28.8	26.8	18.2	22.9	32.5	17.4	39.0	24.1	21.0	13.9	19.5	26.7	38.4	19.0	19.0	20.1	26.9	20.8	18.3	21.2	24.6	20.0	27.8	24.5	22.1	31.1	19.5	30.4	24.8	30.9	22.6	35.4	40.1	32.9	19.3	7.1	14.7	13.9	7.8	9.1	22.0	14.6	11.3	19.4	20.0	9.9	8.0	17.2	20.2	9.4	13.1	9.4	17.0	14.4	27.0	15.6	15.3	9.0	14.1	14.3	14.2	22.7	9.8	8.3	15.9	20.0	24.8	9.1	12.6	18.8	17.2	12.9	15.9	118.8	20.2	16.9	25.5	11.9	16.2	14.5	26.0	12.0	13.6	17.0	19.2	12.8	18.2	14.1	22.4	12.7	12.4	18.0	11.1	11.9	15.9	23.8	27.4	14.1	14.5	27.9	23.2	19.0	44.8	21.6	18.5	30.9	29.3	21.9	40.1	30.4	36.7	35.7	19.4	26.7	38.2	37.2	17.6	35.4	22.6	24.8	35.8	32.9	36.7	34.1	30.4	40.6	31.6	41.8	37.0	28.8	39.0	24.6	26.8	38.4	63.6	94.6	69.1	63.3	63.3	28.1	42.8	36.4	47.1	35.3	67.4	81.2	56.2	17.0	43.9	22.2	23.3	58.4	73.6	49.8	51.7	99.1	27.7	58.7	36.5	47.9	27.0	31.0	13.7	36.8	54.3	64.1	50.5	30.7	70.3	45.0	31.1	41.1	72.5	55.6	38.8	78.0	57.0	37.7	55.5	84.7	66.0	31.3	106.5
BEAN1	SCA31	ENSG00000166546	"Brain expressed associated with NEDD4 1"	Q3B7T3	16	66427297-66493529	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.6"	"Cell type enhanced"	"Detected in some"	9	"Cytotrophoblasts: 4.8;Early spermatids: 8.4;Extravillous trophoblasts: 8.9;Late spermatids: 8.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"eosinophil: 1.9;neutrophil: 5.2;plasmacytoid DC: 2.4"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.4;granulocytes: 5.2"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 9.7;BEWO: 4.9;RPTEC TERT1: 8.6;U-87 MG: 5.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053851	Uncertain		Uncertain	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA053851: AB_2682280"	"unprognostic (1.92e-1)"	"unprognostic (5.79e-4)"	"unprognostic (3.83e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.01e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.89e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.18e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.10e-2)"	1.2	1.2	2.9	1.1	2.5	2.9	1.2	6.9	9.6	1.2	0.7	0.1	0.0	0.6	1.2	1.9	1.8	1.9	1.4	3.0	4.6	4.1	0.9	1.1	1.4	0.9	2.3	3.2	1.4	1.9	0.1	0.4	4.5	11.6	1.0	0.9	5.0	1.9	0.4	3.6	3.2	0.8	0.8	1.7	1.2	1.2	3.1	0.2	0.0	1.9	3.1	0.9	1.0	1.0	0.3	2.4	5.2	0.5	0.4	0.2	0.1	0.8	1.0	1.0	9.7	0.3	0.1	4.9	0.3	0.0	0.1	0.1	0.0	1.0	0.1	0.6	0.3	0.6	0.2	0.1	0.1	0.3	0.0	0.7	0.0	0.2	0.7	0.7	0.1	0.0	0.7	1.9	0.6	0.3	1.4	0.0	0.2	0.1	0.3	0.2	0.5	0.0	0.4	0.3	0.1	0.6	0.1	0.2	0.5	8.6	0.6	0.1	0.2	0.2	0.2	1.4	0.7	0.2	0.1	0.3	0.4	2.7	0.1	0.4	0.5	0.1	0.1	5.6	0.2	1.4	0.4	0.5	1.9	0.2	0.1	0.1	0.2	0.1	0.1	0.3	0.3	0.2	0.1	5.2	0.4	0.2	2.4	0.1	0.1	2.9	2.5	6.9	9.6	4.6	4.1	2.3	3.2	11.6	0.2	0.0	0.0	0.0	0.2	0.1	0.4	1.2	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.2	8.4	0.3	0.0	0.0	0.0	8.9	0.6	1.0	0.0	0.0	0.9	0.0	0.0	1.3	0.0	8.0	0.3	0.0	3.3	0.0	0.0	0.0	1.0	0.0	2.1	0.0	0.9	0.0	0.5	2.9	0.3	0.1	2.4	0.0	0.0	0.3
BICC1		ENSG00000122870	"BicC family RNA binding protein 1"	Q9H694	10	58513140-58831437	"Disease related genes, Predicted intracellular proteins"		"Developmental protein, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 43.0"	"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 119.8;Collecting duct cells: 82.0;Distal tubular cells: 66.3;Ductal cells: 87.3;Leydig cells: 65.9;Proximal tubular cells: 113.1"	"Cancer enhanced"	"Detected in all"		"renal cancer: 25.6"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"basophil: 8.7"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 8.7"	"Cell line enhanced"	"Detected in many"		"A549: 19.9;BJ hTERT+: 21.1;CACO-2: 31.3;RPTEC TERT1: 49.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070797			Approved	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA070797: "	"unprognostic (1.27e-1)"	"unprognostic (1.57e-3)"	"unprognostic (3.61e-1)"	"unprognostic (1.96e-1)"	"unprognostic (6.09e-3)"	"unprognostic (1.72e-1)"	"unprognostic (9.98e-3)"	"unprognostic (1.79e-2)"	"unprognostic (6.69e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.40e-3)"	"unprognostic (7.16e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.37e-3)"	"unprognostic (4.19e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.94e-2)"	11.8	5.7	1.1	5.7	1.5	0.2	9.4	0.5	2.5	9.8	5.1	1.1	4.8	1.0	7.8	12.3	8.1	7.1	11.6	12.1	1.1	1.4	43.0	2.5	5.8	5.2	0.9	2.2	19.0	24.2	0.8	4.6	3.2	2.1	7.8	3.9	18.7	4.8	4.1	22.4	6.5	2.8	6.0	3.9	2.7	3.2	4.9	0.8	0.8	5.1	7.5	3.2	8.6	10.4	0.1	1.1	8.7	0.3	1.0	0.2	0.1	0.0	19.9	0.3	0.0	6.4	8.3	0.0	13.1	21.1	11.9	14.3	31.3	4.2	0.0	13.8	13.3	3.1	0.2	2.1	2.3	16.7	0.0	2.0	0.0	2.6	0.0	4.1	0.0	0.0	12.9	0.7	9.3	10.1	14.9	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.1	0.0	1.3	0.0	5.0	0.0	49.5	2.4	0.0	2.5	0.0	0.1	1.1	0.8	0.0	0.2	0.0	2.9	2.7	0.5	1.6	0.0	0.0	0.0	8.4	0.0	2.7	8.7	0.2	0.1	0.1	0.2	0.2	0.1	0.1	0.1	1.1	0.1	0.1	0.1	0.2	1.0	0.3	0.9	0.1	0.1	1.1	1.5	0.5	2.5	1.1	1.4	0.9	2.2	2.1	0.8	0.0	0.3	0.5	1.1	6.4	0.1	2.2	119.8	17.4	2.3	82.0	0.0	0.4	66.3	87.3	4.0	0.4	0.0	0.0	3.1	0.2	29.2	2.0	0.0	0.5	2.7	0.0	3.5	5.5	0.6	2.2	65.9	0.5	20.3	1.8	1.0	7.5	22.7	0.0	47.0	113.1	0.2	6.5	13.7	0.0	2.1	4.1	3.4	0.0	0.8	0.1
C16orf74	MGC17624	ENSG00000154102	"Chromosome 16 open reading frame 74"	Q96GX8	16	85690084-85751129	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 44.6"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 47.6;Cone photoreceptor cells: 55.0;Rod photoreceptor cells: 69.6;Syncytiotrophoblasts: 62.1;Urothelial cells: 43.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 26.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 34.3;hTCEpi: 29.3;T-47d: 30.5"					"Low region specificity"	"Detected in all"			HPA049367	Uncertain		Approved	"Plasma membrane,Centrosome"		NA	NA			"Plasma membrane"	Centrosome	"HPA049367: AB_2680730"	"unprognostic (1.16e-1)"	"unprognostic (2.21e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.15e-3)"	"unprognostic (3.65e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (1.08e-3)"	"unprognostic (4.22e-3)"	"prognostic unfavorable (4.08e-4)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (1.54e-5)"	"unprognostic (3.40e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.15e-2)"	"unprognostic (9.07e-3)"	2.7	0.7	6.3	5.6	3.9	9.3	6.8	0.6	3.3	4.7	3.0	1.4	10.8	1.5	2.1	3.7	6.8	1.5	2.4	1.8	9.2	1.7	2.0	0.8	2.0	11.7	2.0	2.1	0.9	2.1	3.9	1.0	44.6	1.6	7.1	1.3	18.8	4.5	9.5	1.5	6.3	4.2	3.9	1.5	12.9	3.0	1.4	1.5	0.4	4.7	6.2	10.3	18.9	10.0	26.3	8.8	10.3	8.2	3.3	8.3	5.4	12.2	4.1	0.1	1.7	1.9	2.1	5.1	1.5	2.0	4.8	1.3	3.1	11.5	0.1	17.4	1.2	2.0	17.7	0.7	34.3	2.7	0.0	2.7	0.0	1.8	0.3	5.2	0.3	0.0	4.5	29.3	4.6	20.1	3.6	15.6	2.1	0.0	0.0	0.1	10.3	0.0	18.7	1.1	13.2	11.8	0.5	0.0	1.0	0.0	14.0	3.9	1.0	6.2	3.2	3.1	1.4	30.5	5.2	15.9	3.1	8.0	1.3	4.4	4.3	3.1	13.5	0.0	4.4	0.6	0.0	8.2	10.3	0.6	2.7	2.2	20.4	4.5	3.6	8.8	26.3	7.6	4.7	3.2	3.3	0.8	0.1	8.3	5.4	6.3	3.9	0.6	3.3	9.2	1.7	2.0	2.1	1.6	1.5	3.0	0.6	38.4	47.6	8.2	17.9	1.2	0.0	1.4	3.4	1.8	55.0	38.4	3.3	2.8	1.3	2.1	0.0	0.0	1.0	13.5	4.8	4.1	0.0	0.0	4.3	14.3	0.0	1.3	0.8	0.0	3.1	1.6	18.6	0.0	0.0	8.8	2.2	0.0	3.2	1.7	69.6	0.0	3.4	0.9	6.4	6.0	62.1	0.9	0.0	43.2
C1QTNF2	CTRP2	ENSG00000145861	"C1q and TNF related 2"	Q9BXJ5	5	160347751-160370641	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Fibroblasts: 32.3;Leydig cells: 21.6;Peritubular cells: 28.0;Smooth muscle cells: 27.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RH-30: 26.6;U-138 MG: 11.8;U-2 OS: 6.4;WM-115: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061290	Uncertain		Approved	"Golgi apparatus,Centrosome"	"Secreted to blood"	NA	NA			"Golgi apparatus, Centrosome"		"HPA061290: AB_2684468"	"unprognostic (2.28e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.53e-2)"	"unprognostic (8.92e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.91e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.23e-2)"	"unprognostic (8.32e-2)"	"unprognostic (2.11e-5)"	"unprognostic (5.40e-5)"	"unprognostic (1.14e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.10e-2)"	5.5	2.1	2.1	1.9	5.2	0.6	5.6	4.4	4.9	9.5	4.9	1.1	1.3	3.4	10.9	6.9	6.8	4.9	9.3	8.5	2.0	1.8	1.3	1.0	5.0	1.1	1.4	3.0	2.9	0.9	0.6	1.2	2.4	1.0	7.7	3.4	14.3	3.4	9.6	4.8	3.0	4.6	6.4	1.3	1.7	4.3	5.8	1.5	0.0	4.3	12.1	1.3	6.0	5.8	0.6	0.4	3.7	0.1	1.0	0.2	0.1	0.2	0.0	0.4	0.1	0.0	0.0	0.0	3.0	4.0	0.7	2.5	0.1	0.7	0.0	0.1	1.0	0.5	0.1	0.1	0.3	0.2	0.0	0.1	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	26.6	0.0	0.0	0.1	0.0	0.6	0.7	0.0	0.1	0.1	0.3	0.1	0.2	11.8	6.4	1.1	3.2	0.1	0.0	0.0	0.4	0.0	5.2	3.7	0.1	0.3	0.2	0.1	0.2	0.3	0.2	0.1	0.2	0.6	0.2	0.2	1.1	1.0	0.1	0.4	0.1	0.1	2.1	5.2	4.4	4.9	2.0	1.8	1.4	3.0	1.0	1.5	0.0	0.0	0.0	0.1	5.8	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.0	1.6	0.0	0.0	0.2	0.2	32.3	0.1	0.0	0.0	0.9	0.0	0.0	1.8	0.0	0.0	21.6	0.0	5.0	1.0	0.0	0.0	0.1	0.0	28.0	0.0	0.6	0.0	27.0	0.0	0.1	3.3	0.7	0.0	0.0	0.1
C21orf33	"D21S2048E, ES1, GT335, HES1, KNP-I, KNP-Ia, KNPH, KNPI"	ENSG00000160221	"Chromosome 21 open reading frame 33"	P30042	21	44133605-44210114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 29.2;Melanocytes: 38.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 43.8;U-266/70: 37.2;U-266/84: 31.0"									HPA018517	Supported		Approved	Centrosome,Mitochondria	"Intracellular and membrane"	NA	NA		1800000	Mitochondria	Centrosome	"HPA018517: AB_2669899"	"unprognostic (9.61e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.54e-3)"	"unprognostic (6.57e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.61e-3)"	"unprognostic (9.43e-2)"	"unprognostic (4.60e-3)"	"unprognostic (1.97e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.30e-2)"	16.0	9.6	9.1	6.1	11.4	2.2	7.2	7.9	16.6	5.1	11.7	11.6	12.4	3.0	6.6	22.8	7.6	7.3	5.2	29.2	8.4	8.7	31.6	36.8	8.5	9.9	10.9	9.2	6.7	15.7	2.0	6.5	5.6	8.3	11.0	1.9	6.6	8.8	8.0	45.9	13.4	7.7	7.6	7.3	8.9	13.7	11.8	5.1	5.8	7.1	21.0	15.2	5.1	4.7	22.5	12.3	8.9	20.7	14.7	15.6	23.9	0.4	1.6	0.9	0.2	9.5	9.1	14.2	18.5	10.4	14.6	11.1	22.2	0.2	43.8	0.3	0.1	0.6	0.2	0.1	8.7	6.5	9.6	21.3	1.2	3.6	11.9	10.6	0.6	0.3	0.1	0.9	4.0	0.7	7.4	0.7	10.6	8.3	13.8	5.0	1.6	0.5	1.2	0.4	1.6	0.6	0.4	0.1	15.5	0.9	0.3	14.6	0.2	0.2	0.5	14.2	0.3	1.0	1.5	9.0	5.6	0.3	11.0	0.1	37.2	31.0	0.9	0.6	2.9	6.7	8.9	11.3	6.8	13.0	13.3	11.3	22.5	15.5	15.6	4.6	21.6	14.8	12.8	5.1	14.7	20.7	12.3	14.6	23.9	9.1	11.4	7.9	16.6	8.4	8.7	10.9	9.2	8.3	5.1	6.0	3.5	14.3	0.4	14.5	1.9	0.0	17.8	8.1	3.4	0.0	0.0	2.1	0.0	0.0	1.9	2.9	10.6	0.0	0.0	1.6	4.3	0.5	9.2	2.4	8.1	0.0	7.5	16.5	29.2	1.4	9.2	6.0	38.8	0.0	13.3	7.8	0.0	11.5	16.3	0.0	1.5	12.9	0.0	5.2	12.4	12.7	2.2	15.4	27.5	0.1
CAMK2N2	CaM-KIIN	ENSG00000163888	"Calcium/calmodulin dependent protein kinase II inhibitor 2"	Q96S95	3	184259213-184261463	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"adrenal gland: 14.2;brain: 38.3;pancreas: 37.0;pituitary gland: 12.5"	"Cell type enriched"	"Detected in some"	11	"Horizontal cells: 58.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 11.3;REH: 19.0;SCLC-21H: 20.0;U-138 MG: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050835, HPA075200"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"HPA050835: AB_2681253, HPA075200: "	"unprognostic (7.28e-2)"	"prognostic favorable (9.77e-4)"	"unprognostic (1.24e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.98e-2)"	"unprognostic (9.72e-3)"	"unprognostic (5.17e-9)"	"unprognostic (3.47e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.76e-3)"	1.3	14.2	22.2	1.3	9.6	1.1	1.3	29.7	38.3	1.3	1.3	3.2	0.0	1.4	1.2	1.2	1.2	1.3	1.3	1.2	12.3	32.7	1.3	1.7	1.2	1.2	18.0	8.2	1.1	37.0	2.0	12.5	1.3	25.1	1.4	1.3	1.1	1.2	1.4	1.1	1.2	1.4	1.4	9.3	1.2	1.7	1.3	4.5	0.0	1.3	0.0	1.2	1.2	0.0	0.0	0.5	0.0	0.2	0.0	0.3	0.0	11.3	0.2	1.4	0.6	0.4	0.4	1.0	0.3	4.2	2.7	2.8	0.4	0.5	0.4	2.8	0.2	5.5	1.5	0.7	0.5	1.5	9.3	0.4	0.3	0.2	0.4	0.1	0.2	1.4	0.3	0.7	0.4	1.9	0.6	0.0	0.3	0.0	3.3	0.4	6.0	0.1	0.1	8.1	0.2	3.7	19.0	5.5	1.6	0.6	2.2	20.0	4.3	1.8	0.5	0.1	0.1	6.1	0.1	0.0	20.8	9.1	1.9	3.3	2.2	3.3	2.7	4.8	1.2	1.7	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	22.2	9.6	29.7	38.3	12.3	32.7	18.0	8.2	25.1	4.5	0.0	0.0	0.0	0.0	0.0	5.3	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.6	0.0	0.0	0.1	0.0	0.0	0.0	58.8	3.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.8	1.0	0.0	0.0	0.0	4.8	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0
CAMSAP3	"KIAA1543, Nezha, PPP1R80"	ENSG00000076826	"Calmodulin regulated spectrin associated protein family member 3"	Q9P1Y5	19	7595902-7618304	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 33.9"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 31.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 20.1;Hep G2: 11.4;SK-BR-3: 9.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043830, HPA062149"	Enhanced		Approved	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"HPA043830: AB_10795879, HPA062149: AB_2684698"	"unprognostic (3.83e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.67e-2)"	"unprognostic (7.90e-3)"	"unprognostic (3.66e-1)"	"unprognostic (3.87e-3)"	"unprognostic (7.00e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.41e-1)"	"prognostic favorable (7.55e-7)"	"unprognostic (2.16e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.59e-3)"	0.8	2.8	8.0	1.9	9.2	0.9	4.1	12.0	15.5	4.5	11.4	0.8	13.5	20.9	1.5	8.0	14.7	4.8	7.6	0.9	5.2	4.8	9.7	14.2	4.5	1.1	2.6	6.5	1.0	15.7	4.2	6.2	3.6	7.0	6.7	4.1	8.8	22.1	16.0	1.1	33.9	17.7	1.0	1.0	1.1	14.5	9.1	1.1	0.9	9.6	2.5	5.7	4.1	6.9	0.0	0.1	0.0	0.0	0.0	0.6	0.0	8.4	1.4	0.2	0.7	0.0	0.0	1.6	0.0	0.0	0.0	0.0	20.1	4.5	2.3	3.6	0.0	0.9	7.5	3.3	2.2	0.0	1.5	7.7	0.0	0.3	11.4	0.0	0.0	3.5	0.0	4.3	0.0	0.3	0.3	0.0	3.4	0.7	0.0	0.0	9.6	0.1	0.1	5.2	6.2	3.7	0.5	0.0	2.8	1.5	4.5	6.5	6.9	1.0	9.8	0.0	1.3	8.2	1.3	0.0	0.0	1.6	0.0	0.3	4.0	0.7	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	8.0	9.2	12.0	15.5	5.2	4.8	2.6	6.5	7.0	1.1	8.9	19.2	0.0	2.4	8.8	22.3	0.8	17.8	0.0	4.5	8.7	0.0	0.4	3.3	5.2	4.4	0.6	31.9	0.0	10.2	0.6	0.3	9.0	5.7	20.3	0.2	9.5	12.6	0.6	1.3	2.7	1.4	0.4	0.0	0.0	18.0	1.3	11.5	21.0	0.0	11.3	12.8	0.0	0.7	0.5	1.7	16.6	0.5	0.9	14.0	4.3
CAPN7	PalBH	ENSG00000131375	"Calpain 7"	Q9Y6W3	3	15206152-15252918	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Rod photoreceptor cells: 99.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004745, HPA046617"	Uncertain		Approved	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA004745: , HPA046617: AB_2679721"	"unprognostic (2.70e-2)"	"unprognostic (2.79e-1)"	"prognostic favorable (4.85e-5)"	"unprognostic (1.85e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.22e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.12e-3)"	"unprognostic (3.24e-2)"	"unprognostic (7.84e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.05e-2)"	16.3	15.0	9.7	12.8	13.4	10.5	18.9	21.7	13.7	18.6	15.5	11.1	14.3	11.8	17.6	15.9	13.4	16.7	10.4	13.8	9.2	8.9	14.8	17.6	17.9	20.0	11.4	8.4	20.6	15.9	20.4	29.0	14.7	11.7	14.7	11.7	15.9	15.9	12.7	33.7	14.9	14.5	19.5	14.1	12.1	15.2	12.1	12.3	19.3	22.6	11.1	14.5	17.7	14.5	6.6	5.1	8.7	7.0	5.8	10.0	5.0	8.7	11.5	9.6	6.0	16.9	13.2	32.8	11.3	13.0	14.1	10.8	8.2	6.3	15.1	7.9	12.8	8.7	6.1	14.1	14.5	12.3	14.4	11.1	18.9	16.2	10.8	12.6	15.1	9.6	9.0	21.2	18.3	9.1	13.4	10.0	14.6	18.2	15.9	13.6	12.7	10.7	6.3	9.2	12.7	11.3	6.2	16.0	10.4	10.5	16.0	7.8	10.1	18.4	10.0	12.5	12.8	17.6	15.9	8.9	12.8	9.7	16.5	13.1	11.1	22.0	7.7	11.6	11.1	11.0	6.3	5.4	8.7	6.4	4.4	10.0	6.6	7.0	5.2	5.1	5.9	9.6	8.8	3.2	5.8	7.0	4.3	5.1	5.0	9.7	13.4	21.7	13.7	9.2	8.9	11.4	8.4	11.7	12.3	11.9	17.6	15.2	14.2	19.1	41.7	27.4	7.6	45.5	27.3	1.8	53.0	17.3	8.3	10.3	11.3	16.8	10.2	23.3	14.8	10.3	16.0	16.9	15.1	14.3	10.6	52.4	20.1	15.4	12.4	11.7	23.0	15.2	20.3	12.6	9.8	37.3	10.8	7.0	24.8	12.2	99.8	38.8	22.8	22.4	14.7	20.3	21.9	17.0	10.3	7.3
CCDC92	FLJ22471	ENSG00000119242	"Coiled-coil domain containing 92"	Q53HC0	12	123918660-123972831	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 64.8;Sertoli cells: 71.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038560, HPA057580"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			Centrosome	Nucleoplasm	"HPA038560: AB_10672717, HPA057580: AB_2683476"	"unprognostic (4.77e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (7.15e-4)"	"unprognostic (4.82e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.01e-2)"	"unprognostic (5.69e-2)"	"unprognostic (7.14e-2)"	"prognostic favorable (4.59e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.07e-3)"	"unprognostic (4.99e-2)"	19.3	11.1	35.2	9.4	24.6	3.8	16.3	17.0	34.5	11.4	11.7	16.4	6.0	14.4	11.8	18.6	8.9	12.6	10.6	23.6	33.6	26.5	11.5	11.0	20.1	8.2	27.2	23.0	13.0	11.8	18.3	14.9	17.3	34.2	11.2	7.8	13.6	9.0	12.9	22.3	7.7	14.2	14.2	22.4	9.4	11.1	24.0	13.0	8.0	15.3	4.9	6.6	10.7	12.7	1.7	1.3	4.6	1.3	1.3	3.7	1.8	4.0	4.6	2.3	4.0	15.2	8.4	4.1	6.8	12.9	3.8	4.1	2.4	1.2	1.9	2.4	8.5	2.2	2.8	2.5	1.7	2.6	12.6	5.9	2.5	1.6	1.5	8.1	0.4	9.7	4.7	7.8	4.8	3.0	11.8	10.6	4.4	2.5	0.9	3.4	2.7	2.4	4.4	1.0	1.9	10.1	3.1	1.3	0.5	5.2	4.2	4.4	6.3	3.3	1.7	4.6	5.7	4.8	2.2	10.5	7.7	1.7	4.9	2.3	3.2	1.7	0.6	6.1	3.4	3.2	4.6	1.3	1.9	2.3	0.7	3.7	1.6	3.0	3.5	1.0	1.7	2.3	2.8	1.2	1.3	0.1	1.3	0.5	1.8	35.2	24.6	17.0	34.5	33.6	26.5	27.2	23.0	34.2	13.0	17.9	22.0	4.7	6.2	3.4	17.5	37.2	25.5	9.4	11.4	17.4	13.7	3.8	6.6	12.6	64.8	12.7	8.0	0.0	9.4	2.1	13.8	7.0	19.7	11.9	15.4	20.6	4.6	11.1	8.6	48.4	12.7	9.5	8.5	10.8	7.2	12.8	12.3	2.9	16.3	27.1	12.1	71.1	17.6	44.0	5.3	2.6	4.7	7.9	5.2	6.0
CDIP1	"C16orf5, CDIP, LITAFL"	ENSG00000089486	"Cell death inducing p53 target 1"	Q9H305	16	4510675-4538828	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 75.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 49.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049352	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			Centrosome	Nucleoplasm	"HPA049352: AB_2680724"	"unprognostic (6.38e-3)"	"unprognostic (3.70e-3)"	"unprognostic (2.95e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.74e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.26e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.03e-2)"	"prognostic favorable (2.14e-5)"	"unprognostic (9.05e-2)"	"prognostic favorable (1.14e-6)"	"unprognostic (1.43e-2)"	"unprognostic (3.51e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.65e-2)"	17.7	14.2	36.8	6.9	41.6	5.1	8.2	36.4	54.6	13.6	9.5	16.3	2.7	30.0	13.4	4.4	8.0	10.9	9.5	25.0	33.8	37.1	23.7	13.2	9.6	8.2	34.2	38.9	18.7	22.9	10.4	19.3	8.5	26.3	13.2	4.1	7.8	10.8	14.7	34.0	9.1	24.2	8.7	20.7	12.0	9.2	10.1	15.7	13.0	10.6	6.7	6.9	7.8	6.3	8.7	9.2	19.3	19.2	14.3	15.9	7.2	3.8	1.6	5.5	1.6	0.4	0.0	0.1	6.0	0.9	5.9	5.1	9.5	1.6	0.2	6.1	4.9	1.8	0.1	5.0	21.2	1.0	13.4	9.5	18.0	6.4	24.6	4.0	8.6	11.3	5.9	11.0	5.3	0.9	1.1	4.7	8.7	0.3	4.9	6.7	0.4	6.7	11.3	12.2	4.3	4.7	25.5	4.9	49.0	1.2	0.1	16.6	7.2	12.0	0.5	7.5	2.5	2.2	4.8	0.2	3.1	9.0	2.1	0.2	13.1	12.1	18.1	0.1	8.8	2.0	3.2	7.9	19.3	15.9	12.5	8.6	8.7	5.7	8.9	7.6	8.3	11.4	9.7	6.2	14.3	19.2	9.2	9.1	7.2	36.8	41.6	36.4	50.3	33.8	37.1	34.2	38.9	26.3	15.7	14.9	6.5	15.6	20.1	26.3	67.6	23.4	2.5	0.0	6.8	15.7	11.8	1.2	44.7	11.0	75.7	16.0	12.0	0.0	7.9	1.3	12.5	12.9	23.0	15.6	16.4	66.7	9.2	24.5	12.4	17.9	16.7	12.3	13.5	2.8	2.3	40.4	9.9	14.4	15.6	47.3	13.1	6.5	13.7	6.4	19.0	13.0	5.6	23.0	3.3	10.6
CDK5RAP2	"C48, CEP215, FLJ10867, MCPH3"	ENSG00000136861	"CDK5 regulatory subunit associated protein 2"	Q96SN8	9	120388869-120580170	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	"Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035820, HPA035821, HPA046529, CAB079753"	Approved		Enhanced	"Cell Junctions,Centrosome"		NA	NA			Centrosome	"Cell Junctions"	"CAB079753: AB_2665827, HPA035820: AB_10671939, HPA035821: , HPA046529: AB_2679688"	"unprognostic (7.72e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.84e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.63e-2)"	"unprognostic (6.88e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.41e-2)"	10.3	12.0	12.3	13.0	23.2	21.3	15.2	20.0	19.9	15.7	13.0	22.0	9.1	5.8	11.9	8.4	12.8	11.2	10.2	18.3	14.9	7.9	7.8	20.1	10.9	14.0	21.6	9.8	18.6	9.3	17.0	20.3	8.8	15.1	14.5	9.2	10.6	21.3	11.6	41.7	16.0	10.2	15.6	14.2	11.2	12.3	19.8	25.7	23.4	11.9	8.5	14.9	12.8	16.5	7.4	2.7	13.7	5.2	4.7	4.5	1.9	9.5	16.9	23.5	14.1	10.1	15.0	12.6	12.4	9.5	14.1	13.2	13.2	12.7	17.9	5.7	12.1	9.6	21.2	18.5	14.2	13.6	14.3	7.4	15.3	30.9	23.5	9.5	18.9	10.2	27.0	9.5	12.4	16.5	10.6	12.2	21.7	14.1	15.6	18.4	21.6	20.2	12.1	21.7	20.5	12.8	19.8	28.1	8.4	10.0	7.7	15.4	17.7	21.5	11.8	14.3	10.6	27.8	13.0	8.1	12.2	13.4	14.3	14.0	11.4	15.8	20.1	12.7	12.1	25.7	13.7	2.2	3.5	4.5	2.1	4.4	5.7	4.2	4.1	1.3	7.4	3.5	3.5	2.9	4.7	5.2	2.7	3.3	1.9	12.3	23.2	20.0	19.9	14.9	7.9	21.6	9.8	15.1	25.7	26.8	36.1	14.1	10.3	6.3	24.3	48.4	15.3	41.5	20.5	1.8	15.7	9.3	6.6	10.8	27.1	10.3	5.9	23.3	12.4	10.0	11.9	11.1	16.2	18.8	9.3	17.5	8.1	6.7	10.0	25.6	20.4	12.9	11.8	13.6	10.2	23.9	9.9	5.9	21.9	3.6	28.0	32.3	13.2	57.4	36.8	5.9	6.1	13.8	6.7	7.3
CDKL2	"KKIAMRE, P56"	ENSG00000138769	"Cyclin dependent kinase like 2"	Q92772	4	75578005-75630716	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 27.7"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 55.4;Ciliated cells: 28.1;Spermatocytes: 46.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.6"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"A-431: 5.7;HEK 293: 3.8;HHSteC: 4.4;RPTEC TERT1: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040672			Approved	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"HPA040672: AB_10794744"	"unprognostic (2.07e-1)"	"unprognostic (9.96e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.80e-5)"	"unprognostic (3.43e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.88e-15)"	"unprognostic (5.91e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.52e-2)"	0.7	2.4	7.1	1.2	11.1	0.7	1.2	7.7	13.2	1.7	2.0	6.2	0.0	1.0	1.7	2.3	2.3	4.1	1.4	1.3	5.1	6.7	11.8	0.7	9.2	1.3	7.1	7.0	3.8	1.6	5.7	8.9	0.7	12.5	2.0	2.4	3.4	1.2	2.0	0.7	0.9	0.9	1.5	7.4	0.9	1.5	27.7	6.1	0.0	6.9	0.0	2.0	1.1	0.9	0.4	0.0	0.2	0.0	0.0	1.6	0.1	5.7	0.7	0.3	0.0	0.3	0.3	0.0	0.3	1.8	2.4	2.0	0.5	1.2	0.1	0.9	0.1	2.3	0.8	0.0	0.5	2.3	0.2	3.8	0.0	0.2	0.0	4.4	0.0	0.1	1.5	2.1	0.4	0.8	1.9	0.1	0.0	0.0	0.4	0.9	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	8.2	0.3	3.1	2.5	0.0	0.0	1.2	2.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	2.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.4	1.6	0.0	0.0	0.6	0.5	0.2	0.0	0.0	0.0	1.2	0.1	7.1	11.1	7.7	13.2	5.1	6.7	7.1	7.0	12.5	6.1	23.8	55.4	0.0	0.4	0.1	16.6	0.8	0.0	28.1	7.9	8.7	3.9	0.0	6.6	2.0	24.5	0.0	0.0	0.0	0.2	0.5	0.2	0.3	1.1	0.0	0.1	9.5	1.7	0.6	0.0	16.4	1.7	0.5	1.7	0.0	0.2	10.4	0.1	0.0	1.1	20.7	19.5	0.0	0.0	46.8	1.7	0.3	0.2	1.0	2.6	0.1
CEP164	"KIAA1052, NPHP15"	ENSG00000110274	"Centrosomal protein 164"	Q9UPV0	11	117314557-117413268	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, DNA damage, DNA repair, Mitosis"		"Ciliopathy, Disease mutation, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 428.0;Early spermatids: 226.1;Late spermatids: 212.9;Rod photoreceptor cells: 288.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037605, HPA037606"	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"HPA037605: AB_10672908, HPA037606: AB_10672498"	"unprognostic (1.92e-1)"	"unprognostic (8.99e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (2.40e-5)"	"unprognostic (1.82e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.90e-1)"	"prognostic favorable (5.93e-4)"	"unprognostic (6.54e-2)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (1.30e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.13e-1)"	"unprognostic (7.93e-2)"	7.1	6.8	7.8	11.2	10.4	7.0	7.2	17.4	7.8	10.5	6.8	9.1	11.2	4.7	17.4	9.4	9.7	12.9	12.1	4.6	6.9	6.8	7.1	7.2	7.3	7.7	7.4	8.3	13.9	28.1	10.8	19.1	5.1	8.2	7.4	5.8	16.4	6.9	7.6	3.1	8.3	6.2	11.5	10.4	9.7	6.3	29.7	8.3	10.8	9.6	5.0	14.4	8.0	8.0	18.0	21.1	36.5	16.6	11.8	21.4	4.3	9.0	12.6	9.3	18.4	9.4	16.0	3.0	17.9	10.1	12.9	12.7	15.5	14.7	17.9	13.0	11.0	12.7	12.0	10.3	10.5	11.1	17.7	8.5	5.4	12.4	4.9	13.8	7.7	12.1	11.1	9.0	19.5	19.1	11.6	16.7	8.9	14.6	11.7	10.1	7.8	7.1	7.0	6.6	5.9	13.7	9.6	11.1	7.0	5.7	7.8	10.8	15.7	14.3	8.7	10.3	10.9	12.0	9.1	18.0	15.4	9.6	14.8	16.4	4.2	5.0	10.6	7.5	8.8	10.2	30.7	15.7	9.4	15.9	12.9	10.1	15.2	20.0	17.9	5.8	18.0	18.9	15.1	36.5	11.8	16.6	21.1	21.4	4.3	7.8	10.4	17.4	7.8	6.9	6.8	7.4	8.3	8.2	8.3	6.0	16.2	12.3	9.5	6.8	78.2	4.2	7.6	37.5	11.4	10.4	428.0	3.8	1.7	9.8	226.1	15.7	5.1	0.0	12.7	5.7	11.2	7.3	18.5	8.1	11.2	69.9	14.9	8.6	6.9	212.9	22.2	10.3	5.0	18.0	8.8	21.5	9.9	5.8	15.9	4.5	288.7	0.0	13.7	36.7	17.4	7.0	1.8	15.9	9.3	4.7
CEP192	"FLJ10352, KIAA1569, PPP1R62"	ENSG00000101639	"Centrosomal protein 192"	Q8TEP8	18	12991362-13125052	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039392, HPA040503"	Uncertain		Supported	Centrosome,Cytosol		Yes	No			"Centrosome, Cytosol"		"HPA039392: AB_10697549, HPA040503: AB_10670919"	"unprognostic (6.94e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.13e-3)"	"unprognostic (6.87e-3)"	"unprognostic (5.83e-3)"	"unprognostic (2.20e-2)"	"unprognostic (9.00e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.66e-3)"	7.6	6.5	7.9	14.9	11.8	16.3	8.3	14.5	11.8	8.8	7.7	11.1	7.1	6.7	13.6	9.3	7.6	8.8	9.9	7.1	8.1	4.7	6.9	6.1	8.7	11.0	8.7	11.8	17.4	9.5	10.4	11.1	7.8	11.8	8.0	9.4	7.9	10.4	6.6	6.2	8.2	9.6	9.5	7.6	8.4	8.2	16.4	9.8	18.3	11.1	6.0	12.2	12.1	8.6	3.9	1.8	2.1	4.9	0.9	3.5	1.0	9.9	5.4	14.7	7.6	6.4	10.0	4.7	7.0	9.2	11.1	11.8	7.4	4.4	11.2	4.7	7.0	8.0	4.9	12.7	6.6	13.1	4.4	4.5	10.2	8.2	3.8	3.3	16.1	7.9	6.9	2.5	9.2	8.5	6.3	9.0	8.1	14.0	7.5	8.6	5.0	13.9	7.0	4.6	18.5	3.3	12.0	11.5	5.8	3.8	10.1	10.7	6.0	11.1	5.5	3.4	7.2	4.4	8.4	9.0	8.7	20.6	9.9	9.5	5.1	7.3	12.8	5.6	7.3	8.4	1.5	2.1	1.5	3.2	1.5	2.4	1.8	2.1	2.0	0.9	3.9	2.3	3.5	2.1	0.9	4.9	1.8	1.8	1.0	7.9	11.8	14.5	11.8	8.1	4.7	8.7	11.8	11.8	9.8	8.9	10.9	5.9	3.9	1.6	11.7	21.4	7.6	4.0	10.3	7.0	21.6	3.5	0.0	3.9	21.9	3.5	4.9	0.0	3.1	2.7	3.0	5.3	2.3	4.7	3.8	11.1	0.0	7.4	9.4	9.5	9.5	5.4	1.7	11.8	9.1	6.6	4.0	5.8	13.1	1.1	16.3	25.8	3.5	19.1	21.3	2.8	1.6	10.1	6.4	7.1
CHODL	"C21orf68, FLJ12627, MT75, PRED12"	ENSG00000154645	Chondrolectin	Q9H9P2	21	17901263-18267373	"Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 59.6"	"Cell type enhanced"	"Detected in some"	7	"Basal keratinocytes: 3.5;Early spermatids: 2.2;Late spermatids: 3.1;Leydig cells: 2.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basal ganglia: 6.8;hypothalamus: 8.2;pons and medulla: 8.6"	"Cell type enriched"	"Detected in some"	4	"MAIT T-cell: 4.9"	"Lineage enriched"	"Detected in single"	8	"T-cells: 4.9"	"Cell line enhanced"	"Detected in some"		"U-266/70: 4.1;U-266/84: 10.0;U-87 MG: 11.6"	"Group enriched"	"Detected in many"	4	"basal ganglia: 4.1;hypothalamus: 14.3;pons and medulla: 11.4"	"Region enriched"	"Detected in all"	6	"olfactory region: 208.8"	"HPA017282, HPA057559"	Enhanced		Approved	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA017282: AB_1846687, HPA057559: "	"unprognostic (3.91e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.37e-2)"	"prognostic unfavorable (1.18e-6)"	"unprognostic (6.74e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.79e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.02e-1)"	2.3	1.9	0.8	2.1	6.8	0.0	1.1	0.5	0.8	0.3	2.3	0.5	4.0	1.5	0.7	1.1	1.4	0.5	0.8	3.4	1.3	8.2	4.7	0.0	0.3	0.3	1.4	0.8	0.5	0.0	0.5	2.1	1.7	8.6	8.2	3.4	1.4	0.6	1.8	1.3	2.1	0.9	0.4	2.2	12.3	0.7	59.6	1.1	0.1	0.9	4.3	1.1	1.1	1.1	0.4	0.6	0.0	0.1	0.4	4.9	0.3	0.0	0.0	1.0	0.0	0.0	0.2	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.2	0.1	0.0	2.5	0.2	0.4	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.1	0.0	0.6	0.1	2.1	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.3	0.0	1.1	0.9	1.3	0.0	0.1	0.1	0.1	0.1	0.0	0.0	4.1	10.0	0.3	11.6	0.0	0.1	0.0	0.0	0.0	0.7	0.0	4.9	0.4	0.3	0.8	0.1	0.2	0.0	1.1	0.0	0.4	0.1	0.6	1.0	0.3	0.8	6.8	0.5	0.8	1.3	8.2	1.4	0.8	8.6	1.1	0.0	0.0	0.0	0.6	3.5	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.2	2.2	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	2.8	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.2	1.1	1.7	1.9	0.5	1.0	0.0	0.3
CHST15	"BRAG, GALNAC4S-6ST, KIAA0598"	ENSG00000182022	"Carbohydrate sulfotransferase 15"	Q7LFX5	10	124007666-124093607	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ito cells: 49.7;Kupffer cells: 47.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 29.4"	"Group enriched"	"Detected in many"	10	"granulocytes: 29.4;monocytes: 15.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 27.6;REH: 36.3;U-266/70: 25.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017584	Approved		Approved	Centrosome,Cytosol		NA	NA		560000	Cytosol	Centrosome	"HPA017584: AB_1849437"	"unprognostic (1.19e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.40e-2)"	"unprognostic (7.62e-3)"	"unprognostic (7.90e-2)"	"unprognostic (8.16e-2)"	"prognostic unfavorable (2.22e-7)"	"unprognostic (6.47e-3)"	"unprognostic (7.80e-2)"	"unprognostic (4.63e-3)"	"unprognostic (5.26e-3)"	16.4	10.0	8.7	17.0	20.6	5.7	10.7	3.4	17.9	9.8	15.4	6.6	4.0	8.8	8.6	10.8	11.3	13.1	11.7	6.4	11.3	5.3	9.0	11.9	13.9	35.4	6.5	9.6	35.0	12.6	2.9	7.7	5.9	9.2	8.5	8.3	14.4	8.2	13.4	11.0	8.3	12.5	9.5	9.0	31.5	11.4	4.8	8.7	2.8	19.3	6.1	12.6	12.5	12.0	2.1	2.0	29.4	15.4	0.0	0.1	3.2	12.8	8.7	3.2	0.7	3.2	1.7	0.0	2.6	3.5	1.4	2.0	0.2	7.0	0.0	8.5	10.7	0.9	14.7	0.6	8.5	1.2	0.0	2.4	0.0	3.9	6.4	1.0	0.0	16.6	1.0	9.8	4.0	3.4	3.5	2.8	0.0	0.0	27.6	7.0	7.1	0.0	0.0	2.8	1.9	0.0	36.3	4.4	8.5	7.1	1.2	0.3	0.7	7.0	3.9	0.0	8.4	2.9	0.0	3.3	0.3	0.1	10.1	0.4	25.1	6.0	6.9	0.1	0.0	0.0	0.0	8.8	6.2	0.0	14.0	0.0	2.0	0.0	0.0	1.8	2.1	0.1	0.0	29.4	0.0	15.4	2.0	0.1	3.2	8.7	20.6	3.4	17.9	11.3	5.3	6.5	9.6	9.2	8.7	20.8	11.1	9.7	14.5	14.9	4.4	2.2	7.6	9.4	9.1	19.2	0.0	1.5	0.0	8.2	24.2	10.8	0.0	0.0	0.6	1.9	2.7	14.0	5.7	6.4	9.4	0.0	1.7	49.7	47.8	27.7	9.5	23.2	1.7	1.8	0.0	0.1	5.9	0.0	1.8	0.3	0.3	19.4	11.3	8.4	9.2	10.2	0.8	2.2	0.0	15.2
CLHC1	"C2orf63, FLJ31438"	ENSG00000162994	"Clathrin heavy chain linker domain containing 1"	Q8NHS4	2	55174791-55232563	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 44.2;Early spermatids: 38.5;Late spermatids: 28.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA045418, HPA053557"	Uncertain		Approved	"Nucleoli fibrillar center,Centrosome"		NA	NA			"Nucleoli fibrillar center, Centrosome"		"HPA045418: AB_10962144, HPA053557: AB_2682188"	"unprognostic (1.60e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.43e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.68e-2)"	"unprognostic (4.91e-2)"	"unprognostic (6.41e-3)"	"unprognostic (1.03e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.54e-4)"	"unprognostic (6.36e-2)"	"unprognostic (1.05e-4)"	"unprognostic (1.84e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.19e-2)"	"prognostic favorable (2.15e-4)"	4.8	5.7	10.4	3.6	8.7	3.5	6.7	15.7	11.9	6.0	5.3	12.9	9.3	3.9	8.5	9.8	5.5	9.5	6.2	4.6	8.2	5.1	5.2	3.5	5.3	6.6	6.0	8.3	7.4	5.5	8.4	23.6	6.9	8.9	9.1	6.6	8.9	5.8	8.9	3.0	9.6	5.6	7.1	12.0	7.2	4.9	23.2	8.8	10.1	8.3	1.6	5.2	6.6	6.1	1.3	2.9	4.0	2.0	3.2	2.1	1.0	4.3	3.2	8.2	4.9	3.4	4.6	7.2	5.7	5.4	2.9	2.7	6.3	4.0	6.4	3.4	2.6	3.5	6.6	3.5	4.9	6.0	5.7	4.1	9.2	9.6	5.7	3.7	5.6	4.6	6.6	4.0	3.6	8.3	8.1	2.8	5.8	4.7	3.8	3.3	3.5	4.1	6.2	3.0	1.7	1.3	5.0	4.7	4.0	4.6	5.0	9.5	5.8	3.3	5.4	5.4	6.7	4.0	3.1	8.4	7.3	4.9	3.4	4.0	7.5	1.9	3.7	5.4	5.7	1.8	1.2	0.6	4.0	0.9	2.0	0.1	1.2	1.7	0.9	1.0	1.3	2.1	1.0	0.4	3.2	1.6	2.9	1.1	1.0	10.4	8.7	15.7	11.9	8.2	5.1	6.0	8.3	8.9	8.8	0.0	2.6	2.4	4.8	1.6	11.3	3.7	0.0	44.2	10.3	3.5	15.7	2.8	5.0	3.7	38.5	2.2	1.1	0.0	1.2	1.5	2.5	4.0	0.0	0.2	2.0	9.5	7.0	6.2	4.7	28.8	3.7	2.9	1.7	1.0	2.0	8.0	1.0	0.0	5.3	2.4	20.6	0.0	1.8	20.2	2.1	1.9	2.9	1.0	3.2	3.6
CNTRL	"CEP1, CEP110"	ENSG00000119397	Centriolin	Q7Z7A1	9	121074863-121177610	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Ciliated cells: 156.6;Spermatocytes: 334.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 35.4"	"Low region specificity"	"Detected in all"							"HPA020468, HPA020480, HPA051583"	Approved		Supported	Centrosome,Cytosol		NA	NA			Centrosome	Cytosol	"HPA020468: AB_2670455, HPA020480: AB_2670457, HPA051583: AB_2681542"	"unprognostic (4.33e-3)"	"unprognostic (2.89e-3)"	"unprognostic (2.09e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (9.21e-5)"	"unprognostic (1.05e-2)"	"unprognostic (3.22e-3)"	"unprognostic (3.74e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.47e-2)"	"unprognostic (3.60e-3)"	"unprognostic (9.83e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.13e-2)"	7.7	4.7	5.5	22.2	11.7	24.0	6.8	10.9	8.7	8.4	5.5	4.9	5.9	3.8	7.3	6.4	5.6	8.4	5.1	4.4	6.6	4.3	4.0	3.8	9.3	20.3	8.1	4.1	10.6	5.2	4.0	17.3	5.8	7.0	7.2	5.5	4.4	6.3	8.6	2.8	5.2	8.8	5.7	9.7	14.8	7.1	30.2	9.8	26.7	6.2	4.2	19.2	8.6	7.1	12.7	10.5	15.0	6.9	4.8	10.4	2.5	5.4	3.6	10.2	7.3	1.5	2.3	1.8	3.8	2.8	3.0	2.6	2.1	6.0	25.1	1.5	2.7	5.4	11.5	3.4	2.3	4.9	15.1	2.6	13.1	6.7	2.5	2.1	35.4	15.9	1.4	1.7	3.1	7.6	1.3	6.5	10.4	8.4	14.3	2.9	3.5	13.9	12.1	3.5	7.0	3.0	13.1	15.4	7.2	1.4	2.5	3.8	5.8	12.9	2.3	2.9	1.8	4.9	17.0	4.8	3.2	5.5	4.9	7.0	10.0	10.9	17.0	2.6	14.6	7.2	12.2	6.9	15.0	7.5	4.5	5.7	10.8	7.7	5.5	3.4	12.7	9.3	6.6	2.7	4.8	5.8	10.5	10.4	2.5	5.5	11.7	10.9	8.7	6.6	4.3	8.1	4.1	7.0	9.8	26.8	26.2	35.1	12.7	3.0	28.2	7.0	5.1	156.6	48.9	3.5	35.3	1.5	3.3	3.8	56.2	14.4	2.1	0.0	5.2	2.1	5.9	3.8	49.9	2.0	22.5	28.6	8.1	12.3	34.6	27.0	12.7	37.9	8.5	22.6	7.3	7.0	5.3	3.5	11.3	1.1	64.1	38.8	5.1	334.4	72.6	5.0	0.7	29.8	5.2	4.7
CNTROB	"LIP8, PP1221"	ENSG00000170037	"Centrobin, centriole duplication and spindle assembly protein"	Q8N137	17	7932101-7949918	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 51.2"	"Cell type enhanced"	"Detected in many"	7	"Spermatocytes: 40.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023319, HPA023320, HPA023321, HPA023325"	Approved		Supported	Centrosome,Cytosol		NA	NA			Centrosome	Cytosol	"HPA023319: AB_1852886, HPA023320: AB_1852888, HPA023321: AB_1852890, HPA023325: AB_1852892"	"unprognostic (5.73e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.26e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (9.88e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.48e-2)"	"unprognostic (8.63e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.79e-1)"	"unprognostic (2.16e-2)"	9.0	7.4	7.5	9.2	10.1	18.4	9.3	11.2	12.7	13.0	10.9	9.8	9.9	6.8	21.3	12.6	11.0	10.4	9.0	7.1	9.5	8.0	9.2	8.7	15.0	8.4	9.3	9.9	11.4	11.0	16.5	9.6	9.9	9.9	9.9	12.5	10.3	9.6	8.6	6.8	16.9	9.1	16.3	7.0	9.9	8.4	51.2	6.4	16.0	10.4	6.2	11.2	9.3	10.0	2.1	7.6	9.4	3.4	3.4	3.5	2.6	22.3	14.7	21.9	12.1	9.3	12.8	7.1	19.5	18.3	27.3	20.9	12.4	8.3	23.0	10.3	17.0	12.2	18.0	17.0	13.6	30.6	22.6	13.3	15.2	24.0	9.8	13.7	14.1	23.6	11.7	10.1	19.2	19.4	13.2	16.8	23.1	11.0	11.3	18.9	7.2	21.4	13.6	4.9	8.1	11.5	22.8	15.1	8.6	12.6	6.9	7.2	12.9	15.8	8.1	6.2	12.2	11.0	9.0	13.7	15.3	13.0	20.6	26.8	17.3	11.6	15.9	13.1	18.1	21.7	9.4	2.5	1.0	2.9	3.4	2.6	2.1	2.2	3.5	1.7	1.5	1.4	2.4	0.4	3.4	1.4	7.6	2.9	2.6	7.5	10.1	11.2	12.7	9.5	8.0	9.3	9.9	9.9	6.4	6.0	15.8	4.5	6.8	7.0	5.8	3.0	5.1	4.0	7.9	12.2	7.9	3.3	1.7	4.4	2.1	5.8	3.6	0.0	6.0	3.6	5.0	5.0	18.4	3.4	5.7	3.2	2.9	5.5	5.9	3.4	4.9	7.2	3.3	0.0	5.6	5.3	5.0	3.5	7.4	2.6	6.5	0.0	3.5	40.6	8.3	7.5	2.1	4.9	7.3	4.1
CRMP1	"DPYSL1, DRP-1"	ENSG00000072832	"Collapsin response mediator protein 1"	Q14194	4	5748084-5893058	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 63.1;pituitary gland: 23.0"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 117.0;Horizontal cells: 198.6;Muller glia cells: 68.8"	"Cancer enhanced"	"Detected in all"		"glioma: 37.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"naive B-cell: 2.5"	"Lineage enriched"	"Detected in single"	25	"B-cells: 2.5"	"Cell line enhanced"	"Detected in some"		"AF22: 20.8;HAP1: 29.8;NTERA-2: 21.6;REH: 56.6;RH-30: 33.4;SCLC-21H: 43.3;SH-SY5Y: 27.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035640, CAB037313"	Approved		Supported	Centrosome,Cytosol		NA	NA			Centrosome	Cytosol	"CAB037313: AB_1078571, HPA035640: AB_10670838"	"unprognostic (1.56e-1)"	"unprognostic (7.22e-2)"	"unprognostic (5.14e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.79e-1)"	"unprognostic (9.71e-2)"	"prognostic favorable (4.54e-4)"	"unprognostic (2.26e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.60e-3)"	1.8	8.2	24.2	2.5	21.7	0.7	1.0	32.0	63.1	3.3	2.0	5.9	0.1	1.5	11.7	0.7	2.7	4.3	4.3	2.6	22.2	23.9	2.4	0.9	4.2	1.8	9.9	18.1	6.9	4.8	0.9	23.0	4.6	12.3	3.0	1.9	4.6	2.6	3.1	1.0	3.3	2.5	11.6	4.7	1.4	3.5	2.8	4.5	0.0	2.4	0.9	1.3	2.9	1.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	20.8	0.7	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	7.0	0.5	29.8	0.0	0.0	0.5	0.2	0.0	1.0	0.1	0.3	0.0	0.1	0.2	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	21.6	0.0	0.6	56.6	33.4	5.0	0.0	0.0	43.3	27.4	0.0	0.1	0.3	14.6	0.2	0.0	1.7	1.0	7.2	0.6	0.6	3.8	0.5	0.0	2.5	0.2	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	21.7	32.0	34.2	22.2	23.9	9.9	18.1	12.3	4.5	0.0	1.4	0.0	0.0	0.3	117.0	0.8	0.0	0.0	0.0	0.0	17.7	0.1	0.0	0.0	1.0	2.7	0.0	0.0	0.0	0.1	3.1	0.4	0.0	0.0	0.4	198.6	2.4	0.0	0.0	3.8	0.6	0.0	1.7	0.0	0.0	68.8	0.7	0.0	0.4	0.0	20.1	6.5	2.5	0.6	9.8	0.1	0.2	0.0	0.0	0.0
CROCC	"ROLT, rootletin"	ENSG00000058453	"Ciliary rootlet coiled-coil, rootletin"	Q5TZA2	1	16740273-16972979	"Predicted intracellular proteins"	"Cell cycle, Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"salivary gland: 135.2"	"Cell type enriched"	"Detected in many"	4	"Rod photoreceptor cells: 111.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA021191, HPA021762"	Enhanced		Supported	"Plasma membrane,Centrosome"		NA	NA			"Plasma membrane, Centrosome"		"HPA021191: AB_1856395, HPA021762: AB_1856396"	"unprognostic (9.07e-3)"	"unprognostic (9.03e-2)"	"unprognostic (6.04e-2)"	"prognostic favorable (8.34e-5)"	"unprognostic (3.27e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.42e-3)"	"prognostic favorable (7.92e-4)"	"unprognostic (2.05e-1)"	"unprognostic (7.75e-2)"	"unprognostic (3.36e-3)"	"unprognostic (5.75e-2)"	"prognostic unfavorable (7.97e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.83e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.76e-3)"	5.0	3.8	3.2	3.2	7.0	2.1	2.5	12.9	3.0	3.9	2.8	5.4	2.2	2.4	5.1	2.4	3.2	9.9	2.3	2.1	4.6	3.5	2.4	1.8	3.9	3.2	2.1	2.5	5.0	4.2	3.0	3.6	2.2	11.3	3.3	0.6	30.6	135.2	2.9	8.2	14.4	3.1	1.8	2.3	6.4	3.5	1.9	4.3	2.1	2.5	2.3	1.8	2.9	3.8	1.1	0.6	1.7	0.8	1.3	2.8	0.6	4.1	1.7	3.2	3.2	2.3	2.1	1.3	3.0	1.0	1.0	1.1	0.2	1.9	10.9	2.8	1.2	0.3	5.0	0.8	2.2	0.1	0.9	5.8	5.0	5.3	0.8	3.9	0.3	5.1	1.8	5.2	0.9	0.9	1.7	1.6	7.9	0.7	2.8	0.3	3.5	3.3	1.2	11.6	0.9	2.7	3.1	4.2	3.7	0.7	1.2	9.9	10.6	3.2	2.1	9.7	1.0	4.2	1.4	4.4	2.8	3.7	7.0	2.3	5.0	3.6	2.2	2.8	0.7	3.3	0.0	0.4	1.7	1.6	0.8	2.8	0.7	1.3	1.3	0.2	1.1	1.1	0.9	0.1	1.3	0.3	0.6	1.3	0.6	3.2	7.0	12.9	3.0	4.6	3.5	2.1	2.5	11.3	4.3	0.0	5.8	0.5	4.2	5.6	20.9	3.2	2.5	14.7	3.4	5.2	25.5	1.1	0.0	4.8	3.5	6.8	0.7	0.0	2.0	5.8	4.5	2.1	1.1	2.4	2.0	3.2	3.5	6.7	2.2	1.9	17.8	2.2	5.0	2.8	3.7	11.9	3.2	2.3	12.0	1.3	111.2	0.0	9.2	1.4	13.2	4.4	0.9	3.8	2.5	1.4
CXorf56	FLJ22965	ENSG00000018610	"Chromosome X open reading frame 56"	Q9H5V9	X	119538149-119565408	"Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038245, HPA038617, HPA064831"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA038245: AB_10672407, HPA038617: AB_10674691, HPA064831: AB_2685364"	"prognostic unfavorable (3.45e-4)"	"unprognostic (3.88e-3)"	"unprognostic (7.82e-2)"	"unprognostic (1.03e-3)"	"unprognostic (8.92e-2)"	"unprognostic (7.74e-3)"	"unprognostic (6.38e-3)"	"unprognostic (3.89e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.68e-3)"	"unprognostic (9.26e-3)"	"unprognostic (4.68e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.90e-1)"	15.9	14.5	18.7	12.7	29.1	19.1	21.1	21.0	24.2	15.0	15.6	18.3	15.1	12.3	17.6	14.5	13.6	17.6	12.4	16.3	16.0	20.5	18.2	14.3	14.6	15.7	18.0	21.3	24.0	16.3	20.5	12.6	29.0	20.2	15.3	15.0	18.6	14.6	16.1	16.4	17.4	12.5	16.2	17.8	15.0	13.0	12.7	17.6	12.8	20.2	13.2	19.0	14.4	13.1	19.4	12.0	16.8	15.4	7.7	12.9	10.9	16.5	19.4	11.7	13.3	13.4	9.8	15.0	11.4	11.8	17.9	16.2	16.8	16.8	26.1	28.7	13.3	37.4	11.0	29.5	15.1	25.2	15.7	22.3	9.3	17.7	11.2	10.7	25.8	15.0	10.8	13.1	21.9	18.8	10.4	12.5	16.5	20.9	16.7	8.7	29.0	16.2	13.6	17.5	21.9	20.1	15.8	12.1	19.7	10.7	13.0	8.1	14.1	22.1	12.3	15.3	13.4	10.2	11.3	12.0	10.8	7.5	20.0	24.1	14.5	25.6	26.6	9.8	25.3	13.8	5.7	12.8	16.8	12.4	15.4	11.4	13.5	10.8	12.9	12.0	19.4	11.1	10.5	6.5	7.7	14.1	11.3	12.4	10.9	18.7	29.1	21.0	24.2	16.0	20.5	18.0	21.3	20.2	17.6	3.0	11.5	11.1	7.2	5.6	15.6	10.6	5.1	8.1	4.5	3.5	5.9	16.9	18.3	7.7	1.2	6.8	8.1	0.0	5.8	16.9	6.7	4.9	17.3	3.9	8.9	7.9	8.2	4.9	10.5	1.0	8.9	7.4	11.8	19.8	5.6	17.0	5.8	8.5	10.6	10.5	10.2	12.9	9.1	3.4	7.8	5.1	29.7	5.7	8.4	7.3
DCTN4		ENSG00000132912	"Dynactin subunit 4"	Q9UJW0	5	150708440-150759109	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB017532, HPA038026"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"CAB017532: AB_1122152, HPA038026: AB_2675792"	"unprognostic (1.38e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.06e-1)"	"unprognostic (2.53e-1)"	"unprognostic (7.87e-3)"	"unprognostic (7.82e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.08e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.68e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.83e-1)"	26.1	27.9	27.9	13.3	27.3	41.0	25.7	30.3	36.5	19.8	15.9	32.4	17.7	15.9	20.6	27.6	20.0	18.4	16.5	20.6	27.3	29.0	20.0	22.0	17.8	13.3	30.8	24.0	26.3	32.5	23.9	27.7	25.9	33.2	24.1	18.6	21.3	15.7	22.4	42.0	19.0	15.4	21.3	34.7	13.9	18.0	22.9	25.4	18.8	24.8	15.3	14.5	23.3	16.2	5.0	10.9	16.4	10.7	3.0	6.9	5.2	9.5	11.5	20.9	34.8	25.5	24.7	17.1	17.0	17.1	20.5	20.8	21.5	12.1	9.4	23.8	20.1	18.0	11.7	25.6	19.9	25.2	18.8	20.1	12.1	13.3	13.4	23.3	14.6	17.3	24.9	17.8	18.3	32.3	21.0	14.5	11.7	18.4	12.1	26.6	10.0	8.9	7.8	10.5	11.3	18.1	7.9	12.6	10.4	15.2	16.5	47.4	19.9	18.0	24.6	25.2	15.1	23.8	19.5	16.1	23.0	12.9	15.0	17.9	10.7	13.8	5.6	26.4	19.6	18.7	3.2	10.7	10.5	5.5	7.8	5.6	5.0	6.2	5.4	10.9	4.4	5.9	6.9	16.4	3.0	6.4	5.1	4.3	5.2	27.9	27.3	30.3	33.3	27.3	29.0	30.8	24.0	33.2	25.4	44.7	29.8	14.5	12.5	15.8	19.1	31.7	33.1	13.4	11.4	15.7	19.6	18.8	10.0	10.6	1.9	15.7	15.7	0.0	14.1	14.7	17.4	17.4	11.6	33.6	26.2	28.6	36.1	22.1	41.2	3.3	20.4	19.3	11.8	10.0	26.4	26.6	16.5	17.3	18.0	17.3	31.0	12.9	14.3	18.6	16.7	17.9	24.8	12.9	16.2	14.4
DYNC1H1	"CMT2O, DHC1, DNCH1, Dnchc1, DNCL, DNECL, HL-3, p22"	ENSG00000197102	"Dynein cytoplasmic 1 heavy chain 1"	Q14204	14	101964510-102056443	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transport"	"Motor protein"	"Charcot-Marie-Tooth disease, Disease mutation, Mental retardation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003742, CAB010443"	Enhanced		Supported	Centrosome,Cytosol		NA	NA		120000	"Centrosome, Cytosol"		"CAB010443: AB_2093483, HPA003742: AB_1078713"	"unprognostic (2.58e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.65e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.49e-2)"	"prognostic unfavorable (3.03e-7)"	"unprognostic (8.93e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.31e-1)"	"prognostic favorable (1.09e-6)"	"unprognostic (1.63e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.52e-3)"	23.3	17.2	24.3	13.9	42.9	21.1	12.7	43.9	53.4	16.9	18.4	35.0	10.2	13.9	18.6	12.5	18.3	15.5	16.1	26.6	26.1	26.6	11.2	9.4	14.6	14.0	29.1	23.4	24.7	15.4	28.1	16.4	14.8	51.5	16.7	11.9	15.5	18.0	18.6	44.5	42.0	13.8	17.7	30.3	15.4	15.5	17.2	12.6	15.1	18.1	11.1	12.9	19.1	12.8	2.7	6.3	4.5	6.0	7.8	4.7	3.3	24.2	36.4	20.0	15.4	44.9	29.3	12.2	21.1	19.6	24.9	21.9	15.4	12.3	13.9	17.3	28.7	18.2	22.2	19.6	23.6	9.0	12.0	11.8	9.9	23.7	25.1	20.4	14.6	10.4	19.0	12.5	58.6	43.8	18.4	27.2	17.4	8.6	16.0	28.2	23.8	9.5	3.6	12.1	10.4	45.0	9.1	21.0	8.0	20.1	38.7	22.8	18.5	27.8	14.1	18.3	10.3	11.7	6.3	59.6	29.5	12.6	40.7	28.7	11.0	11.1	9.4	40.6	8.7	18.1	3.6	3.4	2.5	4.6	6.0	4.7	2.2	3.0	4.0	6.3	2.7	3.6	4.2	4.5	7.8	3.9	3.3	3.0	3.3	24.3	42.9	43.9	53.4	26.1	26.6	29.1	23.4	51.5	12.6	116.1	83.2	18.6	34.8	46.5	118.7	165.8	38.2	78.9	83.0	73.3	131.6	39.7	11.6	96.5	11.8	85.7	77.8	0.0	70.2	36.3	58.5	39.8	31.3	31.8	36.0	173.2	68.5	46.6	49.4	11.3	65.3	61.6	67.4	110.0	56.8	57.8	107.3	66.6	67.1	39.6	100.6	84.1	73.1	83.0	71.1	56.0	31.2	49.0	49.4	39.7
DYNC1LI1	DNCLI1	ENSG00000144635	"Dynein cytoplasmic 1 light intermediate chain 1"	Q9Y6G9	3	32525971-32570874	"Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Spermatocytes: 165.8;Spermatogonia: 163.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035013	Approved		Supported	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"HPA035013: AB_10600807"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.38e-2)"	"prognostic unfavorable (9.19e-9)"	"unprognostic (1.07e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.26e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.51e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.27e-2)"	16.1	11.6	15.8	14.8	18.6	27.5	18.9	24.5	28.0	13.4	13.8	12.7	9.2	11.6	17.0	11.6	13.9	14.7	14.1	40.1	16.3	23.4	18.4	15.9	16.3	15.8	18.3	16.4	15.2	18.6	16.8	18.9	14.9	26.5	18.6	14.2	14.1	12.0	12.9	41.1	32.1	13.0	19.7	16.6	18.1	13.8	34.0	11.7	19.3	12.8	16.6	17.2	15.5	13.5	6.2	15.3	29.8	25.1	7.5	6.1	10.7	13.3	14.5	22.5	14.1	13.0	15.3	62.3	20.7	28.6	37.5	30.8	15.3	11.6	16.8	14.1	21.0	17.8	6.9	22.6	16.2	35.8	15.8	15.6	22.2	10.6	13.6	16.0	25.1	13.0	12.3	13.0	26.4	20.7	13.7	24.1	19.2	25.7	15.5	20.0	10.7	19.2	11.1	23.3	12.9	19.5	17.0	12.0	17.5	15.3	12.3	9.7	14.3	14.6	18.0	15.6	18.9	15.0	14.7	17.9	20.7	17.4	17.9	20.8	11.2	28.2	27.2	11.5	21.8	16.0	11.3	13.3	11.7	5.2	16.8	5.4	6.1	5.6	5.7	15.3	6.2	3.9	5.0	29.8	7.5	25.1	8.4	6.1	10.7	15.8	18.6	24.5	28.0	16.3	23.4	18.3	16.4	26.5	11.7	23.8	24.1	30.7	27.6	38.1	44.2	87.1	12.7	57.6	42.1	14.0	17.7	31.9	39.7	46.8	67.1	34.6	15.3	46.7	40.4	30.5	29.2	19.6	16.2	24.9	36.1	62.0	29.6	23.4	32.9	26.8	24.2	50.1	27.0	83.0	18.0	30.8	44.9	17.3	26.9	37.2	71.7	45.3	37.1	165.8	163.3	43.8	9.3	28.0	13.6	14.0
DYNC1LI2	DNCLI2	ENSG00000135720	"Dynein cytoplasmic 1 light intermediate chain 2"	O43237	16	66720893-66751798	"Predicted intracellular proteins"	Transport	"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057201			Approved	Centrosome,Cytosol		NA	NA			Centrosome	Cytosol	"HPA057201: AB_2683366"	"unprognostic (6.03e-2)"	"unprognostic (2.40e-2)"	"unprognostic (8.28e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.80e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.51e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.70e-3)"	"unprognostic (1.34e-1)"	26.5	21.4	63.8	16.8	63.5	16.7	19.0	28.8	43.3	23.0	24.4	61.2	17.6	19.5	23.9	19.5	23.7	17.9	22.5	26.6	68.3	48.3	20.3	13.0	20.8	11.0	75.0	28.9	22.1	20.2	44.7	19.3	21.1	51.1	25.3	28.7	13.6	20.8	24.5	17.2	23.1	19.8	30.1	89.5	15.5	22.6	14.9	55.0	6.7	28.8	7.9	12.6	20.4	20.0	9.0	12.1	16.3	17.1	8.2	14.9	7.9	15.1	16.0	23.8	21.3	30.8	30.5	21.6	24.9	20.0	20.4	26.6	21.6	15.0	6.3	19.9	24.4	14.8	22.1	18.2	17.8	30.0	4.3	13.1	7.8	18.5	20.4	17.1	8.2	11.6	19.9	24.5	23.5	16.3	28.7	28.6	6.6	12.7	8.4	26.4	10.8	5.1	10.8	14.3	16.9	27.8	11.3	50.3	7.6	20.3	21.4	23.9	16.7	45.0	9.8	28.9	17.9	11.8	8.3	36.3	26.5	13.2	12.9	16.9	10.7	7.8	12.6	22.8	8.0	16.6	10.1	17.1	16.1	13.4	9.8	14.9	5.2	11.3	10.7	12.1	9.0	9.6	9.1	16.3	8.2	13.1	7.6	10.9	7.9	63.8	63.5	28.8	43.3	68.3	48.3	75.0	28.9	51.1	55.0	95.3	106.1	25.9	55.1	58.7	77.3	44.2	50.9	123.1	95.5	26.2	31.4	49.4	6.6	70.7	85.1	86.2	65.1	0.0	50.4	50.0	55.7	71.0	34.8	29.3	26.9	101.7	101.8	51.5	44.8	54.2	58.7	48.5	65.8	19.0	68.1	106.0	84.7	57.5	75.7	38.3	61.1	116.4	75.0	66.6	52.2	61.1	70.9	23.5	54.7	68.6
E2F1	"RBBP3, RBP3"	ENSG00000101412	"E2F transcription factor 1"	Q01094	20	33675683-33686404	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.5;lymphoid tissue: 21.9"	"Cell type enriched"	"Detected in many"	5	"Spermatogonia: 37.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 3.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB000329, HPA008003, CAB019308, HPA029735"	Enhanced		Supported	Nucleoplasm,Centrosome		NA	Yes			"Nucleoplasm, Centrosome"		"CAB000329: AB_627476, CAB019308: , HPA008003: AB_1847936, HPA029735: AB_2673176"	"unprognostic (7.46e-2)"	"prognostic favorable (9.22e-6)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (4.33e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (3.83e-5)"	"unprognostic (1.25e-2)"	"unprognostic (8.23e-2)"	"unprognostic (9.66e-2)"	"prognostic unfavorable (4.18e-4)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (8.99e-5)"	"unprognostic (1.05e-2)"	"unprognostic (7.50e-2)"	"prognostic favorable (1.62e-4)"	"unprognostic (1.91e-1)"	2.4	5.3	6.8	12.7	9.7	32.5	2.1	1.1	6.4	1.2	4.4	5.1	0.7	3.9	1.4	0.8	5.1	1.5	4.1	2.0	7.1	3.6	0.9	1.7	8.1	9.3	6.2	2.9	3.4	1.2	2.3	0.3	3.3	5.9	1.7	4.8	0.3	1.6	1.4	1.4	5.4	4.9	3.3	6.2	4.8	3.4	12.1	6.0	21.9	1.0	4.9	7.7	1.9	3.1	2.2	0.6	0.7	3.7	1.4	1.2	0.6	16.0	15.6	18.1	14.1	1.8	1.3	13.8	15.4	7.5	19.7	16.6	27.6	16.6	29.6	15.6	6.9	23.9	12.1	8.8	8.2	8.8	8.9	12.6	24.2	23.2	16.0	0.1	11.3	15.3	1.0	0.5	10.8	1.9	2.0	5.0	18.6	6.4	20.9	12.1	14.2	24.0	24.0	5.4	16.2	22.5	23.9	49.4	12.2	3.3	9.8	27.1	19.1	18.8	13.1	7.6	5.4	16.4	14.3	2.7	23.0	13.5	15.9	21.8	20.5	13.8	24.4	19.2	6.7	13.6	0.0	0.0	0.7	0.1	0.9	0.0	2.2	0.6	0.4	0.2	0.2	0.2	1.2	0.3	1.4	3.7	0.6	0.8	0.6	6.8	9.7	1.1	6.4	7.1	3.6	6.2	2.9	5.9	6.0	0.0	0.6	2.9	0.7	2.6	2.2	0.4	0.0	0.0	2.3	0.0	0.0	2.6	0.0	0.9	0.7	0.1	0.5	0.0	0.2	7.9	1.1	0.6	0.0	0.8	3.8	0.0	0.0	0.6	0.0	2.3	2.0	0.9	1.7	0.0	2.9	1.2	0.5	0.0	1.1	0.0	2.0	0.0	0.9	3.8	37.5	1.5	1.5	0.7	4.6	0.9
EMC6	"MGC2963, TMEM93"	ENSG00000127774	"ER membrane protein complex subunit 6"	Q9BV81	17	3668815-3669668	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"skeletal muscle: 100.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062681	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Centrosome	Nucleoplasm	"HPA062681: AB_2684831"	"unprognostic (2.21e-1)"	"prognostic unfavorable (7.73e-4)"	"unprognostic (2.21e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.20e-3)"	"unprognostic (4.03e-2)"	"prognostic unfavorable (9.39e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.58e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.37e-2)"	"unprognostic (3.27e-1)"	"unprognostic (6.32e-2)"	14.6	18.5	15.5	12.2	15.5	21.4	12.5	9.9	21.2	8.9	15.9	14.9	10.0	16.9	9.8	10.8	15.6	9.5	12.1	26.2	14.5	12.3	19.8	42.1	10.2	10.7	14.2	11.0	8.7	24.5	7.6	9.3	16.6	12.2	12.9	9.7	14.6	17.8	10.5	100.1	10.6	16.8	10.1	13.6	12.5	18.8	27.4	11.1	14.3	14.9	31.5	14.3	9.7	9.1	34.5	56.1	40.7	42.0	25.2	43.4	38.5	31.2	30.8	13.5	14.1	9.7	7.8	26.0	22.5	11.0	18.5	17.1	18.6	11.8	19.7	32.8	10.5	16.3	30.2	15.6	15.8	13.4	19.0	58.3	14.3	21.6	25.8	14.1	9.9	14.7	9.8	18.0	17.0	11.9	14.6	14.0	23.7	17.9	14.3	13.5	19.0	20.2	29.2	19.4	19.1	34.8	18.9	12.6	18.6	25.9	8.9	11.1	20.2	18.4	14.5	23.9	14.1	16.9	10.7	15.3	15.5	19.2	23.3	32.8	14.0	15.4	12.9	24.3	13.0	18.6	34.5	42.0	40.7	34.9	39.7	32.0	34.5	39.0	38.3	35.8	32.3	40.6	36.7	31.6	25.2	27.9	56.1	43.4	38.5	15.5	15.5	9.9	21.2	14.5	12.3	14.2	11.0	12.2	11.1	14.9	23.4	62.6	99.3	79.0	40.5	0.3	94.3	53.5	23.9	55.8	33.4	102.2	140.9	117.4	202.1	52.2	55.0	23.3	123.7	126.4	43.1	113.2	54.3	108.8	90.3	31.8	49.3	39.3	53.3	121.5	35.6	54.6	64.1	101.0	61.0	85.4	129.4	63.1	32.2	149.9	38.8	38.8	51.5	146.4	87.0	89.1	107.9	52.2	68.0	156.9
ENGASE	FLJ21865	ENSG00000167280	Endo-beta-N-acetylglucosaminidase	Q8NFI3	17	79074939-79088599	"Enzymes, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 51.4"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021551	Enhanced		Approved	Centrosome,Cytosol		No	No			Cytosol	Centrosome	"HPA021551: AB_1848156"	"unprognostic (7.49e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.08e-3)"	"unprognostic (9.62e-2)"	"unprognostic (4.09e-2)"	"unprognostic (9.07e-2)"	"unprognostic (7.00e-3)"	"prognostic favorable (2.60e-4)"	"unprognostic (4.79e-2)"	"prognostic unfavorable (8.97e-6)"	"unprognostic (8.38e-3)"	"unprognostic (6.03e-1)"	"unprognostic (2.06e-2)"	"prognostic favorable (8.73e-5)"	10.0	10.1	9.5	20.7	18.4	8.9	11.4	7.0	13.9	10.9	15.1	12.4	8.8	20.3	11.4	6.8	6.5	10.6	8.6	10.3	9.3	5.8	9.2	10.2	10.1	10.7	16.8	8.5	16.3	9.3	11.3	9.8	8.1	13.6	12.3	12.5	10.7	12.1	9.6	35.4	11.9	17.3	7.3	11.9	24.9	11.4	3.9	14.0	8.1	13.6	7.0	9.1	17.5	51.4	0.2	0.7	0.0	1.1	0.0	2.1	0.6	4.5	9.8	3.4	6.3	3.6	1.5	6.6	3.5	1.8	2.9	2.0	5.2	5.0	0.0	4.2	3.5	4.8	6.8	5.4	3.8	1.6	2.7	7.3	4.1	10.0	3.1	2.7	4.7	7.8	4.1	5.3	2.5	2.8	5.6	3.0	8.9	5.9	2.9	1.8	3.9	0.4	4.5	1.5	9.5	8.8	8.6	11.7	3.0	1.5	12.9	2.9	5.7	5.6	25.9	2.6	5.3	9.1	4.4	3.9	5.6	4.2	4.8	3.4	6.9	1.2	2.0	2.3	8.7	4.0	0.0	0.7	0.0	0.0	1.1	0.9	0.0	0.1	0.4	0.7	0.2	0.0	0.0	0.0	0.0	0.5	0.6	2.1	0.6	9.5	18.4	7.0	13.9	9.3	5.8	16.8	8.5	13.6	14.0	0.0	13.6	6.4	3.8	3.9	10.7	4.8	7.6	0.0	6.8	10.4	33.4	4.2	0.0	3.5	1.5	6.5	16.4	0.0	3.6	3.8	4.8	7.4	4.7	10.6	7.5	7.9	25.1	9.8	10.8	1.0	3.1	8.2	0.0	5.4	15.9	5.6	2.5	11.5	1.8	1.7	24.7	12.9	6.0	2.2	1.4	5.1	5.6	5.7	18.8	4.1
ERVV-1	"ENVV1, FLJ32214, HERV-V1"	ENSG00000269526	"Endogenous retrovirus group V member 1, envelope"	B6SEH8	19	53013921-53016122	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"placenta: 19.7"	"Cell type enriched"	"Detected in some"	31	"Syncytiotrophoblasts: 218.2"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"BEWO: 11.7;SuSa: 9.8"									HPA076115			Approved	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA076115: "	"unprognostic (1.04e-3)"			"unprognostic (7.32e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.70e-2)"		"unprognostic (1.67e-2)"		"unprognostic (9.92e-2)"		"unprognostic (6.75e-2)"	"unprognostic (4.34e-5)"	"unprognostic (3.48e-2)"	"unprognostic (5.80e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.35e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.9	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	19.7		0.8	0.0		0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	1.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	9.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	218.2	0.0	0.0	0.0
ERVV-2	ENVV2	ENSG00000268964	"Endogenous retrovirus group V member 2, envelope"	B6SEH9	19	53044738-53051076	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	105	"placenta: 85.9"	"Cell type enriched"	"Detected in single"	5	"Syncytiotrophoblasts: 3.2"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 19.1;SuSa: 12.9;T-47d: 5.4"									HPA076115			Approved	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA076115: "				"unprognostic (3.14e-3)"		"unprognostic (2.06e-1)"				"unprognostic (1.31e-1)"			"unprognostic (4.33e-9)"	"unprognostic (3.01e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.60e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	85.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.9	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0
EXTL1	"EXTL, MGC70794"	ENSG00000158008	"Exostosin like glycosyltransferase 1"	Q92935	1	26019884-26036464	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 21.1;heart muscle: 6.0;skeletal muscle: 20.5"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 6.2;Cardiomyocytes: 2.9;Horizontal cells: 9.5;Melanocytes: 6.8"	"Cancer enriched"	"Detected in some"	13	"melanoma: 21.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"WM-115: 58.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA010726, HPA037749"	Approved		Approved	Vesicles,Centrosome	"Intracellular and membrane"	NA	NA		68000	Centrosome	Vesicles	"HPA010726: , HPA037749: AB_10805350"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.47e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.14e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.40e-3)"	"unprognostic (2.27e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.35e-2)"	0.6	2.1	15.3	0.6	9.5	0.5	2.0	1.1	21.1	1.3	0.6	1.4	0.0	0.7	2.5	0.7	1.5	1.7	1.2	6.0	12.7	3.7	0.7	0.5	0.7	0.8	3.7	7.9	2.3	1.0	0.5	0.5	1.0	2.9	1.2	0.6	2.7	0.8	0.9	20.5	1.6	0.7	2.9	2.7	2.2	0.6	1.0	0.8	0.0	0.9	3.2	0.6	0.9	0.2	0.1	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.9	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	58.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.8	0.3	0.0	0.0	0.0	0.1	0.0	0.1	15.3	9.5	1.1	21.1	12.7	3.7	3.7	7.9	2.9	0.8	0.0	0.0	0.0	0.0	0.1	6.2	2.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	9.5	0.0	0.0	0.0	0.4	1.4	0.0	6.8	0.0	0.0	0.6	0.0	0.0	2.5	0.0	1.4	0.0	0.3	0.2	0.2	0.0	0.8	0.0	0.0	0.0
FAM117B	"ALS2CR13, FLJ38771"	ENSG00000138439	"Family with sequence similarity 117 member B"	Q6P1L5	2	202635188-202769757	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003229, HPA028746"	Uncertain		Approved	Nucleoplasm,Centrosome		Yes	No			Nucleoplasm	Centrosome	"HPA003229: AB_2246696, HPA028746: AB_2672760"	"unprognostic (1.39e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.53e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.07e-3)"	"unprognostic (1.55e-2)"	"unprognostic (4.84e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.40e-3)"	"unprognostic (5.75e-1)"	"unprognostic (6.01e-2)"	"unprognostic (8.93e-2)"	"unprognostic (3.18e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.37e-3)"	5.8	12.5	10.1	11.1	10.3	4.3	10.0	20.8	18.1	5.5	7.9	3.2	7.1	7.0	5.0	7.5	9.6	6.6	6.2	4.3	8.6	10.8	8.3	3.6	6.2	13.0	5.9	9.1	8.8	11.6	24.7	7.5	11.0	4.7	8.6	7.9	3.7	8.6	9.3	5.8	9.0	6.0	7.3	5.7	8.2	6.6	12.6	5.8	22.4	5.5	4.8	11.7	7.2	12.7	9.0	4.8	2.3	8.9	4.5	9.9	3.3	1.6	2.0	8.9	6.1	3.0	1.7	8.6	0.5	0.8	0.5	1.0	2.5	3.5	6.7	5.5	1.0	1.3	1.6	7.5	3.8	1.5	0.1	6.1	5.6	3.8	9.4	2.4	4.7	2.5	2.3	5.3	1.1	1.7	4.0	2.4	8.9	8.0	1.4	0.5	3.2	12.7	9.9	9.0	4.7	3.8	10.1	1.8	7.8	4.7	4.3	15.1	13.1	6.6	4.4	3.2	7.8	1.9	6.6	1.4	1.1	2.1	1.5	0.9	4.9	2.8	8.9	2.0	3.7	1.1	0.3	4.5	1.6	1.6	8.9	4.0	9.0	3.6	3.1	4.8	8.5	9.9	6.8	2.3	4.5	8.8	1.7	1.3	3.3	10.1	10.3	20.8	18.1	8.6	10.8	5.9	9.1	4.7	5.8	3.0	6.9	14.1	1.9	15.2	4.7	3.9	10.2	2.7	2.3	17.4	3.9	6.1	0.0	6.7	1.7	3.3	5.2	0.0	5.5	4.9	8.4	7.0	5.7	1.7	2.5	6.4	24.8	5.5	22.9	0.9	12.0	9.9	3.3	1.0	12.9	1.9	5.7	7.0	22.3	4.9	2.7	6.5	3.1	4.4	16.3	17.3	2.3	6.4	11.9	5.4
FP565260.6		ENSG00000280071			21	5079294-5128425	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"blood: 47.1"	"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 2: 3.5;Ciliated cells: 4.0;Club cells: 3.4;Collecting duct cells: 3.5;Hofbauer cells: 7.2"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA018517	Uncertain		Approved	Centrosome,Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria	Centrosome	"HPA018517: AB_2669899"	"unprognostic (4.87e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.96e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.39e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.67e-4)"	"unprognostic (1.88e-2)"	"unprognostic (6.80e-2)"	"unprognostic (4.25e-1)"	"unprognostic (2.84e-2)"	3.9	6.7	2.8	2.0	6.6	1.3	3.4	8.2	7.0	3.0	5.7	5.2	2.5	5.7	2.2	5.0	3.9	3.3	2.8	15.5	3.2		12.9	14.4	4.8	10.5	6.7	4.7	5.6	2.7	4.0	0.9	6.4	4.2	3.0	4.7	4.4	4.9	2.3	17.1	1.3	3.6	2.4	3.0	2.6	2.2	1.4	3.9	1.1	4.2	11.1	2.4	3.9	2.0	47.1	43.8	19.9	46.4	37.1	41.4	46.1	13.2	12.5	13.9	24.4	13.3	12.7	6.8	0.0	2.6	0.8	1.2	2.0	13.6	1.2	15.4	16.3	13.8	9.5	20.0	10.4	1.2	9.1	8.9	51.5	13.3	12.7	12.1	22.1	9.8	20.3	17.6	8.0	14.7	11.9	16.1	17.5	20.2	15.3	9.6	27.8	22.0	24.2	27.2	37.2	20.4	45.2	10.5	48.2	18.2	12.3	14.1	23.7	18.4	34.7	12.9	7.5	35.7	31.1	5.7	8.0	9.9	0.8	8.0	20.7	21.1	8.7	16.4	45.8	6.7	19.9	33.6	16.9	31.6	36.0	31.6	43.9	41.4	32.9	43.8	47.1	39.7	30.2	6.8	37.1	46.4	28.9	40.0	46.1											0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	4.0	3.4	3.5	0.0	2.8	0.0	1.4	0.0	0.0	0.0	0.0	1.2	2.7	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.8	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0
GAPDHS	"GAPD2, GAPDH-2, GAPDS"	ENSG00000105679	"Glyceraldehyde-3-phosphate dehydrogenase, spermatogenic"	O14556	19	35533412-35545316	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"testis: 154.6"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 6946.0"	"Cancer enriched"	"Detected in single"	97	"melanoma: 13.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 16.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042666	Enhanced		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA042666: AB_2678104"	"unprognostic (3.74e-1)"	"unprognostic (1.59e-1)"			"unprognostic (7.41e-2)"			"unprognostic (1.56e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.81e-2)"			"unprognostic (2.96e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.37e-1)"	0.3	0.5	0.3	0.8	0.3	0.2	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.6	0.5	1.6	0.6	0.2	0.8	0.8	0.3	0.3	0.3	0.3	0.3	1.6	0.3	0.3	0.7	1.3	0.0	0.3	0.3	0.3	0.3	0.0	4.2	1.3	0.3	0.3	4.4	0.6	0.3	0.3	1.2	0.4	154.6	0.3	0.3	3.6	0.3	0.3	0.6	0.3	2.1	1.0	1.2	0.8	1.4	2.0	0.8	4.5	16.5	4.6	6.9	0.0	0.0	3.9	1.3	0.0	0.0	0.0	10.0	7.6	7.5	2.2	0.0	1.9	5.5	0.0	0.0	0.0	7.3	8.0	5.0	10.5	5.1	0.1	4.5	6.0	0.0	0.0	0.0	0.0	2.9	0.0	7.3	12.0	4.4	0.0	14.1	1.7	2.1	6.2	2.9	2.2	5.3	3.2	5.8	0.0	4.5	8.3	3.7	1.7	4.2	4.9	3.3	3.4	1.9	1.5	5.3	6.0	1.3	1.9	12.3	3.3	4.4	2.9	8.1	1.9	0.0	0.8	1.2	1.1	0.6	2.0	1.1	0.4	1.9	1.0	2.1	1.1	1.2	0.0	1.4	0.3	0.8	0.3	0.8	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1712.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	6946.0	23.0	0.0	42.2	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	25.8	0.2	30.4	13.5	0.1	0.0	0.0	0.0	0.0
GINS4	"MGC14799, SLD5"	ENSG00000147536	"GINS complex subunit 4"	Q9BRT9	8	41529206-41545046	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"B-cells: 13.0;monocytes: 15.4;Spermatogonia: 11.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024663, HPA026580"	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA024663: AB_1857224, HPA026580: AB_1857225"	"unprognostic (7.74e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.25e-3)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (1.70e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.71e-3)"	"unprognostic (8.01e-3)"	"unprognostic (4.03e-3)"	"unprognostic (1.50e-2)"	"unprognostic (4.34e-4)"	"unprognostic (1.79e-1)"	"unprognostic (3.67e-5)"	"unprognostic (2.40e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.11e-1)"	"unprognostic (3.22e-1)"	2.0	3.0	2.3	6.2	4.7	9.0	2.7	1.6	3.7	2.7	3.4	6.8	0.0	2.5	2.4	3.0	6.0	1.6	2.4	5.7	3.7	1.8	2.2	2.2	2.5	7.9	5.9	3.3	2.6	1.3	1.6	1.2	4.8	2.8	1.8	5.1	1.9	2.6	0.8	3.7	3.4	3.7	2.4	4.7	5.0	2.1	8.6	5.6	14.0	2.1	5.7	9.6	2.1	3.0	5.8	5.2	3.9	1.4	2.7	6.7	1.7	9.7	14.0	19.8	8.9	1.2	1.6	8.2	13.9	8.4	14.4	17.0	12.9	8.5	13.5	5.7	7.0	11.0	7.4	15.9	11.4	21.3	5.0	8.9	19.6	10.3	8.7	0.3	4.2	10.2	0.8	0.5	23.8	5.3	3.3	7.1	16.4	9.6	4.5	10.1	6.6	17.6	4.8	11.0	10.4	7.7	16.6	18.5	5.7	5.1	9.3	6.1	4.8	9.8	4.4	4.0	10.5	11.3	4.7	4.9	9.8	14.9	18.0	13.9	5.3	7.8	16.1	7.0	10.1	23.7	2.4	1.4	0.5	3.0	1.3	1.7	2.4	4.8	2.0	0.7	5.8	3.1	2.0	3.9	2.7	0.7	5.2	6.7	1.7	2.3	4.7	1.6	3.7	3.7	1.8	5.9	3.3	2.8	5.6	0.0	1.4	13.0	2.6	2.5	5.0	0.8	0.0	0.0	1.2	8.7	2.0	6.2	0.0	1.3	0.5	0.7	0.4	0.0	1.6	10.0	2.6	1.1	1.1	0.5	4.0	0.0	3.4	1.3	1.9	0.0	1.1	4.0	0.0	15.4	2.3	1.9	1.5	0.0	2.1	0.8	1.8	0.0	1.4	7.7	11.5	1.0	4.9	4.9	3.3	0.8
GTSE1	"B99, GTSE-1"	ENSG00000075218	"G2 and S-phase expressed 1"	Q9NYZ3	22	46296741-46330810	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.0;testis: 22.3"	"Cell type enhanced"	"Detected in many"	18	"Erythroid cells: 93.5;Extravillous trophoblasts: 27.0;Spermatocytes: 47.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029457			Approved	"Plasma membrane,Centrosome"		Yes	Yes			Centrosome	"Plasma membrane"	"HPA029457: "	"unprognostic (1.97e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.59e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (1.90e-10)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (1.09e-1)"	"unprognostic (8.37e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (3.49e-3)"	"unprognostic (0.00e+0)"	"unprognostic (6.52e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.85e-2)"	1.1	1.3	0.3	10.4	0.8	10.2	1.3	1.0	1.1	1.2	2.5	0.7	0.1	4.1	1.1	1.3	6.6	0.4	0.4	0.8	1.0	0.3	0.9	0.9	1.3	9.0	0.6	0.4	0.9	0.5	0.0	0.9	2.8	1.8	0.6	2.6	0.7	1.5	0.1	0.3	2.4	3.3	1.0	0.6	4.6	2.4	22.3	0.3	20.0	0.5	5.8	8.8	1.1	2.1	1.4	1.9	3.0	0.2	1.8	1.6	0.9	21.8	10.4	20.5	16.2	0.4	1.2	9.8	19.0	9.0	27.7	22.9	10.8	8.3	20.7	5.0	7.3	12.7	11.5	18.3	4.8	17.8	12.4	19.7	13.8	14.6	8.4	0.0	24.7	16.9	0.2	0.3	11.9	6.1	2.9	11.9	15.0	10.5	26.0	16.5	12.2	22.1	12.1	14.3	9.0	11.7	22.0	23.0	13.5	4.5	4.0	10.6	14.5	18.1	11.8	8.4	9.6	10.0	9.6	9.4	15.8	30.0	12.9	19.9	14.9	7.1	21.0	10.0	11.9	23.0	0.1	0.2	1.5	1.3	0.1	0.4	1.4	0.6	0.6	0.3	0.6	0.4	0.3	3.0	1.8	0.1	1.9	1.6	0.9	0.3	0.8	1.0	1.1	1.0	0.3	0.6	0.4	1.8	0.3	0.0	0.0	0.8	0.6	2.5	0.6	1.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.5	3.9	0.4	0.5	93.5	0.2	27.0	1.1	0.6	0.0	0.5	16.0	0.0	1.2	5.5	6.2	3.8	0.3	3.5	0.0	0.0	2.0	0.2	0.4	0.0	0.7	0.4	0.1	6.5	0.9	47.7	20.4	2.3	1.3	2.9	3.7	1.4
HAUS1	"CCDC5, FLJ40084, HEI-C, HsT1461"	ENSG00000152240	"HAUS augmin like complex subunit 1"	Q96CS2	18	46104332-46128333	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 91.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040601, HPA040652"	Supported		Supported	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA040601: AB_10794743, HPA040652: AB_10793966"	"unprognostic (1.74e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.13e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (1.39e-1)"	"unprognostic (4.76e-3)"	"prognostic favorable (1.55e-4)"	"unprognostic (3.75e-1)"	"prognostic unfavorable (6.76e-4)"	"unprognostic (5.97e-3)"	"unprognostic (5.40e-2)"	"unprognostic (9.79e-3)"	"unprognostic (3.66e-2)"	"unprognostic (7.96e-2)"	15.2	11.8	10.3	14.6	13.1	23.1	14.5	15.8	12.2	14.3	13.4	6.2	13.1	9.9	15.5	28.4	15.9	13.8	11.6	9.3	10.3	8.0	14.4	12.1	10.9	22.9	13.6	6.8	20.4	12.0	6.5	18.1	13.0	12.0	14.8	16.3	7.3	11.4	14.4	7.1	8.6	13.4	12.2	14.4	17.9	12.2	11.8	15.4	38.4	14.3	14.4	26.1	13.9	12.3	28.1	23.4	13.0	18.2	19.3	34.9	19.3	18.7	11.3	43.1	23.2	11.1	17.2	11.6	18.3	18.3	29.4	29.2	11.1	10.6	35.8	11.1	13.1	13.6	20.0	25.8	15.6	32.4	20.1	17.3	26.3	12.2	20.9	9.3	47.9	16.2	8.3	6.2	18.1	9.3	13.0	32.0	25.8	18.7	10.2	26.1	10.9	37.9	23.0	27.5	9.0	6.7	38.1	30.9	25.6	23.2	13.2	20.3	21.1	17.0	5.9	13.8	17.8	8.6	23.3	18.0	17.2	11.7	7.4	19.1	12.0	18.2	33.2	11.0	40.7	19.6	4.4	18.2	13.0	16.0	16.4	17.7	28.1	21.6	18.9	21.6	23.7	15.4	18.1	2.0	19.3	12.7	23.4	34.9	19.3	10.3	13.1	15.8	12.2	10.3	8.0	13.6	6.8	12.0	15.4	11.9	12.6	27.6	18.2	15.5	4.5	8.7	15.3	30.8	33.0	14.0	3.9	42.3	14.9	32.5	5.8	26.6	9.0	0.0	37.0	91.5	29.6	7.0	28.9	7.7	44.3	11.1	11.6	17.8	38.3	8.6	21.0	31.9	20.3	43.3	22.2	18.1	25.9	10.5	24.4	18.9	8.0	19.4	16.5	51.9	57.7	13.6	19.8	25.9	26.4	6.7
HOXB4	"HOX2, HOX2F"	ENSG00000182742	"Homeobox B4"	P17483	17	48575513-48580111	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 13.3"	"Cell type enhanced"	"Detected in many"	15	"Collecting duct cells: 61.1;Cytotrophoblasts: 18.4;Spermatogonia: 21.8"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"EFO-21: 23.4;HEK 293: 11.3;HMC-1: 14.4;K-562: 11.4"	"Region enriched"	"Detected in single"	36	"pons and medulla: 3.7"	"Region enriched"	"Detected in single"	23	"pons and medulla: 7.5"	HPA057432	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA057432: AB_2683437"	"unprognostic (2.71e-2)"	"unprognostic (3.87e-2)"	"unprognostic (8.97e-3)"	"unprognostic (5.39e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.10e-1)"	"unprognostic (4.85e-2)"	"unprognostic (9.25e-3)"	"unprognostic (3.41e-3)"	4.4	2.4	0.0	1.5	0.0	0.0	2.9	0.0	0.0	4.2	8.1			1.2	2.3	13.3	2.7	8.5	1.5	0.4	0.0	0.0	5.7	0.7	3.6	0.6	0.0		0.0	0.7	1.8	0.0	1.0		0.6	1.1		0.0	4.8	0.8	0.9	4.3	2.0	2.4	3.0	3.9	0.5			0.6		0.2	1.3	1.7	0.3	2.4	0.0	0.1	0.6	0.7	0.1	0.1	0.3	0.0	0.1	4.9	3.9	1.9	0.0	0.0	0.2	0.1	2.2	2.0	3.1	23.4	1.5	0.4	0.1	4.1	0.0	0.0	8.0	11.3	7.6	0.7	0.0	5.0	0.0	14.4	3.8	0.0	5.7	0.0	0.8	6.6	5.2	11.4	0.2	5.6	0.0	1.8	0.0	0.0	2.1	0.0	0.0	4.4	1.6	4.6	1.9	0.0	0.0	0.6	0.0	2.9	1.6	0.4	1.5	2.5	0.3	0.2	0.8	0.2	1.9	4.0	0.7	1.6	0.0	2.2	0.0	0.1	0.0	0.7	0.0	0.1	0.3	0.2	0.5	0.0	0.1	0.2	0.1	0.0	0.6	0.0	2.4	0.0	0.1											0.0	0.0	1.7	0.9	3.4	0.0	0.8	0.0	1.4	0.0	61.1	0.0	18.4	10.0	0.1	0.0	7.1	0.8	0.0	0.0	11.0	9.7	0.4	3.5	0.0	3.2	0.0	0.0	15.4	1.8	0.0	0.3	1.9	5.0	0.0	2.0	0.0	0.0	1.9	0.0	1.4	0.0	0.0	5.2	0.2	21.8	1.6	5.0	10.5	1.5	2.6
HSPA4L	"APG-1, HSPH3, Osp94"	ENSG00000164070	"Heat shock protein family A (Hsp70) member 4 like"	O95757	4	127781821-127840733	"Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 73.0;vagina: 32.0"	"Group enriched"	"Detected in many"	4	"Early spermatids: 393.1;Late spermatids: 711.4;Spermatocytes: 194.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.9"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.9"	"Cell line enhanced"	"Detected in many"		"HAP1: 38.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034450, HPA039149, HPA061446"	Enhanced		Approved	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"CAB034450: AB_2119823, HPA039149: AB_2676366, HPA061446: AB_2684520"	"unprognostic (6.66e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.33e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.40e-2)"	"unprognostic (3.28e-1)"	"prognostic favorable (3.80e-9)"	"unprognostic (8.53e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.99e-2)"	"prognostic unfavorable (6.78e-4)"	1.6	9.3	7.4	1.4	9.0	2.8	5.5	16.6	11.4	2.9	2.5	1.7	1.6	2.5	1.5	1.7	10.9	5.9	3.5	5.3	6.1	10.1	10.6	5.9	1.9	1.0	6.6	6.6	3.5	3.6	12.2	23.2	2.8	20.1	3.9	3.5	3.5	4.6	4.7	1.5	6.5	1.6	3.8	5.0	1.4	2.1	73.0	5.2	1.0	3.7	4.1	4.0	2.8	32.0	0.7	0.5	3.9	0.4	0.5	0.4	0.1	9.1	12.0	6.5	10.3	4.5	4.6	7.6	4.2	1.7	4.0	4.5	8.8	4.2	0.0	7.7	1.2	3.3	2.1	38.0	15.0	5.6	17.0	11.3	4.9	16.5	10.7	1.7	18.8	8.4	4.2	14.0	2.6	9.6	4.2	5.2	4.3	8.7	5.6	5.0	6.6	6.0	1.6	1.5	9.7	10.0	0.0	0.7	0.9	13.8	4.2	12.0	4.4	7.5	13.1	0.7	4.1	10.0	3.2	1.4	1.4	0.0	1.7	10.0	11.0	12.6	2.9	5.5	12.9	4.3	1.6	0.4	3.9	0.4	0.2	0.2	0.4	0.3	0.3	0.5	0.7	0.4	0.4	1.3	0.5	0.3	0.4	0.3	0.1	7.4	9.0	16.6	11.4	6.1	10.1	6.6	6.6	20.1	5.2	3.0	9.4	0.8	68.9	25.2	54.9	12.6	12.7	56.2	31.8	8.7	98.2	9.5	16.6	6.7	393.1	5.4	0.4	0.0	2.5	1.7	7.0	17.8	15.1	8.3	1.0	38.1	17.6	2.5	1.6	711.4	9.5	7.3	8.5	4.6	2.0	15.2	3.2	0.0	9.2	19.6	62.8	0.0	15.5	194.6	9.3	37.1	14.0	2.9	2.9	72.9
IFT81	"CDV-1R, CDV1, MGC4027"	ENSG00000122970	"Intraflagellar transport 81"	Q8WYA0	12	110124335-110218797	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Ciliated cells: 199.4;Spermatocytes: 160.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019087, HPA020051"	Enhanced		Approved	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"HPA019087: AB_1851462, HPA020051: AB_1851465"	"unprognostic (2.54e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.85e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.45e-1)"	5.3	9.6	8.9	4.6	13.2	1.7	9.2	14.4	11.9	12.6	11.5	6.6	18.8	3.0	14.9	19.6	6.4	18.8	8.9	7.3	8.9	8.5	10.0	4.4	8.5	3.0	5.9	8.4	14.7	5.1	21.8	30.4	5.2	10.7	13.7	6.2	11.8	8.9	15.5	6.4	5.9	4.6	17.7	8.5	4.0	7.4	29.8	8.4	6.2	14.3	5.4	3.1	13.5	10.4	1.8	3.5	3.0	1.3	2.1	1.9	1.3	7.1	13.6	28.1	11.9	5.2	10.7	2.1	4.6	7.1	9.9	8.5	2.6	4.0	2.3	2.5	8.8	7.1	6.4	10.3	5.4	12.9	3.0	5.6	4.9	8.0	4.2	4.4	3.0	2.4	7.6	6.1	9.4	2.4	24.2	6.2	4.7	6.0	1.3	9.1	1.5	6.1	5.1	13.9	4.1	4.5	7.3	7.4	3.1	12.3	4.8	17.5	19.4	12.5	2.6	18.6	8.2	14.1	4.6	4.1	5.6	2.9	4.6	4.2	4.1	4.0	3.2	13.6	3.9	6.3	0.3	1.3	0.6	0.7	0.8	1.9	1.6	1.7	0.8	3.5	1.8	1.5	0.7	3.0	2.1	1.0	3.5	0.7	1.3	8.9	13.2	14.4	11.9	8.9	8.5	5.9	8.4	10.7	8.4	11.9	16.1	2.0	11.5	5.5	16.8	16.5	10.2	199.4	37.5	14.0	39.3	2.2	13.3	8.9	31.3	4.5	0.7	0.0	3.5	1.2	10.0	4.0	3.5	4.0	2.1	23.8	20.7	3.7	1.9	13.2	13.0	1.8	33.7	1.8	4.8	18.2	5.1	1.7	26.2	8.4	36.1	6.5	12.2	160.5	28.1	5.6	0.8	0.0	3.5	3.8
KIAA0753	"MNR, OFIP"	ENSG00000198920	KIAA0753	Q2KHM9	17	6578148-6640927	"Disease related genes, Predicted intracellular proteins"			Ciliopathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 41.5;Early spermatids: 63.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023057, HPA023494"	Enhanced		Enhanced	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"HPA023057: AB_1852338, HPA023494: AB_1852339"	"unprognostic (3.72e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.93e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.01e-3)"	"unprognostic (1.82e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.47e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.77e-3)"	6.5	7.0	7.5	11.7	12.8	4.5	9.9	7.4	9.4	10.1	7.7	7.3	20.1	4.4	17.8	15.6	8.5	13.4	10.7	5.0	8.3	7.7	8.7	4.3	8.3	6.6	4.9	7.9	15.4	10.5	26.4	26.0	7.4	8.0	9.6	9.2	9.6	7.0	13.6	5.4	7.4	6.4	11.5	7.2	9.0	7.9	20.1	5.1	13.7	12.1	4.1	6.8	8.4	7.7	2.3	1.8	5.5	2.2	1.1	2.0	0.7	15.9	12.3	16.1	11.2	6.1	10.5	6.1	8.6	8.1	12.3	10.8	9.1	3.7	5.7	5.8	7.9	8.3	14.9	15.1	7.8	19.7	5.7	12.1	3.3	10.7	6.4	9.1	5.6	7.3	6.9	11.0	12.3	10.1	12.6	9.0	7.7	8.0	0.8	9.5	5.6	6.1	4.9	9.8	7.7	6.5	8.9	5.4	1.9	10.9	10.3	6.0	10.8	11.4	3.0	6.6	11.0	5.1	3.6	8.3	11.6	5.3	6.1	12.7	1.4	1.9	2.4	8.1	3.2	7.8	0.0	2.0	1.7	1.8	2.2	2.0	2.3	1.5	1.6	1.3	1.4	1.2	1.1	5.5	1.1	1.1	1.8	1.1	0.7	7.5	12.8	7.4	9.4	8.3	7.7	4.9	7.9	8.0	5.1	6.0	10.5	1.4	2.6	2.9	3.8	3.0	5.1	41.5	11.4	0.0	15.7	1.8	0.0	3.8	63.1	3.6	2.1	0.0	3.4	0.9	2.8	3.6	1.1	1.8	2.2	9.5	6.9	4.3	3.7	9.9	4.0	2.2	0.0	1.0	4.8	2.4	3.4	4.0	3.2	2.9	10.8	0.0	3.3	14.1	7.5	2.0	1.0	0.0	4.0	2.6
KIAA1109	"FLJ21404, FSA, KIAA1371, Tweek"	ENSG00000138688	KIAA1109	Q2LD37	4	122152333-122362758	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Rod photoreceptor cells: 143.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038076	Approved		Approved	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"HPA038076: AB_10670652"	"unprognostic (2.53e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (6.62e-2)"	"unprognostic (7.61e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.97e-2)"	"prognostic favorable (4.33e-8)"	"unprognostic (2.04e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.29e-2)"	18.4	17.1	25.6	18.0	34.1	42.9	26.1	33.4	34.2	22.9	18.7	24.1	17.9	15.6	20.9	25.4	12.3	16.8	16.4	15.3	25.5	22.0	24.0	17.4	19.5	14.8	26.4	26.2	34.3	16.6	68.2	33.1	14.3	33.6	19.1	18.8	22.6	16.6	21.5	40.1	23.1	20.8	18.6	29.3	20.0	15.2	20.4	24.2	15.3	25.4	12.6	13.6	18.0	18.5	3.1	2.3	7.7	3.6	1.7	3.5	0.7	16.4	5.4	12.5	8.3	21.0	27.3	6.5	7.5	14.1	7.7	8.5	4.0	8.7	8.7	4.4	17.6	10.4	6.2	7.7	9.2	12.6	6.5	4.9	9.5	9.8	7.4	10.9	8.9	5.3	15.7	11.1	9.2	12.8	21.1	16.4	9.4	6.2	10.5	15.8	5.5	7.7	7.0	4.2	7.9	5.9	4.4	17.5	2.2	13.6	12.4	7.4	6.6	4.7	5.4	10.5	21.2	5.9	7.3	21.9	9.6	9.6	7.9	7.6	10.2	6.5	6.3	10.2	7.9	7.0	3.3	1.4	7.7	3.3	3.6	3.5	2.5	2.3	2.3	1.4	3.1	2.0	2.3	6.6	1.7	1.7	2.3	2.9	0.7	25.6	34.1	33.4	34.2	25.5	22.0	26.4	26.2	33.6	24.2	80.4	33.9	13.7	17.7	18.5	114.9	62.7	7.6	37.5	44.3	40.1	117.8	8.9	1.7	11.4	26.6	33.8	40.9	23.3	15.1	5.7	21.1	21.2	20.8	21.5	11.1	87.4	20.7	36.2	31.0	20.3	47.5	20.1	15.1	17.2	25.2	59.6	17.8	25.9	47.7	10.5	143.8	32.3	29.9	49.5	31.9	21.3	10.9	32.4	23.9	23.0
LMNTD1	"FLJ36004, IFLTD1, Pas1c1"	ENSG00000152936	"Lamin tail domain containing 1"	Q8N9Z9	12	25409307-25648579	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.4;fallopian tube: 19.0;pituitary gland: 21.3;testis: 15.0"	"Group enriched"	"Detected in some"	15	"Ciliated cells: 26.8;Early spermatids: 38.5;Late spermatids: 35.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 5.5;RT4: 6.7;SH-SY5Y: 6.9;U-2197: 24.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA038640			Approved	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"HPA038640: AB_2676127"				"unprognostic (8.92e-3)"	"unprognostic (3.21e-1)"			"unprognostic (2.41e-1)"		"unprognostic (1.19e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.68e-1)"		"unprognostic (6.18e-2)"	"unprognostic (2.42e-1)"	"unprognostic (7.80e-2)"	"unprognostic (3.89e-2)"	0.4	0.3	4.3	0.7	6.7	0.4	1.1	3.3	1.6	1.4	3.9	7.1	0.0	1.5	0.8	6.0	0.3	19.0	0.9	0.5	8.5	2.8	0.8	0.2	4.1	0.4	1.1	3.0	4.0	0.7	0.1	21.3	0.3	13.4	0.4	3.8	1.3	0.2	0.3	0.2	0.6	0.6	1.2	4.1	0.6	0.6	15.0	6.5	0.0	1.1	0.0	0.2	0.4	0.3	2.6	2.2	2.7	0.9	0.7	1.6	0.6	0.3	0.3	0.1	0.2	0.2	1.6	2.4	3.1	5.5	1.2	0.2	0.0	0.3	0.2	0.1	0.0	3.5	0.1	0.2	0.1	0.3	0.9	0.1	1.0	0.8	2.0	0.3	0.1	0.1	0.5	0.2	1.6	0.4	0.1	0.1	0.1	1.9	0.3	0.0	0.4	0.0	0.3	1.7	0.1	0.5	0.4	0.2	0.2	0.2	6.7	0.1	6.9	0.2	0.4	3.9	0.8	0.3	1.5	0.3	0.2	0.9	24.0	0.2	0.8	1.3	1.7	0.3	1.6	2.6	1.9	0.9	0.6	1.4	0.3	0.5	2.1	1.0	1.3	0.4	2.6	1.4	1.6	2.7	0.7	0.4	2.2	0.5	0.6	4.3	6.7	3.3	1.6	8.5	2.8	1.1	3.0	13.4	6.5	0.0	0.0	0.5	1.1	0.0	0.0	0.4	0.0	26.8	2.3	0.0	0.0	0.2	1.7	0.0	38.5	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.8	35.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.2	0.0	0.0	0.7
MAGEB16		ENSG00000189023	"MAGE family member B16"	A2A368	X	35798342-35803735	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	44	"testis: 9.0"	"Group enriched"	"Detected in some"	25	"Spermatocytes: 4.7;Spermatogonia: 9.7"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-266/70: 37.0"									"HPA055743, HPA076456"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA055743: AB_2682902, HPA076456: "															"unprognostic (2.12e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	9.7	0.0	0.0	0.0	0.0	0.0
MAL		ENSG00000172005	"Mal, T cell differentiation protein"	P21145	2	95025677-95053996	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	5	"esophagus: 447.4"	"Cell type enhanced"	"Detected in many"	24	"Collecting duct cells: 354.2;Distal tubular cells: 200.6;Muller glia cells: 85.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"memory CD4 T-cell: 42.0;naive CD4 T-cell: 57.9;naive CD8 T-cell: 26.4;T-reg: 40.1"	"Lineage enriched"	"Detected in many"	44	"T-cells: 57.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 45.9;MOLT-4: 64.2;RPMI-8226: 22.7;RPTEC TERT1: 232.7"	"Low region specificity"	"Detected in all"							HPA065691			Approved	"Golgi apparatus,Centrosome"		NA	NA			"Golgi apparatus"	Centrosome	"HPA065691: AB_2685533"	"unprognostic (1.57e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (5.18e-6)"	"unprognostic (1.67e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.59e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.89e-2)"	"prognostic favorable (3.96e-9)"	"unprognostic (1.91e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.57e-1)"	2.3	2.0	14.3	3.5	21.8	3.7	2.0	1.8	20.6	35.8	3.7	43.2	0.4	2.0	1.8	3.4	447.4	3.4	2.2	3.3	18.2	8.3	53.1	1.7	4.3	5.9	27.4	13.2	2.0	1.9	1.6	0.2	2.2	11.8	2.5	2.9	2.8	42.5	3.9	2.0	3.7	2.4	2.1	27.6	3.2	9.3	1.7	27.2	35.0	5.8	56.1	90.1	2.6	64.8	0.6	0.2	0.4	0.1	1.3	57.9	13.7	4.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	45.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	64.2	0.0	0.0	0.0	0.0	0.0	0.0	22.7	232.7	5.8	0.0	0.0	0.0	0.8	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.4	0.6	42.0	7.5	0.0	0.5	57.9	26.4	0.4	1.3	0.0	0.2	40.1	13.7	14.3	21.8	1.8	20.6	18.2	8.3	27.4	13.2	11.8	27.2	0.0	0.0	0.0	0.1	1.0	1.1	8.1	0.0	0.0	0.0	354.2	3.9	0.1	200.6	0.1	5.3	0.1	0.0	0.0	0.0	0.0	1.9	0.2	1.1	0.0	0.1	4.8	0.0	4.3	0.0	16.2	0.9	0.5	16.9	0.0	0.0	85.5	0.1	0.0	0.0	2.8	2.5	6.5	1.5	0.0	0.4	0.9	0.2	17.0	0.0	0.7
MAPKAPK2		ENSG00000162889	"Mitogen-activated protein kinase-activated protein kinase 2"	P49137	1	206684944-206734283	"Cancer-related genes, Enzymes, Predicted membrane proteins"	"DNA damage"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"plasmacytoid DC: 18.7"	"Lineage enriched"	"Detected in all"	6	"dendritic cells: 18.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010297, HPA045556, HPA063708, HPA064435"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"CAB010297: AB_2250405, HPA045556: AB_2679367, HPA063708: AB_2685100, HPA064435: AB_2685263"	"unprognostic (7.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.27e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (4.58e-6)"	"unprognostic (2.12e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.96e-2)"	"unprognostic (3.29e-2)"	23.0	25.3	11.6	21.2	15.7	58.6	23.9	11.1	14.5	19.3	25.6	17.2	14.5	25.7	20.0	18.5	23.5	17.3	26.0	89.2	12.3	8.7	33.7	26.7	26.7	21.5	16.7	6.5	23.3	19.1	16.9	22.8	13.6	15.7	20.2	14.4	17.8	19.8	14.4	62.9	18.3	32.9	18.3	14.6	37.7	23.1	21.3	14.6	26.9	24.3	25.2	28.2	22.9	46.1	1.1	18.7	3.2	1.1	2.3	1.6	0.5	21.2	8.4	11.7	13.2	34.6	20.3	14.6	14.8	33.7	22.7	21.4	16.1	10.4	10.2	10.4	29.9	14.2	16.1	8.7	15.8	16.3	11.9	6.6	17.2	10.5	10.3	26.7	25.4	57.6	28.0	20.2	21.8	24.1	18.9	18.5	13.9	19.8	46.7	18.3	26.4	10.2	18.4	13.5	7.5	11.8	26.2	24.6	3.3	17.1	13.1	9.4	12.1	17.5	29.6	20.5	22.8	14.4	24.7	17.6	20.5	17.3	23.7	20.2	60.9	54.0	8.3	23.2	15.5	6.7	1.1	0.7	1.4	1.6	1.1	1.5	1.0	1.2	1.5	0.6	1.1	0.6	1.1	3.2	2.3	1.0	18.7	1.4	0.5	11.6	15.7	11.1	14.5	12.3	8.7	16.7	6.5	15.7	14.6	50.6	53.7	28.9	47.2	75.9	11.3	97.2	40.8	6.7	29.6	29.6	19.6	5.0	13.3	28.0	71.3	26.3	27.4	23.3	50.4	7.0	28.6	55.9	34.6	34.4	22.4	0.0	59.3	21.5	27.7	20.1	21.0	27.9	32.1	12.6	32.0	17.7	50.5	21.2	16.3	21.0	14.8	25.8	48.7	11.8	4.1	63.0	13.8	37.4	24.1	68.1
MDH1		ENSG00000014641	"Malate dehydrogenase 1"	P40925	2	63588609-63607197	"Cancer-related genes, Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 155.8"	"Cell type enhanced"	"Detected in all"	12	"Cardiomyocytes: 1859.7;Proximal tubular cells: 683.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA027296, CAB047333, HPA054276"	Uncertain		Supported	Centrosome,Cytosol		NA	NA		63000000	"Centrosome, Cytosol"		"CAB047333: , HPA027296: AB_10611118, HPA054276: AB_2682434"	"unprognostic (1.01e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.61e-2)"	"prognostic unfavorable (7.13e-4)"	"unprognostic (1.83e-1)"	"unprognostic (8.84e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.79e-2)"	"unprognostic (9.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.26e-1)"	"unprognostic (8.80e-2)"	"prognostic favorable (9.95e-4)"	"unprognostic (6.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.97e-2)"	"unprognostic (3.05e-1)"	32.0	28.6	28.0	10.5	58.1	9.2	18.4	38.0	69.5	12.4	21.4	12.5	9.0	19.3	13.4	22.6	16.7	14.7	11.5	155.8	33.6	37.5	47.6	33.2	11.2	14.7	33.4	40.1	10.9	8.9	26.0	18.3	11.4	65.9	16.1	24.9	13.8	15.4	19.9	91.1	11.1	17.1	21.5	18.6	9.4	22.4	8.6	12.2	14.1	15.6	47.1	20.2	15.6	10.2	61.7	57.1	50.7	61.5	46.7	74.5	67.8	44.2	36.3	49.1	32.1	69.7	51.7	50.8	34.9	51.6	53.1	53.9	42.9	39.4	55.8	20.7	45.7	66.4	39.0	55.2	64.6	76.3	33.7	42.6	52.3	33.9	68.2	38.3	60.2	41.5	51.2	44.2	49.8	29.4	43.3	40.5	56.8	28.9	40.6	69.9	26.6	52.7	60.8	28.7	66.4	45.2	42.1	57.8	54.7	88.0	42.0	45.5	27.1	29.2	47.2	66.8	39.1	34.4	62.9	23.6	40.8	40.0	33.9	43.8	50.7	44.4	68.3	50.4	54.5	33.7	50.7	45.8	45.8	52.7	61.5	55.0	61.7	61.3	57.6	57.1	56.4	60.5	57.5	7.0	46.7	55.7	43.3	74.5	67.8	28.0	58.1	38.0	69.5	33.6	37.5	33.4	40.1	65.9	12.2	56.6	41.7	76.8	91.9	72.5	153.0	1859.7	86.6	136.5	79.6	127.4	66.8	222.4	533.9	152.0	8.3	50.1	143.7	70.0	94.8	211.6	90.4	54.0	78.5	143.3	336.7	116.0	60.3	41.1	68.1	11.1	92.6	78.1	168.7	212.0	97.2	112.7	85.3	103.5	102.6	683.5	120.0	58.2	87.6	48.3	49.0	73.4	125.1	76.2	138.8	88.5
MDM1		ENSG00000111554	"Mdm1 nuclear protein"	Q8TC05	12	68272443-68332381	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 49.5;Spermatocytes: 38.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"							"HPA040411, HPA041594"	Uncertain		Supported	Centrosome,Cytosol		NA	NA			Centrosome	Cytosol	"HPA040411: AB_10805711, HPA041594: AB_10793968"	"unprognostic (7.41e-2)"	"prognostic favorable (6.01e-4)"	"unprognostic (8.58e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.50e-3)"	"unprognostic (4.24e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.92e-1)"	"unprognostic (2.56e-3)"	"unprognostic (3.13e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.63e-2)"	"unprognostic (5.23e-3)"	7.0	6.7	11.5	11.9	11.4	15.4	10.0	8.2	12.7	11.9	28.7	9.6	12.4	5.1	15.2	12.7	5.4	20.3	6.5	6.7	12.3	10.0	8.8	4.9	6.8	12.8	11.4	10.5	10.9	11.3	8.8	22.8	6.0	14.9	12.3	11.1	9.0	6.8	15.9	3.8	4.2	9.0	18.8	11.4	9.5	9.8	20.7	12.4	14.6	11.0	5.3	13.4	17.0	8.9	7.1	4.0	13.3	17.2	6.0	8.1	5.4	5.0	4.2	8.1	7.8	4.0	5.5	6.2	6.7	3.7	10.7	9.9	5.0	2.3	11.6	4.4	3.0	5.3	5.2	5.5	3.6	12.2	15.1	5.3	25.4	5.4	3.4	6.2	14.0	10.1	2.5	4.7	7.2	7.0	5.8	6.0	13.4	4.8	13.0	6.2	3.6	19.8	9.9	4.3	5.0	5.1	19.5	7.2	3.4	5.1	4.4	7.4	3.9	6.5	3.9	6.6	6.7	9.3	10.1	3.2	8.6	3.8	5.4	6.1	6.8	19.8	7.8	4.5	9.2	5.5	6.0	4.7	13.3	5.0	11.1	8.1	6.8	6.4	5.2	4.0	7.1	7.7	6.2	3.1	6.0	17.2	2.3	5.9	5.4	11.5	11.4	8.2	12.7	12.3	10.0	11.4	10.5	14.9	12.4	3.0	5.8	13.3	3.9	4.2	12.7	8.1	0.0	49.5	7.9	7.0	0.0	3.7	8.3	4.3	22.5	6.3	1.6	23.3	3.1	3.8	5.8	2.3	6.9	4.2	5.4	7.9	2.4	3.7	2.4	9.0	8.3	7.6	15.1	3.6	2.6	24.9	2.7	3.6	12.7	8.4	32.9	6.5	7.2	38.1	17.8	3.6	0.2	13.6	4.1	1.3
MED20	"DKFZp586D2223, PRO0213, SRB2, TRFP"	ENSG00000124641	"Mediator complex subunit 20"	Q9H944	6	41905354-41921139	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040717	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Centrosome	Nucleoplasm	"HPA040717: AB_10794146"	"unprognostic (1.45e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.58e-3)"	"unprognostic (8.32e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.16e-3)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.48e-5)"	"unprognostic (1.58e-3)"	"unprognostic (4.23e-2)"	"unprognostic (5.10e-2)"	"prognostic favorable (1.17e-4)"	"unprognostic (1.71e-2)"	"unprognostic (4.63e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.31e-1)"	11.8	22.1	12.4	12.1	14.2	7.0	14.2	17.0	15.4	15.3	14.0	16.4	17.4	13.1	16.1	17.8	17.0	13.2	9.9	15.3	12.7	9.5	17.5	14.7	10.4	11.4	14.8	9.3	12.8	17.6	14.5	23.5	17.4	13.8	16.3	15.4	13.2	15.3	14.0	23.0	12.1	15.4	15.3	9.6	13.3	12.9	14.6	11.5	20.9	15.5	13.1	16.4	16.0	12.9	15.0	20.0	13.6	22.1	11.6	10.8	11.5	13.5	11.5	12.4	14.8	11.7	13.0	15.3	8.6	8.3	12.3	9.9	14.6	9.3	18.4	17.1	10.1	7.0	10.3	21.1	11.6	15.6	10.6	6.7	16.5	8.9	12.8	11.2	14.0	10.4	10.1	18.2	11.7	17.6	9.8	15.2	17.8	22.3	8.9	14.7	12.1	15.6	10.0	16.1	43.1	9.3	21.7	14.9	6.6	17.6	8.7	11.5	9.1	12.3	5.8	11.6	15.4	11.7	14.7	14.8	8.7	19.0	5.3	10.6	9.2	12.3	38.9	4.8	15.6	12.3	13.0	19.6	13.6	8.7	22.1	10.8	14.2	5.8	9.8	20.0	15.0	7.9	9.3	7.3	11.6	14.8	17.8	10.2	11.5	12.4	14.2	17.0	15.4	12.7	9.5	14.8	9.3	13.8	11.5	8.9	3.8	7.7	3.5	3.3	2.1	4.0	0.0	4.0	5.7	7.0	0.0	19.8	6.6	5.5	0.4	2.8	5.1	0.0	2.9	15.6	5.3	4.1	6.9	7.3	7.2	1.6	9.2	8.6	6.0	0.0	3.1	3.0	1.7	1.8	6.4	4.0	4.1	3.5	6.3	8.0	3.7	0.0	3.4	4.1	13.4	5.0	20.8	2.5	6.6	4.7
MFAP1	AMP	ENSG00000140259	"Microfibril associated protein 1"	P55081	15	43804492-43824802	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA015583, HPA042370"	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA015583: , HPA042370: AB_10796904"	"unprognostic (1.05e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.28e-2)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (4.08e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.02e-2)"	"prognostic favorable (1.04e-9)"	"unprognostic (1.66e-2)"	"unprognostic (9.68e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.54e-2)"	23.7	32.9	23.8	25.4	25.0	12.5	24.3	35.5	29.2	22.5	19.5	17.7	20.0	15.9	25.2	27.2	28.0	21.2	16.8	21.9	24.6	21.2	28.1	20.0	16.8	26.7	21.5	30.9	29.2	20.0	38.5	33.0	25.2	24.0	26.3	20.7	15.5	21.9	21.8	33.3	24.4	19.3	21.5	26.7	23.9	21.0	21.7	27.3	33.9	28.2	19.2	34.1	24.1	28.2	21.2	20.3	34.3	21.5	29.6	26.0	15.1	15.5	16.2	28.2	18.5	24.0	15.2	17.4	25.1	17.5	20.4	23.9	25.2	10.2	16.7	24.0	15.5	20.8	28.3	25.1	20.5	24.2	28.2	15.0	40.5	29.2	18.8	18.9	24.0	21.7	14.1	22.5	19.5	17.7	19.7	19.9	19.3	36.6	14.4	24.4	11.6	19.5	18.2	19.9	29.1	14.2	28.7	28.3	10.7	21.2	23.3	17.9	17.6	22.1	19.0	10.2	23.5	28.5	15.5	18.8	20.8	14.8	22.8	20.2	17.7	42.6	36.6	17.5	23.0	15.2	21.4	15.8	34.3	23.4	21.5	22.9	21.2	23.4	22.0	20.3	18.6	24.1	23.5	14.4	29.6	17.1	16.7	26.0	15.1	23.8	25.0	35.5	29.2	24.6	21.2	21.5	30.9	24.0	27.3	32.8	24.6	22.3	53.2	27.0	43.5	27.8	22.9	76.3	37.5	48.8	5.9	80.4	48.0	35.7	4.6	33.8	18.8	0.0	25.6	46.4	25.7	30.0	46.1	16.3	30.6	30.2	10.9	19.0	22.6	4.7	25.9	22.6	25.3	32.5	19.6	45.9	21.9	28.1	33.6	32.8	30.7	19.4	23.5	42.6	76.1	24.2	123.1	30.6	18.8	39.7
MT-ND4L	"MTND4L, NAD4L, ND4L"	ENSG00000212907	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L"	P03901	MT	10470-10766	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease mutation, Leber hereditary optic neuropathy, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"blood: 434.4;skeletal muscle: 294.4"	"Group enriched"	"Detected in many"	4	"Cardiomyocytes: 16050.3;Hepatocytes: 4100.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 885.9"	"Low region specificity"	"Detected in all"							HPA075648			Approved	Centrosome,Mitochondria		NA	NA			Mitochondria	Centrosome	"HPA075648: AB_2686760"	"unprognostic (5.81e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.76e-2)"	"unprognostic (7.91e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (4.47e-4)"	"unprognostic (1.97e-1)"	"unprognostic (4.04e-2)"	"unprognostic (4.63e-3)"	"unprognostic (6.61e-2)"	"unprognostic (7.38e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.97e-2)"	"unprognostic (5.68e-2)"	101.1	71.9	102.4	20.3	114.5	13.2	39.4	41.5	73.3	39.4	83.8			48.0	26.1	34.1	30.7	23.9	23.4	187.5	102.7	79.1	123.5	185.7	20.2	13.1	88.6		26.2	43.4	29.7	18.5	30.9		34.2	80.0		43.2	75.4	294.4	31.8	38.4	38.6	59.2	16.1	62.5	27.5			24.6		24.4	25.8	14.3	200.8	111.2	434.4	139.9	112.1	153.0	66.8	97.1	90.4	163.1	166.1	571.6	120.3	71.9	208.6	52.3	32.7	59.8	150.2	89.8	241.1	85.5	140.9	53.6	185.3	25.3	223.3	65.2	94.9	104.4	173.3	885.9	279.0	83.9	178.2	155.8	210.6	228.8	62.4	218.5	246.4	65.5	125.0	95.5	172.9	119.9	173.6	67.7	228.6	41.1	103.4	109.2	39.3	70.3	107.2	174.1	205.2	49.5	67.0	102.3	162.1	69.9	366.4	115.3	224.3	209.4	86.0	107.1	125.8	79.8	156.5	73.2	128.4	61.7	242.4	40.1	434.4	139.9	290.0	102.4	110.6	140.6	166.9	110.0	117.5	86.1	200.8	132.4	153.0	78.4	112.1	99.4	111.2	79.0	66.8											208.4	153.9	1221.6	193.7	203.1	0.0	16050.3	1630.6	940.9	684.7	307.1	0.0	0.0	76.3	127.4	46.0	141.8	949.6	2499.6	297.1	0.0	116.0	126.2	448.0	4100.6	0.0	0.0	246.6	1665.3	1966.8	217.5	386.3	249.3	243.0	242.5	657.8	0.0	237.0	573.3	217.1	415.7	0.0	342.8	211.1	226.8	167.2	211.8	0.0	631.2	458.3	137.0
MTMR9	"C8orf9, DKFZp434K171, LIP-STYX, MTMR8"	ENSG00000104643	"Myotubularin related protein 9"	Q96QG7	8	11284416-11328146	"Plasma proteins, Predicted intracellular proteins"	Endocytosis		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 65.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070944			Approved	"Actin filaments,Centrosome"		NA	NA			Centrosome	"Actin filaments"	"HPA070944: AB_2686325"	"unprognostic (1.97e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.64e-2)"	"unprognostic (8.09e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.43e-2)"	8.2	7.0	11.5	7.5	14.0	8.0	9.2	18.2	26.2	6.6	9.9	10.3	2.7	4.4	8.3	5.7	6.4	5.6	5.9	12.9	11.6	14.4	8.2	5.7	6.6	6.9	11.7	12.2	6.9	7.2	9.4	8.4	7.8	13.1	9.3	6.3	6.4	4.8	7.6	9.1	6.9	5.2	11.1	10.8	6.6	5.3	16.8	7.4	8.2	7.1	3.7	7.4	6.4	5.6	4.5	4.1	3.6	3.9	2.3	3.7	1.2	2.6	7.3	6.6	5.2	8.2	7.0	5.2	8.3	5.5	6.7	6.2	6.6	2.0	6.8	2.2	9.9	6.3	3.8	7.3	7.3	7.7	1.4	4.5	9.0	5.9	3.3	8.9	2.3	5.3	6.9	5.9	9.5	12.1	5.5	10.4	4.1	6.1	5.5	10.8	2.0	4.0	2.4	11.9	7.8	4.4	2.9	10.8	2.1	7.3	6.7	2.5	10.1	5.6	2.5	5.9	11.0	3.0	4.8	12.9	7.9	5.9	4.4	4.4	1.5	3.0	3.9	6.6	5.1	7.7	1.5	3.2	3.6	3.2	3.9	2.8	3.5	2.7	2.7	2.8	4.5	3.2	3.7	3.1	2.3	3.2	4.1	2.0	1.2	11.5	14.0	18.2	23.2	11.6	14.4	11.7	12.2	13.1	7.4	11.9	12.6	15.9	10.8	12.0	0.0	22.1	30.6	13.4	13.6	14.0	0.0	9.8	3.3	10.1	9.5	16.1	8.4	0.0	6.1	11.2	15.4	20.3	13.9	12.9	12.6	0.0	15.5	26.4	20.8	5.2	21.6	22.5	15.1	13.6	9.7	0.0	10.9	6.8	18.4	9.1	0.0	38.8	13.9	65.6	27.4	11.3	3.8	21.8	8.2	7.3
MYO18B	BK125H2.1	ENSG00000133454	"Myosin XVIIIB"		22	25742144-26031041	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in some"	5	"skeletal muscle: 141.2"	"Group enriched"	"Detected in some"	45	"Cardiomyocytes: 88.1;Early spermatids: 50.3;Late spermatids: 28.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.8;REH: 11.2;RH-30: 23.8;U-2 OS: 10.5;U-266/70: 7.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA000953	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"HPA000953: AB_1079440"	"unprognostic (3.28e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.01e-2)"	"unprognostic (5.93e-4)"	"unprognostic (2.46e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.14e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.96e-3)"	"unprognostic (3.93e-7)"	"unprognostic (1.14e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.65e-1)"	3.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.4	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	1.0	0.0	141.2	0.1	0.0	1.5	0.0	0.0	0.3	2.4	0.0	0.3	1.1	16.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	4.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.7	2.9	0.0	0.3	1.2	0.0	0.0	0.0	11.2	23.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.5	0.0	0.0	7.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	28.5	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.0
MZT2A	"FAM128A, MOZART2A"	ENSG00000173272	"Mitotic spindle organizing protein 2A"	Q6P582	2	131464900-131492743	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 31.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 70.8"									"HPA051758, HPA052623"	Approved		Supported	Centrosome,Cytosol		NA	NA			Centrosome	Cytosol	"HPA051758: , HPA052623: AB_2681888"	"prognostic favorable (3.04e-4)"	"unprognostic (3.82e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.39e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.44e-2)"	"unprognostic (6.47e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavorable (3.04e-11)"	"unprognostic (1.51e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.66e-1)"	17.7	17.1	34.7	22.1	22.6	31.3	17.1	9.6	25.1	17.5	20.3	7.6	23.0	30.0	11.9	22.3	23.5	14.0	17.5	57.5	28.0	20.7	14.4	15.9	7.5	15.6	18.9	16.4	20.8	55.4	5.6	7.2	5.3	8.8	16.4	3.4	9.3	48.5	19.7	40.7	12.6	22.8	17.3	12.0	15.5	24.0	11.1	5.5	28.3	17.8	23.8	17.0	16.2	12.8	11.9	5.4	31.9	1.0	2.6	9.3	2.2	36.0	19.5	0.4	7.5	0.5	1.3	7.8	12.2	2.9	4.7	4.6	47.7	12.5	23.4	15.9	0.5	0.5	16.3	1.2	8.2	0.1	9.2	59.4	9.6	21.8	56.4	2.9	16.8	3.6	3.7	4.5	3.0	1.4	1.0	3.8	20.6	18.9	24.6	1.1	32.6	23.2	70.8	12.6	4.6	44.6	19.8	6.7	52.3	2.9	16.7	28.3	3.5	12.4	8.5	22.3	0.3	13.3	30.4	10.7	12.4	30.2	5.2	11.9	23.1	17.1	18.8	17.4	10.9	7.3	6.9	1.0	31.9	3.8	0.6	4.2	11.9	8.5	4.9	3.4	6.2	9.3	4.5	0.4	2.6	0.3	5.4	8.4	2.2	34.7	22.6	9.6	23.1	28.0	20.7	18.9	16.4	8.8	5.5	14.9	14.4	124.6	117.1	131.5	40.9	255.9	112.1	8.1	19.4	68.0	19.6	68.5	144.2	181.3	20.5	65.2	170.0	23.3	144.3	204.7	90.3	143.8	24.1	118.5	108.3	25.4	104.6	85.3	77.6	66.4	141.5	90.6	97.8	130.8	207.2	54.1	253.1	157.8	193.0	188.7	35.9	90.5	69.3	35.8	155.3	125.0	35.5	160.8	232.9	112.8
MZT2B	"FAM128B, FLJ14346, MOZART2B"	ENSG00000152082	"Mitotic spindle organizing protein 2B"	Q6NZ67	2	130181737-130190729	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 93.9"									"HPA051758, HPA052623"	Approved		Supported	Centrosome,Cytosol		NA	NA			Centrosome	Cytosol	"HPA051758: , HPA052623: AB_2681888"	"unprognostic (8.09e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (9.65e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (9.37e-8)"	"unprognostic (1.67e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.09e-1)"	28.9	39.1	50.8	23.9	33.5	63.4	23.8	19.5	35.1	24.3	31.3	14.4	27.7	34.2	24.7	24.0	30.6	19.4	26.7	56.6	33.7	29.3	22.5	31.1	14.4	27.8	32.8	33.3	31.0	104.2	10.9	17.1	16.2	19.7	28.4	11.6	18.6	63.6	24.9	87.5	20.9	32.1	31.8	21.7	26.8	33.8	26.1	15.4	35.3	36.0	27.1	22.2	24.4	34.9	15.3	21.7	31.7	9.3	12.1	13.3	4.9	41.2	17.4	4.4	21.2	1.7	6.4	20.5	19.8	7.3	7.6	5.6	35.6	21.5	22.7	30.9	4.5	5.1	23.4	2.3	6.5	1.2	33.6	53.9	12.3	25.5	38.9	7.6	16.1	12.2	7.0	9.1	5.1	2.6	5.7	8.4	30.0	16.1	34.0	5.5	47.8	36.1	93.9	14.1	8.7	32.0	42.2	11.1	71.2	4.5	13.7	30.7	37.6	11.9	21.6	32.1	2.0	25.5	47.8	15.0	22.1	35.8	17.6	18.7	41.4	25.9	28.0	33.3	23.9	15.9	0.1	9.3	31.7	7.7	9.1	6.2	15.3	11.3	10.7	11.2	14.8	13.3	10.7	4.6	12.1	8.4	21.7	8.7	4.9	50.8	33.5	19.5	35.1	33.7	29.3	32.8	33.3	19.7	15.4	38.7	21.9	238.2	264.1	264.0	158.4	293.3	170.7	40.2	50.0	230.3	41.2	229.1	396.3	323.5	266.4	198.6	241.8	140.2	511.3	411.3	250.4	326.9	50.7	320.9	295.2	123.9	166.1	171.9	146.8	852.0	231.3	260.0	254.8	212.0	316.3	142.6	514.2	241.6	135.1	586.2	76.3	161.7	241.9	132.8	161.7	329.7	138.1	211.9	294.6	315.0
N4BP3	LZTS4	ENSG00000145911	"NEDD4 binding protein 3"	O15049	5	178113443-178126087	"Predicted intracellular proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 31.5"	"Cell type enriched"	"Detected in many"	4	"Extravillous trophoblasts: 120.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 4.0;naive B-cell: 4.0;naive CD8 T-cell: 2.6;plasmacytoid DC: 4.4"	"Group enriched"	"Detected in many"	18	"B-cells: 4.0;dendritic cells: 4.4;T-cells: 2.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 8.0;MCF7: 10.9;RH-30: 10.9;SK-BR-3: 38.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030972, HPA030973, HPA061387"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA030972: AB_2673680, HPA030973: AB_10603574, HPA061387: "	"unprognostic (1.84e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.96e-3)"	"unprognostic (6.64e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.88e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.28e-3)"	"unprognostic (9.55e-2)"	"prognostic favorable (2.38e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	6.6	1.3	1.9	2.6	2.1	3.5	13.9	6.5	4.3	2.5	1.8	0.7	0.5	0.8	1.1	0.6	16.2	1.5	1.3	3.2	1.8	2.6	2.5	0.2	8.4	4.0	2.1	1.2	1.4	1.1	10.1	2.5	31.5	3.1	2.0	0.6	1.5	9.5	1.3	5.7	7.8	1.9	1.3	1.2	5.9	3.1	1.4	1.3	0.4	2.0	4.7	11.2	4.9	3.8	4.0	4.4	0.0	0.0	0.2	2.6	0.5	0.0	0.0	1.2	0.9	0.1	0.0	8.0	0.0	0.0	0.0	0.0	1.7	0.6	0.7	1.1	0.0	0.1	2.5	0.2	0.0	0.0	1.2	0.4	2.1	0.8	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	6.4	0.7	1.3	0.5	0.0	10.9	0.1	0.1	6.0	1.8	0.0	6.0	10.9	2.7	0.6	1.2	0.9	0.4	0.3	38.8	2.5	1.6	1.4	0.0	1.2	0.0	0.9	0.0	0.0	1.7	1.2	6.8	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.3	4.0	0.2	0.2	0.0	4.0	0.9	2.6	0.0	0.2	0.0	4.4	0.0	0.5	1.9	2.1	6.5	4.3	1.8	2.6	2.1	1.2	3.1	1.3	3.0	1.1	5.9	11.5	8.4	27.3	1.5	2.5	0.0	0.0	1.8	11.8	1.7	11.6	3.4	0.1	4.0	2.6	0.0	0.7	120.1	0.9	9.9	4.6	0.0	2.0	1.6	4.1	0.0	0.0	0.4	0.6	1.1	11.8	1.8	1.8	1.9	4.7	5.3	1.8	0.3	8.9	0.0	0.9	0.1	6.9	5.9	19.3	1.0	1.9	10.6
N6AMT1	"C21orf127, HEMK2, MTQ2, N6AMT, PRED28"	ENSG00000156239	"N-6 adenine-specific DNA methyltransferase 1"	Q9Y5N5	21	28872191-28885371	"Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB034133, CAB034135, HPA059242"	Approved		Approved	Nucleoplasm,Centrosome		Yes	No			Centrosome	Nucleoplasm	"CAB034133: AB_2147189, CAB034135: AB_2250945, HPA059242: AB_2683957"	"unprognostic (2.20e-2)"	"unprognostic (4.93e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.24e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.43e-2)"	"unprognostic (5.51e-3)"	5.4	10.9	10.1	6.0	18.6	2.0	10.5	7.4	14.8	9.9	7.0	17.0	6.0	6.7	13.8	13.7	5.6	9.3	6.2	10.8	10.8	9.2	9.0	6.3	5.5	6.7	21.3	8.4	18.3	6.6	14.6	15.6	13.1	14.1	10.1	7.4	8.4	6.5	9.0	11.3	8.0	6.2	7.8	14.5	7.9	6.7	7.6	19.3	3.9	12.1	4.0	6.9	8.7	9.2	2.2	2.0	1.6	2.1	4.1	4.8	1.8	3.4	3.1	7.8	10.8	6.5	7.2	6.0	7.4	3.1	4.4	2.6	3.8	6.2	3.8	3.8	4.0	7.8	4.1	6.6	3.7	5.4	4.8	5.1	8.0	4.7	4.8	5.8	4.8	3.1	3.7	8.0	4.4	3.1	8.2	3.2	4.7	9.9	6.8	9.0	3.4	2.3	3.9	9.8	7.2	4.3	3.4	7.4	2.9	8.0	5.0	5.9	8.3	6.7	2.4	2.7	7.3	3.3	4.2	7.5	3.7	6.6	6.7	4.5	4.1	4.6	2.1	5.8	12.6	6.8	1.1	1.5	1.6	1.8	2.1	2.0	2.2	3.4	2.3	2.0	2.2	4.8	3.4	0.5	4.1	1.6	1.7	1.4	1.8	10.1	18.6	7.4	14.8	10.8	9.2	21.3	8.4	14.1	19.3	3.0	4.8	1.4	5.3	1.6	11.1	14.0	7.6	21.4	6.8	12.2	7.9	15.0	6.6	9.7	2.5	4.9	0.9	23.3	5.5	9.8	6.1	3.4	1.1	2.8	6.2	9.5	0.0	4.9	1.2	3.4	8.9	2.6	1.7	2.8	2.6	10.3	6.4	4.8	9.6	7.3	10.0	0.0	8.2	2.6	8.1	3.1	12.5	2.5	3.3	4.8
NDC80	"HEC, HEC1, hsNDC80, KNTC2, TID3"	ENSG00000080986	"NDC80, kinetochore complex component"	O14777	18	2571511-2616635	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 51.3"	"Cell type enhanced"	"Detected in many"	15	"Erythroid cells: 23.3;Spermatocytes: 84.6;Spermatogonia: 25.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 7.9;granulocytes: 9.3;T-cells: 11.5"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA066330			Supported	Nucleoplasm,Centrosome		NA	Yes			Nucleoplasm	Centrosome	"HPA066330: AB_2685661"	"unprognostic (1.96e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.63e-2)"	"prognostic unfavorable (2.53e-8)"	"unprognostic (1.16e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.86e-2)"	"unprognostic (3.19e-3)"	"unprognostic (7.74e-2)"	"unprognostic (0.00e+0)"	"unprognostic (9.69e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.71e-1)"	2.9	1.3	0.8	15.3	0.8	14.6	0.9	0.7	0.9	2.9	3.8	0.8	0.6	2.7	4.2	3.8	8.3	1.3	1.8	2.7	0.6	0.4	1.6	1.4	2.9	10.1	0.6	0.8	1.2	0.8	0.0	0.6	6.0	1.1	4.3	5.1	0.8	1.9	7.6	0.6	4.0	4.8	2.2	0.6	7.9	3.0	15.9	0.6	51.3	0.9	8.1	9.9	2.2	6.7	7.9	1.6	9.3	0.7	2.2	11.5	1.4	21.9	5.0	24.8	11.0	1.3	3.0	12.8	25.8	13.9	33.8	28.9	13.6	12.5	24.0	11.7	10.0	14.3	13.6	27.7	11.1	35.8	9.0	7.0	18.9	14.2	10.4	0.5	36.2	15.9	1.5	1.0	19.4	13.8	3.5	15.3	14.9	15.4	30.6	29.5	9.9	17.6	15.8	12.8	14.2	7.3	19.5	25.4	19.2	8.8	10.6	20.1	9.0	23.6	6.2	9.4	10.3	10.4	14.5	9.3	22.1	49.2	17.4	34.0	13.4	21.1	32.2	9.7	16.8	18.6	3.7	0.7	2.8	2.2	0.6	2.0	7.9	3.7	4.3	0.3	5.7	2.4	2.4	9.3	2.2	0.5	1.6	11.5	1.4	0.8	0.8	0.7	0.9	0.6	0.4	0.6	0.8	1.1	0.6	0.0	1.1	3.7	0.8	2.1	0.0	17.3	0.0	1.4	3.4	0.0	0.0	1.7	0.0	0.9	9.7	0.3	0.2	23.3	0.3	20.1	1.9	0.1	0.0	0.0	9.3	0.0	0.0	6.2	2.5	3.6	6.9	2.2	0.0	0.0	0.9	0.0	0.2	0.0	21.9	0.1	0.0	19.4	3.1	84.6	25.0	0.5	1.7	6.9	2.3	0.9
NEK2	"NEK2A, NLK1, PPP1R111, RP67"	ENSG00000117650	"NIMA related kinase 2"	P51955	1	211658657-211675630	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.0;testis: 41.0"	"Cell type enhanced"	"Detected in many"	22	"Early spermatids: 44.4;Erythroid cells: 93.5;Spermatocytes: 191.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 3.2"	"Not detected"	"Not detected"			"CAB017530, HPA064967"	Enhanced		Supported	Nucleoplasm,Centrosome		NA	Yes			"Nucleoplasm, Centrosome"		"CAB017530: AB_1126558, HPA064967: AB_2685393"	"unprognostic (1.28e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (9.47e-6)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.95e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.09e-3)"	"unprognostic (8.49e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.21e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.71e-1)"	1.1	0.7	0.6	6.7	0.5	7.4	1.3	0.3	0.9	0.9	2.5	0.3	0.3	3.4	0.3	1.2	4.2	0.7	1.4	0.9	1.0	0.3	0.6	0.6	1.0	3.9	0.3	0.3	0.6	0.3	0.0	0.3	1.2	0.4	0.9	3.6	0.4	1.0	0.3	0.3	1.8	3.0	0.6	0.6	1.6	1.1	41.0	0.4	14.0	0.3	1.5	4.8	0.6	1.6	1.8	0.9	2.7	0.5	3.9	4.3	0.9	30.7	22.2	17.0	12.2	1.0	1.7	18.8	11.9	11.2	21.0	18.1	11.8	30.3	16.4	5.7	9.2	13.3	16.5	14.8	8.9	26.5	25.0	12.3	7.8	19.4	15.9	0.1	15.4	10.7	0.5	1.1	16.1	17.4	5.1	13.5	16.7	21.4	28.8	21.0	8.6	16.8	10.4	16.1	19.9	11.4	16.6	26.1	24.9	7.3	8.8	15.4	17.1	17.2	19.2	14.9	15.2	29.6	9.2	7.0	10.5	20.8	20.6	31.9	11.9	22.0	21.7	9.1	11.9	17.4	2.7	0.5	0.4	0.5	0.3	0.2	1.5	0.6	0.3	0.1	1.8	1.1	0.7	2.4	3.9	0.4	0.9	4.3	0.9	0.6	0.5	0.3	0.9	1.0	0.3	0.3	0.3	0.4	0.4	0.0	0.3	0.8	0.5	2.6	0.7	0.4	0.0	2.7	3.4	0.0	0.0	0.9	0.0	0.1	44.4	0.1	1.1	93.5	0.2	11.4	0.2	0.3	0.0	0.0	4.7	3.2	0.0	2.5	2.8	28.5	2.3	1.1	0.0	0.0	1.2	0.8	0.0	0.8	0.7	0.0	1.9	6.5	0.0	191.1	25.4	1.5	1.1	0.7	2.3	0.9
NIT2		ENSG00000114021	"Nitrilase family member 2"	Q9NQR4	3	100334701-100361635	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 41.1"	"Cell type enhanced"	"Detected in many"	10	"Proximal tubular cells: 436.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036999, HPA041289"	Approved		Supported	Centrosome,Cytosol		NA	NA		960000	Cytosol	Centrosome	"HPA036999: AB_10672105, HPA041289: "	"unprognostic (3.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.06e-3)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (6.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.60e-3)"	"unprognostic (2.21e-1)"	"unprognostic (6.68e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.47e-3)"	9.9	7.4	6.7	5.4	9.9	5.9	12.4	3.7	10.5	6.4	7.2	6.1	10.6	5.5	6.6	13.3	9.2	7.9	7.1	7.4	5.8	6.3	29.8	41.1	5.6	8.9	5.9	8.0	7.2	8.5	4.7	7.6	4.9	7.7	7.2	6.8	11.3	8.2	10.2	14.7	7.7	5.3	7.0	5.4	5.7	6.8	3.3	3.3	4.4	10.8	14.5	10.5	8.2	5.6	4.2	5.9	1.5	2.4	3.0	4.3	1.3	9.9	9.9	1.2	5.2	8.9	12.1	6.2	4.1	6.1	9.7	9.3	8.4	11.2	10.0	6.2	5.9	4.2	7.5	4.5	11.0	11.6	3.1	2.3	7.2	3.2	4.3	10.9	4.7	4.9	7.6	16.8	5.2	8.5	5.1	6.2	5.7	3.3	8.1	11.8	9.5	3.1	4.3	4.4	12.5	15.1	3.5	4.2	9.8	16.0	6.3	6.9	3.2	5.6	9.6	6.1	3.3	7.1	4.5	4.5	6.1	2.5	2.9	3.5	5.0	5.5	8.5	9.6	8.0	7.7	0.4	2.4	1.1	3.3	2.1	4.3	4.2	3.1	2.5	5.9	3.7	3.6	3.5	1.5	3.0	1.6	1.8	3.1	1.3	6.7	9.9	3.7	10.5	5.8	6.3	5.9	8.0	7.7	3.3	11.9	12.1	26.5	41.3	29.0	11.3	49.4	30.6	38.8	26.1	55.8	15.7	80.0	159.2	63.8	2.3	15.5	14.9	0.0	46.2	64.1	34.7	40.0	20.7	147.3	56.1	12.7	23.1	16.0	18.8	2.4	40.9	33.3	47.2	136.1	20.8	11.7	55.0	25.7	35.3	436.2	23.6	38.8	46.4	1.5	14.5	36.4	49.5	26.2	34.7	40.6
NLRC5	"CLR16.1, FLJ21709, NOD27"	ENSG00000140853	"NLR family CARD domain containing 5"	Q86WI3	16	56989485-57083531	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"B-cells: 22.9;T-cells: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 41.5;NB-4: 22.8;U-2197: 15.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA060405, HPA074724"			Supported	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA060405: AB_2684277, HPA074724: "	"unprognostic (9.66e-2)"	"prognostic favorable (9.69e-4)"	"unprognostic (1.64e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.12e-1)"	"unprognostic (9.27e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.24e-2)"	"prognostic favorable (2.30e-4)"	"unprognostic (2.69e-1)"	"unprognostic (3.46e-1)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (2.99e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.75e-3)"	10.0	5.7	3.4	26.4	7.0	24.9	6.0	1.6	6.2	5.4	7.0	4.2	2.9	4.9	10.8	4.4	6.4	4.9	8.9	3.7	4.3	2.4	5.5	5.5	12.8	21.3	7.0	2.0	3.9	3.6	2.1	20.2	2.3	6.0	5.2	5.6	4.7	8.9	3.0	3.5	10.9	16.1	5.8	7.8	24.6	7.2	1.3	6.3	9.4	5.9	6.6	29.7	7.3	7.0	5.4	1.7	13.2	4.0	2.7	7.0	2.7	4.9	0.9	0.1	0.3	0.3	1.7	0.0	2.7	4.3	8.8	8.6	0.0	8.6	10.1	2.1	4.5	3.5	3.3	1.1	0.3	1.0	0.4	0.3	41.5	8.8	1.0	3.1	1.4	2.5	3.3	0.1	7.1	0.8	2.8	3.4	1.4	0.0	2.0	1.8	0.1	2.2	22.8	0.0	0.1	0.9	10.8	3.1	4.2	1.0	0.4	0.3	0.3	5.6	0.5	1.2	0.0	0.6	5.5	4.3	4.2	1.5	15.4	2.2	4.1	2.1	10.3	7.5	3.1	0.8	6.4	4.0	13.2	7.0	2.2	4.2	5.4	4.0	6.6	1.7	3.1	2.6	2.7	9.8	2.7	2.5	1.3	4.6	2.7	3.4	7.0	1.6	6.2	4.3	2.4	7.0	2.0	6.0	6.3	0.0	15.7	22.9	0.8	6.1	0.4	3.1	0.0	2.7	5.7	5.2	0.0	0.0	0.0	5.5	0.4	10.5	19.1	0.0	7.2	0.1	2.8	1.7	9.2	3.9	4.4	0.0	8.1	9.8	17.0	0.0	0.9	7.3	0.0	6.4	10.5	0.3	6.9	10.5	0.4	0.6	1.3	0.0	5.7	0.0	0.0	8.7	0.1	30.5	9.0	3.8
NUDT17	FLJ34433	ENSG00000186364	"Nudix hydrolase 17"	P0C025	1	145845629-145848953	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Muller glia cells: 9.0;Spermatogonia: 11.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 5.8;eosinophil: 11.5;plasmacytoid DC: 18.4"	"Group enriched"	"Detected in many"	8	"dendritic cells: 18.4;granulocytes: 11.5"	"Cell line enhanced"	"Detected in many"		"T-47d: 14.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030145	Approved		Approved	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"HPA030145: AB_10603883"	"unprognostic (8.93e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.63e-3)"	"unprognostic (8.72e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (1.07e-3)"	"unprognostic (6.55e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.40e-2)"	"prognostic unfavorable (1.81e-7)"	"unprognostic (5.59e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.96e-1)"	4.6	3.3	8.3	3.9	13.5	6.7	4.9	8.9	10.9	3.8	3.4	5.1	1.5	1.2	4.6	3.1	3.5	7.0	4.4	8.4	6.6	7.7	3.8	2.6	3.4	9.0	5.9	8.1	6.8	6.2	6.2	4.7	2.2	5.4	4.2	2.9	8.0	6.3	5.8	6.7	4.3	3.3	11.1	5.5	6.0	3.3	7.1	2.2	3.5	5.7	3.4	7.7	4.1	3.2	0.9	18.4	11.5	1.8	0.2	1.1	0.7	4.2	3.1	2.9	1.6	1.6	2.4	2.9	2.0	3.4	2.1	3.0	1.9	3.1	6.2	2.2	3.5	0.5	0.8	2.1	1.2	1.4	0.7	3.6	2.4	2.5	2.8	4.7	1.9	8.0	2.5	2.0	1.4	2.4	2.7	4.2	10.1	5.2	5.8	3.8	6.7	2.1	3.6	2.4	2.6	0.3	5.4	1.1	1.9	3.3	1.0	1.4	3.2	1.3	2.6	3.5	3.1	14.5	8.6	2.5	2.5	1.7	1.2	0.8	5.1	2.4	1.5	2.4	2.6	1.9	5.8	0.6	11.5	0.6	1.8	0.4	0.9	0.5	0.3	0.6	0.6	1.1	0.8	0.1	0.2	1.1	18.4	0.5	0.7	8.3	13.5	8.9	10.9	6.6	7.7	5.9	8.1	5.4	2.2	3.0	5.6	0.0	0.9	1.5	1.9	0.4	0.0	2.7	4.5	0.0	0.0	0.4	1.7	1.2	2.9	1.0	0.7	0.0	0.6	0.6	1.9	0.9	2.3	0.6	2.6	0.0	1.2	2.5	0.8	1.3	1.4	1.2	1.7	0.0	0.2	9.0	1.2	0.6	0.4	0.6	3.9	0.0	1.4	6.9	11.7	1.1	0.5	1.3	1.2	0.7
PAOX	PAO	ENSG00000148832	"Polyamine oxidase"	Q6QHF9	10	133379234-133391694	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 36.7"	"Group enriched"	"Detected in many"	11	"Early spermatids: 115.5;Late spermatids: 346.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 4.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 6.4;K-562: 5.0;U-266/70: 18.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047782			Uncertain	Nucleoplasm,Centrosome		NA	NA			Centrosome	Nucleoplasm	"HPA047782: "	"unprognostic (3.67e-3)"	"prognostic favorable (6.07e-5)"	"unprognostic (2.49e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.96e-2)"	"prognostic favorable (1.38e-5)"	"unprognostic (7.39e-2)"	"unprognostic (1.99e-3)"	"unprognostic (2.20e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.99e-1)"	"prognostic favorable (9.49e-4)"	"unprognostic (3.56e-2)"	"unprognostic (2.86e-1)"	"unprognostic (7.61e-2)"	"unprognostic (8.29e-3)"	6.7	4.1	4.3	5.8	6.7	1.5	4.7	6.8	8.7	3.7	6.0	10.8	5.6	5.6	3.7	1.8	7.4	3.4	2.4	2.5	5.7	2.7	8.9	9.2	2.8	5.2	10.0	3.4	3.6	3.2	1.9	2.5	2.1	4.2	4.8	1.5	2.8	9.9	5.1	3.5	4.4	8.5	2.8	4.7	8.2	7.5	36.7	7.6	0.7	2.4	2.1	5.4	4.6	4.2	4.3	1.1	1.0	1.0	1.7	0.3	0.4	6.4	0.0	0.2	1.2	0.0	0.7	1.6	2.9	1.2	1.4	0.2	1.1	0.1	0.0	0.9	0.6	0.8	3.5	0.4	0.8	0.6	4.2	0.5	0.6	0.0	0.2	1.7	0.0	1.0	0.1	0.3	0.9	0.4	0.0	0.1	0.0	5.0	0.3	0.0	0.1	0.0	0.1	1.2	0.0	3.0	4.6	0.0	0.0	0.2	0.0	0.3	2.2	0.9	0.1	0.0	0.0	1.4	0.0	2.8	0.3	1.4	1.2	0.0	18.5	3.4	1.7	0.0	0.0	0.1	1.0	0.3	0.0	0.2	1.0	0.0	1.6	0.3	0.2	1.1	4.3	0.0	0.0	0.0	1.7	0.9	0.8	0.0	0.4	4.3	6.7	6.8	6.5	5.7	2.7	10.0	3.4	4.2	7.6	0.0	5.8	20.9	6.2	3.3	1.5	1.5	5.1	1.4	0.0	1.8	0.0	0.7	5.0	4.5	115.5	2.3	6.8	0.0	3.0	1.7	2.3	4.8	5.7	11.3	4.1	4.8	0.0	3.7	10.4	346.0	8.9	3.9	0.0	17.2	3.4	7.7	2.9	2.9	7.4	13.2	2.7	19.4	2.5	9.9	3.0	3.1	0.2	4.6	3.2	8.6
PCDH9		ENSG00000184226	"Protocadherin 9"	Q9HC56	13	66302834-67230445	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 16.5;brain: 47.0"	"Cell type enhanced"	"Detected in many"	16	"Bipolar cells: 324.5;Cardiomyocytes: 94.6;Horizontal cells: 187.5;Muller glia cells: 87.9"	"Cancer enriched"	"Detected in single"	8	"glioma: 2.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"naive B-cell: 16.5"	"Lineage enriched"	"Detected in many"	7	"B-cells: 16.5"	"Cell line enhanced"	"Detected in many"		"AF22: 12.6;LHCN-M2: 20.8;TIME: 24.1;U-698: 31.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015581			Approved	Nucleoplasm,Centrosome		NA	NA		1300000	"Nucleoplasm, Centrosome"		"HPA015581: AB_1855048"	"unprognostic (1.77e-1)"	"unprognostic (8.36e-2)"	"unprognostic (9.12e-3)"	"unprognostic (4.42e-5)"	"unprognostic (7.54e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.35e-1)"	"unprognostic (8.21e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.47e-4)"	"unprognostic (6.44e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.35e-4)"	4.5	3.2	18.4	1.1	24.7	4.1	1.5	6.7	47.0	1.8	1.3	7.8	0.0	0.9	1.0	2.1	1.0	1.1	2.4	5.7	15.0	10.0	3.5	2.3	2.3	1.4	21.4	11.0	1.4	2.0	0.7	1.3	0.7	16.6	2.5	1.3	0.0	1.0	5.6	2.0	0.9	1.0	1.2	11.0	1.6	1.7	1.6	18.9	0.7	1.8	0.0	1.4	1.1	0.6	16.5	1.0	2.5	0.0	0.7	0.1	0.2	0.0	9.5	12.6	0.0	3.4	2.6	0.0	1.9	0.1	1.3	0.5	0.0	0.0	2.7	0.0	1.4	0.4	0.0	1.0	0.3	0.6	0.0	5.0	0.1	0.1	0.0	3.3	0.3	0.1	6.3	0.3	1.5	2.5	0.3	1.0	1.1	0.3	0.1	20.8	0.7	5.7	0.0	0.1	0.2	1.2	8.7	0.4	0.0	0.2	0.0	1.6	0.6	0.0	0.1	0.1	0.3	0.0	0.0	24.1	0.7	0.6	2.9	1.0	3.7	0.0	31.7	5.4	0.0	2.5	2.5	0.0	0.1	0.0	0.0	0.0	3.7	0.0	0.0	0.0	16.5	0.1	0.1	0.1	0.7	0.0	1.0	0.0	0.2	18.4	24.7	6.7	24.6	15.0	10.0	21.4	11.0	16.6	18.9	17.9	45.8	7.2	2.3	1.6	324.5	94.6	0.0	0.0	7.9	5.2	19.6	0.1	8.3	1.7	3.0	2.9	0.0	0.0	0.0	0.2	8.7	2.6	1.1	3.4	0.2	187.5	60.1	19.0	2.2	2.2	27.3	1.0	10.1	0.0	0.2	87.9	0.2	0.3	13.8	0.6	25.3	6.5	25.0	4.7	5.8	0.3	0.0	1.7	0.4	0.7
PGBD4	"FLJ32638, FLJ37497"	ENSG00000182405	"PiggyBac transposable element derived 4"	Q96DM1	15	34102073-34108684	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 18.6"	"Cell type enhanced"	"Detected in many"	4	"Sertoli cells: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA040896, HPA059823"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA040896: AB_10805831, HPA059823: AB_2684134"	"unprognostic (9.54e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.51e-2)"	"unprognostic (7.43e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.35e-2)"	"unprognostic (6.47e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.32e-3)"	"unprognostic (9.70e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.15e-2)"	"unprognostic (7.73e-2)"	2.5	3.6	3.9	4.1	8.5	6.7	3.4	5.3	11.1	2.6	2.8	4.8	4.7	3.2	2.6	3.9	3.8	4.6	2.4	4.0	5.4	3.6	3.4	5.3	2.4	5.2	6.0	6.1	3.0	4.6	4.9	6.7	2.5	12.7	3.0	3.4	3.2	3.3	2.6	18.6	4.4	5.1	2.2	4.0	6.0	4.5	7.9	5.8	4.5	3.3	2.0	4.2	3.2	2.7	2.8	1.7	6.4	1.4	1.6	2.6	0.6	2.0	3.6	2.5	4.1	7.4	4.9	1.5	3.1	3.0	2.0	2.5	2.5	2.7	4.1	2.6	2.4	4.0	5.6	1.4	3.6	2.5	4.3	3.8	6.7	6.9	1.8	3.1	2.3	6.1	3.8	4.1	2.6	4.7	3.4	2.2	7.6	4.6	5.0	4.1	1.4	3.7	5.4	1.0	4.1	2.7	5.6	3.4	2.1	2.6	4.2	3.7	3.4	1.6	3.5	1.1	3.1	3.5	3.6	2.5	6.1	3.5	3.2	2.0	5.9	3.8	2.3	5.4	5.2	3.6	6.4	1.4	1.5	1.3	1.2	1.1	1.5	1.7	1.3	0.8	2.8	2.6	2.4	3.2	1.6	0.9	1.7	1.3	0.6	3.9	8.5	5.3	11.1	5.4	3.6	6.0	6.1	12.7	5.8	0.0	2.7	4.9	1.9	0.7	5.3	3.7	2.5	5.3	3.4	0.0	5.9	1.5	8.3	1.1	8.8	1.4	3.2	0.0	0.6	0.6	0.6	1.8	1.1	1.7	1.1	9.5	0.0	4.3	3.5	10.2	1.1	2.1	0.0	1.8	1.8	3.8	1.7	0.9	0.4	0.7	6.1	12.9	0.9	6.0	0.7	0.3	2.7	4.5	1.7	1.4
PIAS4	"FLJ12419, Piasg, PIASY, ZMIZ6"	ENSG00000105229	"Protein inhibitor of activated STAT 4"	Q8N2W9	19	4007646-4039386	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway, Wnt signaling pathway"	"DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 73.5;Late spermatids: 189.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010598, HPA076008"	Enhanced		Supported	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA010598: AB_1079616, HPA076008: "	"unprognostic (1.23e-1)"	"unprognostic (8.94e-3)"	"unprognostic (3.50e-2)"	"prognostic favorable (1.18e-5)"	"unprognostic (2.45e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.01e-3)"	"unprognostic (9.79e-2)"	"unprognostic (6.89e-2)"	"unprognostic (6.22e-2)"	"prognostic favorable (7.04e-4)"	"unprognostic (1.33e-2)"	"unprognostic (5.98e-2)"	"unprognostic (4.52e-3)"	"unprognostic (5.76e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.67e-3)"	11.0	9.2	12.4	11.1	16.8	8.6	7.6	22.5	15.7	8.8	11.9	16.7	8.1	13.0	9.5	9.2	9.1	8.4	9.7	6.9	9.7	7.1	7.3	12.4	7.8	10.2	18.2	9.3	11.2	16.0	7.1	9.3	12.9	12.6	9.9	5.4	6.5	14.7	8.7	15.2	12.2	11.2	8.0	12.3	12.0	13.9	38.1	15.9	11.0	6.6	6.3	8.3	8.8	9.8	17.9	11.8	20.2	19.1	16.3	17.3	11.3	10.6	7.7	7.2	6.8	3.5	3.2	11.5	6.5	3.6	6.9	6.3	12.0	5.0	8.1	5.9	3.5	7.5	11.2	7.4	5.2	3.0	13.0	11.6	5.8	5.5	9.2	7.3	8.4	10.3	3.7	5.7	6.2	3.8	3.8	8.1	8.5	10.8	11.2	3.3	10.9	15.3	9.9	15.9	5.2	7.1	13.7	7.3	10.6	4.5	6.0	13.2	14.7	9.3	9.1	7.1	5.6	8.4	7.8	5.9	6.9	9.9	14.3	10.1	21.1	15.7	10.3	5.7	10.4	8.4	10.5	14.9	20.2	17.3	16.0	12.2	17.9	12.6	15.9	11.8	15.9	11.1	12.5	16.6	16.3	19.1	11.8	13.4	11.3	12.4	16.8	22.5	15.7	9.7	7.1	18.2	9.3	12.6	15.9	3.0	12.9	7.5	7.0	16.4	17.6	3.0	5.1	13.4	7.9	8.7	11.8	19.8	6.6	16.0	73.5	9.8	12.3	0.0	15.5	13.7	7.1	11.8	6.9	9.3	12.6	25.4	21.2	10.4	9.8	189.7	13.0	8.3	6.8	11.8	14.3	10.4	13.0	5.8	17.3	10.2	21.3	6.5	7.2	35.8	35.3	13.6	30.4	7.5	10.8	7.4
PLEKHG6	"FLJ10665, MYOGEF"	ENSG00000008323	"Pleckstrin homology and RhoGEF domain containing G6"	Q3KR16	12	6310436-6328506	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 43.4;placenta: 39.6"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 64.9;Extravillous trophoblasts: 43.1;Paneth cells: 35.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"neutrophil: 2.5;plasmacytoid DC: 3.9"	"Group enriched"	"Detected in many"	7	"dendritic cells: 3.9;granulocytes: 2.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 56.1;CACO-2: 17.8;CAPAN-2: 9.8;OE19: 16.9;RT4: 18.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041459, HPA058230"	Uncertain		Supported	"Cell Junctions,Centrosome"		NA	NA			"Cell Junctions"	Centrosome	"HPA041459: AB_10794518, HPA058230: AB_2683645"	"unprognostic (1.67e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.44e-1)"	"unprognostic (8.03e-3)"	"unprognostic (5.84e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.44e-1)"	"unprognostic (4.18e-2)"	"unprognostic (5.73e-2)"	7.5	0.2	0.3	8.9	0.7	1.0	15.8	0.3	0.4	4.4	30.3	0.4	1.1	19.4	0.6	1.6	19.9	0.5	6.7	1.2	0.3	0.0	1.1	2.5	1.8	0.3	0.3	0.3	0.6	4.5	1.9	3.3	39.6	0.5	2.6	9.6	0.7	8.8	2.3	0.3	6.7	43.4	0.5	0.3	0.4	5.7	0.5	0.3	0.5	3.4	11.3	8.6	6.8	8.6	0.3	3.9	2.5	0.2	0.1	0.4	0.1	0.2	2.1	0.2	0.0	1.1	0.1	56.1	0.1	0.0	0.1	0.1	17.8	9.8	0.1	0.1	0.0	0.0	4.6	0.0	0.1	0.0	0.0	0.0	0.0	0.5	3.5	0.2	0.2	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	2.7	0.0	0.2	4.6	16.9	0.3	0.0	0.0	0.1	0.0	18.9	0.1	0.0	0.4	8.4	0.1	4.2	2.7	0.0	0.4	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.6	0.2	0.6	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.3	0.1	0.4	2.5	0.1	0.1	3.9	0.1	0.1	0.3	0.7	0.3	0.4	0.3	0.0	0.3	0.3	0.5	0.3	0.0	0.0	0.0	5.7	4.4	0.0	0.3	5.1	0.0	0.0	1.8	0.0	13.8	0.0	8.3	1.1	0.3	64.9	0.0	1.6	43.1	1.1	6.7	0.0	2.1	2.4	0.0	8.1	0.0	0.0	1.5	2.3	0.0	0.0	0.0	18.6	0.9	2.5	35.4	0.7	0.7	0.0	0.0	3.1	0.2	0.5	6.0	20.0	0.0	20.6	16.8
PLEKHS1	"bA211N11.2, C10orf81, FLJ23537"	ENSG00000148735	"Pleckstrin homology domain containing S1"	Q5SXH7	10	113751454-113783429	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 26.8;intestine: 38.8;pancreas: 26.6;salivary gland: 53.1"	"Cell type enhanced"	"Detected in some"	29	"Ciliated cells: 152.6;Club cells: 46.6;Exocrine glandular cells: 28.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.7;OE19: 31.9;RT4: 10.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA037583			Approved	Vesicles,Centrosome		NA	NA			Centrosome	Vesicles	"HPA037583: AB_10671762"	"unprognostic (2.64e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.74e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.36e-2)"	"unprognostic (8.43e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.21e-2)"	"unprognostic (0.00e+0)"	"unprognostic (4.00e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (1.03e-4)"	0.2	0.1	0.2	1.6	0.2	0.0	11.7	0.2	0.2	26.8	18.5	0.2	10.2	17.0	1.0	2.2	0.8	3.4	6.4	0.2	0.2	0.1	0.6	0.2	4.8	0.2	0.2	0.2	1.3	26.6	0.0	1.9	0.3	0.3	3.5	1.8	0.4	53.1	4.9	0.2	0.7	38.8	0.2	0.2	0.2	2.9	1.1	0.2	0.2	0.2	1.3	2.0	0.8	0.2	0.8	0.5	1.3	0.3	0.7	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	5.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	31.9	0.0	0.0	2.7	0.0	0.9	10.5	0.0	0.1	0.0	0.9	0.0	0.0	3.6	0.0	0.0	0.1	0.0	0.0	0.2	2.1	0.1	0.0	0.0	0.0	1.3	0.8	0.1	0.2	0.3	0.1	0.1	0.8	0.2	0.2	0.0	0.5	0.2	0.3	1.3	0.7	0.3	0.5	0.1	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.3	0.2	3.0	2.7	0.0	0.3	0.1	0.0	0.4	0.0	152.6	46.6	0.0	0.0	0.0	0.0	2.8	7.1	0.0	13.8	0.0	28.3	0.0	0.1	2.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	1.0	1.1	0.0	1.4	0.8	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.3	0.3
PLK4	"Sak, STK18"	ENSG00000142731	"Polo like kinase 4"	O00444	4	127880861-127899195	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.5;lymphoid tissue: 21.7;testis: 21.7"	"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 48.9;Erythroid cells: 23.3;Late spermatids: 60.1;Spermatocytes: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA017327, HPA035026, HPA043198"	Approved		Supported	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"HPA017327: AB_2669584, HPA035026: AB_10602080, HPA043198: AB_2732504"	"unprognostic (2.44e-1)"	"unprognostic (4.24e-2)"	"prognostic favorable (7.46e-5)"	"unprognostic (2.18e-1)"	"unprognostic (3.79e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.06e-5)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (1.44e-3)"	"unprognostic (5.66e-2)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.22e-11)"	"unprognostic (2.29e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.93e-2)"	1.4	1.3	1.5	4.7	2.4	16.5	2.2	0.5	2.2	2.0	3.2	0.3	0.6	2.3	1.3	1.3	5.4	1.1	1.2	2.0	1.2	1.3	1.5	0.9	1.5	5.9	1.2	1.4	1.5	0.9	0.3	0.6	5.0	2.6	1.4	3.7	0.8	1.7	0.7	0.4	2.7	3.2	1.9	1.8	2.7	1.6	21.7	1.0	21.7	1.0	2.1	6.0	1.5	2.2	0.7	0.7	1.5	0.8	1.4	4.0	0.8	11.8	5.6	21.1	10.8	0.7	2.1	9.6	11.6	8.2	15.5	16.0	7.8	12.2	16.0	4.3	6.4	12.6	7.8	14.8	9.3	23.9	12.4	6.1	14.5	9.0	7.3	0.2	20.4	17.1	0.6	0.9	14.1	6.5	2.8	11.9	12.3	16.8	21.4	13.0	8.2	31.4	9.1	9.8	12.1	6.4	16.4	14.7	5.5	5.1	7.6	11.6	9.6	7.3	6.7	3.5	9.3	5.4	8.8	5.1	12.2	11.8	8.3	14.4	11.0	12.1	22.8	6.2	15.5	13.5	0.0	0.4	1.5	1.6	0.8	1.1	0.3	1.8	1.7	0.7	0.7	0.6	2.3	0.0	1.4	0.3	0.4	4.0	0.8	1.5	2.4	0.5	2.2	1.2	1.3	1.2	1.4	2.6	1.0	0.0	1.1	0.8	0.6	1.4	2.1	0.5	0.0	2.7	0.0	1.8	0.0	3.6	0.0	0.6	48.9	0.4	0.0	23.3	0.3	10.4	0.7	0.4	1.1	0.2	3.1	0.0	2.4	0.6	1.0	60.1	2.6	1.6	0.0	1.8	1.9	1.1	0.1	0.0	0.4	0.3	0.7	0.0	0.3	27.0	12.1	0.6	3.2	1.8	2.1	0.9
PSMB5	"MB1, X"	ENSG00000100804	"Proteasome subunit beta 5"	P28074	14	23016543-23035230	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA049518, HPA061796"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA		8200000	"Nucleoplasm, Centrosome"		"HPA049518: AB_2680802, HPA061796: AB_2684612"	"unprognostic (3.03e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.35e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (2.85e-4)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (2.55e-2)"	"unprognostic (9.95e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (4.73e-4)"	28.1	38.8	33.6	19.3	35.5	9.6	29.0	19.4	42.9	24.7	28.3	26.8	25.4	21.0	24.2	49.2	31.6	31.6	22.0	37.7	32.9	33.3	35.3	45.4	20.6	18.3	37.5	35.4	22.2	36.6	35.4	26.6	32.5	33.9	27.2	32.2	21.1	28.4	28.7	101.2	22.3	17.2	34.9	32.5	16.7	25.1	27.6	27.3	15.7	29.0	47.3	22.7	20.6	25.2	32.3	53.4	24.6	39.9	19.4	46.8	39.5	22.5	48.1	34.4	32.6	46.4	40.1	34.0	32.2	38.4	56.9	48.4	40.5	36.0	28.0	30.1	43.8	39.5	30.8	54.9	40.2	55.0	17.2	37.9	17.8	35.1	142.5	36.6	21.6	21.4	44.7	37.7	42.2	35.2	37.8	58.8	24.7	26.7	16.0	46.5	66.5	12.3	29.6	38.2	43.6	78.0	16.6	26.0	18.7	44.2	32.7	43.9	34.2	22.7	46.1	31.0	47.0	22.2	28.1	31.6	27.9	28.4	25.8	31.6	13.8	27.3	21.0	21.8	17.4	34.5	24.6	39.9	17.3	29.3	39.0	34.2	32.3	35.1	28.1	42.6	30.1	46.8	35.6	15.5	19.4	27.9	53.4	28.7	39.5	33.6	35.5	19.4	42.9	32.9	33.3	37.5	35.4	33.9	27.3	71.5	50.9	58.0	134.8	124.6	57.4	134.8	129.9	149.9	80.8	90.7	27.5	350.9	233.8	261.5	57.3	106.7	63.2	0.0	201.1	383.6	136.2	130.9	30.1	134.4	190.5	66.7	148.5	90.9	54.9	77.1	109.9	70.7	109.6	199.2	94.1	137.0	244.2	80.7	114.9	331.7	53.8	97.0	134.4	207.4	76.8	137.3	359.7	49.8	123.0	163.4
QRSL1	"DKFZP564C1278, FLJ10989, FLJ12189, FLJ13447, GatA"	ENSG00000130348	"Glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like 1"	Q9H0R6	6	106629578-106668417	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"B-cells: 62.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"memory B-cell: 32.6;naive B-cell: 26.1"	"Lineage enriched"	"Detected in all"	7	"B-cells: 32.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029585, HPA029587"	Approved		Approved	Vesicles,Centrosome		NA	NA			Vesicles	Centrosome	"HPA029585: AB_10599823, HPA029587: AB_10602311"	"unprognostic (1.86e-3)"	"unprognostic (5.58e-2)"	"unprognostic (6.19e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (8.36e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (3.83e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.46e-1)"	9.8	10.8	12.4	17.0	14.7	8.5	15.6	10.1	15.6	7.6	11.7	10.1	11.9	11.3	9.5	10.8	10.3	8.5	8.3	13.9	10.4	9.1	15.5	12.5	7.7	21.0	15.8	8.3	10.2	10.8	10.9	11.9	8.7	9.9	8.3	13.7	7.5	10.6	12.5	35.7	8.8	14.8	8.8	11.9	16.7	11.0	10.6	13.7	13.8	13.7	14.6	21.3	8.9	8.6	32.6	4.0	1.6	4.5	2.6	3.1	2.2	6.2	6.5	9.0	13.0	5.8	7.3	12.7	7.1	7.4	9.6	9.6	7.5	5.2	20.9	6.6	7.9	9.9	11.1	13.3	8.6	12.1	9.9	10.2	10.1	6.9	7.8	9.1	22.9	9.1	7.2	13.5	10.2	15.1	7.3	6.8	13.2	18.4	6.8	7.9	7.0	7.3	11.2	9.3	10.9	7.6	20.1	11.5	5.3	10.4	7.2	7.8	8.0	5.7	13.4	10.5	8.2	8.7	17.8	6.6	6.8	5.6	7.2	11.0	4.0	5.6	12.2	9.3	15.6	10.0	1.6	2.4	0.4	2.6	3.6	2.5	32.6	2.9	2.2	4.0	26.1	2.7	2.6	0.7	2.6	4.5	3.2	3.1	2.2	12.4	14.7	10.1	15.6	10.4	9.1	15.8	8.3	9.9	13.7	17.9	8.4	62.4	6.4	3.5	14.2	24.6	10.2	26.8	7.9	10.4	15.7	18.2	14.9	13.3	10.4	10.4	10.5	0.0	15.9	19.4	7.2	6.4	17.4	13.0	11.3	3.2	16.7	8.0	13.2	4.5	7.8	9.0	8.5	14.4	10.5	9.4	12.8	7.0	8.5	14.6	18.7	0.0	6.6	20.7	12.0	4.6	10.3	11.4	19.0	8.4
RABL2A		ENSG00000144134	"RAB, member of RAS oncogene family like 2A"	Q9UBK7	2	113627229-113643396	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 29.3"	"Cell type enriched"	"Detected in many"	6	"Ciliated cells: 119.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 12.2"									"HPA042642, HPA042700, HPA044007"	Approved		Approved	Vesicles,Centrosome		NA	NA			Centrosome	Vesicles	"HPA042642: , HPA042700: AB_2678120, HPA044007: AB_2678770"	"unprognostic (7.76e-3)"	"unprognostic (7.79e-3)"	"unprognostic (7.00e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.23e-2)"	"unprognostic (4.89e-2)"	"unprognostic (6.77e-3)"	"unprognostic (6.61e-2)"	"unprognostic (7.36e-2)"	"unprognostic (5.78e-3)"	"unprognostic (4.29e-2)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (1.89e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.87e-2)"	"unprognostic (3.19e-5)"	2.2	1.7	6.0	5.9	9.5	1.7	3.3	6.3	20.9	4.3	3.4	4.2	0.4	2.4	4.7	9.0	2.7	29.3	2.8	3.3	7.0	6.0	3.5	3.4	12.9	1.8	4.0	7.5	7.4	2.6	1.2	6.3	1.6	6.4	3.8	2.0	3.8	5.2	12.2	2.2	2.1	2.2	3.6	4.8	2.7	2.1	4.8	4.3	2.0	5.5	2.0	3.1	2.1	2.7	8.8	9.8	2.5	7.6	12.2	10.4	5.5	2.6	4.3	6.0	4.8	5.0	7.3	4.6	2.4	2.0	3.5	2.5	3.8	1.6	3.7	10.4	0.8	2.5	2.7	3.0	0.3	2.3	5.1	5.8	1.8	0.1	0.5	4.1	0.8	1.3	2.6	5.2	0.7	1.5	5.1	2.5	5.5	1.7	0.9	2.1	2.1	12.2	0.9	3.3	2.2	1.5	2.3	2.3	1.6	2.4	0.6	2.5	8.5	2.3	2.6	2.2	1.9	0.5	3.5	0.6	0.5	0.8	0.9	1.7	3.6	3.8	0.8	7.1	2.7	1.2	0.0	4.8	2.5	7.1	7.6	7.7	8.8	10.4	7.2	7.5	8.0	8.6	6.8	0.5	12.2	7.2	9.8	5.0	5.5	6.0	9.5	6.3	20.9	7.0	6.0	4.0	7.5	6.4	4.3	8.9	7.2	7.5	4.3	3.9	7.0	4.0	0.0	119.1	12.5	7.0	9.8	2.8	11.6	6.7	9.4	3.0	5.2	0.0	2.7	2.2	7.3	3.0	11.5	3.9	3.1	15.9	6.9	6.7	2.8	9.8	7.5	4.6	6.8	6.4	3.7	6.5	4.0	3.5	6.7	5.0	17.6	0.0	6.6	20.4	8.3	4.3	2.1	5.7	4.3	3.4
RABL2B		ENSG00000079974	"RAB, member of RAS oncogene family like 2B"	Q9UNT1	22	50767501-50783663	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 59.0"	"Cell type enriched"	"Detected in many"	4	"Ciliated cells: 167.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA042642, HPA042700, HPA044007"	Approved		Approved	Vesicles,Centrosome		NA	NA			Centrosome	Vesicles	"HPA042642: , HPA042700: AB_2678120, HPA044007: AB_2678770"	"unprognostic (2.09e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.86e-3)"	"prognostic favorable (5.58e-4)"	"unprognostic (7.85e-2)"	"unprognostic (9.98e-2)"	"prognostic unfavorable (4.58e-5)"	"unprognostic (3.14e-1)"	"unprognostic (6.97e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.19e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.71e-3)"	"unprognostic (7.43e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.37e-3)"	8.2	8.2	12.4	11.1	22.1	8.1	12.9	19.7	21.2	13.0	8.4	12.7	12.6	7.9	13.9	59.0	8.1	41.9	9.4	5.8	13.1	15.3	10.6	7.0	14.4	13.3	9.9	16.5	17.8	9.6	10.9	16.7	7.4	14.3	10.0	11.0	9.5	9.5	11.6	5.1	13.8	8.6	10.2	9.5	11.5	9.1	12.2	14.5	12.6	17.9	3.5	12.3	9.4	9.2	13.6	13.2	9.2	19.4	10.8	16.8	10.3	13.3	12.1	20.8	16.2	23.3	18.6	15.2	10.0	11.1	8.1	11.1	3.4	11.8	8.6	8.9	14.3	13.2	17.5	9.4	11.7	8.8	7.4	13.4	7.4	20.9	8.8	9.7	20.9	8.0	15.8	16.0	10.6	13.4	24.1	9.0	15.5	5.6	10.9	16.1	16.8	10.4	9.2	7.9	8.2	9.1	17.6	12.0	9.0	15.7	13.3	8.9	16.2	12.2	10.8	7.5	15.0	10.7	6.5	13.8	7.8	15.6	6.6	6.7	9.2	4.2	4.2	14.7	5.2	10.9	1.0	10.9	9.2	16.8	17.4	12.2	11.2	13.0	13.7	11.6	13.6	15.2	14.7	4.3	10.8	19.4	13.2	13.0	10.3	12.4	22.1	19.7	21.2	13.1	15.3	9.9	16.5	14.3	14.5	11.9	11.2	10.4	10.3	4.7	14.6	3.6	12.7	167.3	29.6	21.0	29.5	10.4	11.6	17.3	17.0	7.3	7.8	0.0	9.5	9.3	8.5	7.5	3.5	6.4	10.7	15.9	5.2	5.5	10.1	16.3	13.0	8.5	16.9	15.4	7.2	12.9	9.0	3.5	10.3	12.2	37.4	6.5	10.3	27.4	27.0	5.0	5.6	15.8	10.1	6.3
RABL6	"bA216L13.9, C9orf86, FLJ10101, FLJ13045, Parf, pp8875, RBEL1"	ENSG00000196642	"RAB, member RAS oncogene family like 6"	Q3YEC7	9	136807943-136841187	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 98.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044037	Uncertain		Approved	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA044037: AB_10966437"	"unprognostic (3.10e-3)"	"unprognostic (8.52e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (4.00e-4)"	"unprognostic (9.23e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.90e-3)"	"unprognostic (7.55e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.92e-2)"	"prognostic favorable (1.46e-4)"	"unprognostic (5.23e-2)"	"unprognostic (1.03e-3)"	"prognostic favorable (9.14e-4)"	"unprognostic (4.08e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.15e-1)"	20.8	17.7	31.0	21.6	42.8	32.9	17.9	43.6	41.4	12.5	25.1	18.0	14.8	29.4	13.7	14.6	17.9	12.8	22.2	29.4	28.2	22.2	17.1	7.3	17.2	18.5	22.7	21.6	13.9	39.6	17.4	23.3	16.0	16.7	24.3	16.6	13.1	24.8	16.9	98.6	21.5	29.4	15.6	20.6	20.0	24.5	16.5	17.2	20.9	13.9	22.6	13.9	13.8	19.9	4.7	4.1	2.9	5.7	6.1	5.2	1.4	19.2	25.6	18.4	21.5	7.5	8.5	48.4	17.5	11.3	17.0	12.5	28.5	20.5	27.3	11.0	13.6	17.9	42.3	20.4	15.5	5.8	28.4	26.3	16.7	32.0	33.3	13.6	30.9	21.5	9.4	16.0	10.5	11.7	10.4	17.7	23.6	36.3	13.4	11.6	38.5	33.0	21.4	34.4	23.7	22.1	43.3	22.0	26.6	11.2	17.2	60.6	25.1	30.9	36.3	21.6	10.2	31.2	31.2	21.3	22.1	19.2	23.2	28.3	11.5	13.1	22.2	18.5	15.1	20.6	1.2	4.8	2.9	3.7	5.7	3.8	4.5	3.9	3.6	3.3	4.7	3.2	4.1	2.3	6.1	2.0	4.1	5.2	1.4	31.0	42.8	43.6	41.4	28.2	22.2	22.7	21.6	16.7	17.2	26.8	48.3	8.9	15.4	16.0	37.2	29.1	0.0	8.1	7.9	24.4	19.6	20.7	26.6	28.0	10.1	16.9	100.2	0.0	49.7	27.9	22.0	31.8	15.0	0.0	27.4	36.5	49.8	0.0	0.0	10.9	18.1	26.0	38.8	26.2	55.1	18.1	55.1	51.0	25.1	38.5	38.3	0.0	17.3	15.4	26.4	16.9	23.7	12.9	57.2	21.6
RAPGEF6	"PDZ-GEF2, PDZGEF2, RA-GEF-2"	ENSG00000158987	"Rap guanine nucleotide exchange factor 6"	Q8TEU7	5	131423921-131635236	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 30.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA037982, HPA037983"	Approved		Approved	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA037982: AB_10670535, HPA037983: AB_2675769"	"unprognostic (1.86e-1)"	"unprognostic (5.16e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.72e-3)"	"prognostic unfavorable (3.87e-4)"	"unprognostic (3.57e-1)"	"unprognostic (4.10e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.81e-4)"	7.2	7.3	8.4	15.2	11.2	15.7	9.9	34.1	12.7	7.2	6.7	13.7	6.1	5.0	6.9	5.9	6.5	6.1	7.7	6.6	9.4	10.5	6.2	8.4	9.5	24.6	13.1	9.0	8.6	6.2	12.5	9.5	8.0	17.1	7.2	7.8	5.4	6.9	7.9	6.9	8.1	7.3	6.9	10.9	11.3	6.5	19.7	14.5	21.2	7.1	5.5	22.0	7.7	7.2	5.4	1.6	8.7	2.0	5.3	14.2	5.4	7.0	5.1	7.2	6.7	3.8	4.3	6.9	7.8	6.2	6.7	10.1	9.3	5.0	16.5	5.2	5.2	10.3	5.7	10.0	8.2	13.6	8.0	5.5	10.4	7.4	5.0	3.1	7.2	11.0	3.1	3.9	9.7	9.5	4.7	5.9	9.3	5.9	10.0	5.9	3.6	7.4	5.8	3.1	3.9	3.8	11.1	10.4	8.7	4.8	5.5	24.9	5.7	8.1	3.7	9.7	8.2	5.2	6.3	5.7	8.9	6.3	7.1	8.9	5.8	6.9	17.9	5.1	9.5	7.5	1.4	1.7	6.3	6.3	2.0	10.7	4.5	8.5	6.8	1.4	5.4	14.2	10.1	8.7	5.3	1.5	1.6	9.6	5.4	8.4	11.2	34.1	12.7	9.4	10.5	13.1	9.0	17.1	14.5	11.9	16.2	5.3	4.7	14.1	10.0	3.6	0.0	8.1	7.9	7.0	19.6	4.9	1.7	3.6	30.7	3.8	3.6	0.0	2.4	2.9	7.4	5.7	2.3	4.4	6.6	1.6	13.3	8.0	11.4	13.2	4.0	11.2	13.5	7.2	7.8	4.2	3.8	5.8	4.9	1.9	8.8	0.0	5.1	11.6	10.6	15.3	5.8	14.4	6.8	4.7
RFPL4A	"RFPL4, RNF210"	ENSG00000223638	"Ret finger protein like 4A"	A6NLU0	19	55759014-55763175	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 12.7;epididymis: 5.2;liver: 7.1;testis: 3.8"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	6	"testis cancer: 0.9"					"Cell type enhanced"	"Detected in some"		"classical monocyte: 12.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.8;monocytes: 12.7"	"Cell line enriched"	"Detected in some"	17	"U-2 OS: 44.7"									HPA046368	Uncertain		Approved	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"HPA046368: AB_2679640"							"unprognostic (3.74e-1)"						"unprognostic (2.96e-2)"		"unprognostic (9.20e-2)"			0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3			0.0	0.0	5.2	0.0	0.1	0.2	0.0	0.0	0.0	0.4	7.1	0.0	0.8	0.0		0.1	0.4	0.0	0.1	0.0		0.0	0.1		0.0	0.0	0.0	0.0	0.4	0.1	0.0	1.6	0.4	3.8			0.0		0.1	0.0	0.0	0.0	3.8	1.7	12.7	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	44.7	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	12.7	0.0	0.0	2.7	0.0	0.0	0.0	0.0	3.8	0.0	0.1	0.0	1.7	0.0	0.8	0.0	0.0	2.8											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0
RFPL4AL1	RNF210B	ENSG00000229292	"Ret finger protein like 4A like 1"	F8VTS6	19	55769141-55773179	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"blood: 5.4;epididymis: 1.7;liver: 3.0;lymphoid tissue: 2.3;testis: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"classical monocyte: 5.4;myeloid DC: 2.5"	"Group enriched"	"Detected in many"	9	"dendritic cells: 2.5;monocytes: 5.4"	"Cell line enriched"	"Detected in some"	24	"U-2 OS: 24.8"									HPA046368	Uncertain		Approved	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"HPA046368: AB_2679640"															"unprognostic (8.87e-2)"			0.1	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1			0.0	0.0	1.7	0.0	0.1	0.3	0.0	0.0	0.0	0.3	3.0	0.0	0.4	0.0		0.6	0.7	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.1	0.3	0.0	0.1	2.3	0.2	1.5			0.3		0.0	0.3	0.0	0.0	2.5	0.4	5.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	24.8	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	2.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0
RHEBL1	"FLJ25797, MGC34869, RHEB2"	ENSG00000167550	"RHEB like 1"	Q8TAI7	12	49064685-49070025	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 10.6;brain: 9.5"	"Cell type enhanced"	"Detected in many"	15	"Ciliated cells: 9.4;Erythroid cells: 23.3;monocytes: 7.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 3.1;granulocytes: 10.6;T-cells: 10.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 16.7;U-266/84: 33.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA053111, HPA061001"	Uncertain		Uncertain	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"HPA053111: AB_2682047, HPA061001: AB_2684409"	"unprognostic (2.94e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.36e-2)"	"unprognostic (9.81e-3)"	"unprognostic (8.76e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.03e-5)"	"unprognostic (9.13e-2)"	"unprognostic (9.02e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-10)"	"unprognostic (4.67e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.07e-1)"	1.6	0.6	3.6	2.7	2.0	4.0	2.3	4.0	9.5	0.8	1.1	0.4	1.3	1.1	3.3	2.5	0.9	5.5	1.0	1.4	2.2	2.7	0.9	0.7	2.6	6.8	2.0	5.1	1.0	0.6	0.2	0.7	1.4	1.9	0.5	1.8	0.4	1.0	1.3	0.6	5.6	1.8	1.0	1.2	5.2	1.2	3.0	0.9	2.5	0.8	0.0	3.9	1.0	4.1	3.1	0.9	10.6	1.6	1.3	10.1	1.2	0.9	2.0	1.2	2.9	0.7	0.1	1.2	0.9	2.7	5.1	5.8	1.8	1.6	2.8	0.9	0.2	2.9	0.8	0.8	1.1	2.3	16.7	0.1	2.7	1.4	0.9	0.6	1.1	5.8	0.3	0.4	2.6	0.8	0.3	2.0	5.0	3.5	8.1	1.9	0.8	1.2	6.8	1.8	3.5	2.9	2.6	1.8	4.4	0.4	0.1	0.6	1.7	0.7	0.7	4.5	1.8	0.3	1.8	1.0	1.6	2.6	3.1	0.9	9.8	33.3	1.7	1.3	4.1	0.6	10.6	0.3	0.7	7.3	1.6	10.1	1.9	3.1	3.9	0.7	3.1	1.0	3.8	0.6	1.3	1.4	0.9	6.1	1.2	3.6	2.0	4.0	9.5	2.2	2.7	2.0	5.1	1.9	0.9	0.0	0.0	4.3	0.2	1.1	1.5	0.8	2.5	9.4	2.3	0.0	0.0	0.1	0.0	0.4	0.4	1.4	0.0	23.3	0.2	0.4	0.8	0.3	0.0	0.0	1.5	3.2	0.0	1.3	0.0	0.4	0.0	1.8	0.0	7.2	0.0	0.3	0.2	0.0	0.0	0.0	0.2	0.0	1.0	0.9	5.0	1.8	0.1	5.1	0.2	0.0
RMDN1	"CGI-90, FAM82B, FLJ20665, RMD1"	ENSG00000176623	"Regulator of microtubule dynamics 1"	Q96DB5	8	86468257-86514357	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026495	Approved		Supported	"Actin filaments,Centrosome"		NA	NA			Centrosome	"Actin filaments"	"HPA026495: AB_1848414"	"unprognostic (1.68e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.60e-1)"	"prognostic favorable (8.51e-4)"	"unprognostic (2.08e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.71e-3)"	"unprognostic (3.47e-1)"	20.4	20.1	19.0	19.5	18.4	12.2	16.9	10.8	13.3	13.8	22.5	13.9	7.7	16.3	11.6	13.3	21.1	12.4	14.2	44.3	17.6	16.7	35.0	32.5	21.0	23.6	22.2	10.7	11.6	13.0	14.5	15.6	12.7	19.1	12.6	17.2	13.6	12.2	18.9	45.2	18.5	29.0	17.7	23.1	19.2	16.9	14.4	15.3	25.6	29.3	27.1	18.0	14.3	11.2	17.8	22.1	38.6	27.9	15.5	18.0	12.6	21.2	9.2	10.8	6.1	21.3	35.1	13.2	15.6	14.1	12.4	12.2	10.9	13.7	25.4	13.3	13.0	11.6	20.7	13.8	15.6	14.9	21.6	10.9	13.3	10.9	27.3	11.5	6.0	0.3	19.0	14.8	16.6	25.7	22.3	27.9	15.1	14.0	14.0	19.7	19.2	21.2	2.8	5.5	37.3	23.2	12.1	15.2	26.1	14.7	13.4	5.1	11.4	12.9	51.6	22.0	12.0	29.0	11.3	15.1	13.9	22.6	17.6	9.4	18.2	15.0	19.7	18.1	9.7	18.8	5.6	17.1	38.6	12.3	21.6	14.3	17.8	12.8	14.4	19.5	12.3	10.6	13.7	6.8	15.5	27.9	22.1	18.0	12.6	19.0	18.4	10.8	12.5	17.6	16.7	22.2	10.7	19.1	15.3	38.7	30.0	8.2	11.9	11.9	13.3	104.4	28.1	37.5	44.3	19.2	15.7	37.2	41.4	36.4	68.7	24.1	20.2	0.0	46.2	44.7	20.4	7.5	1.1	52.1	48.2	19.1	9.8	20.3	43.0	59.6	12.0	27.5	15.1	44.1	20.5	25.6	40.0	14.0	8.5	46.4	20.2	0.0	18.6	44.1	30.4	13.6	23.8	19.2	26.4	9.7
RTTN	DKFZP434G145	ENSG00000176225	Rotatin	Q86VV8	18	70003031-70205945	"Disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 15.9;Sertoli cells: 12.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 19.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041343, HPA041967, HPA075089"	Uncertain		Approved	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA041343: AB_10794409, HPA041967: AB_10796790, HPA075089: "	"unprognostic (1.76e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.11e-2)"	"unprognostic (3.44e-2)"	"unprognostic (6.16e-3)"	"unprognostic (4.63e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.90e-1)"	"unprognostic (8.25e-2)"	"unprognostic (6.94e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.96e-2)"	5.5	6.2	6.2	8.1	13.0	12.9	8.0	12.3	8.0	8.0	5.2	26.5	4.0	5.6	12.1	6.1	4.7	6.0	5.9	8.3	7.2	6.4	8.9	9.0	6.3	8.5	14.2	5.9	11.0	8.4	13.0	7.0	6.8	12.8	5.5	6.2	13.9	5.2	6.4	5.9	6.0	6.1	7.5	12.4	7.9	5.4	14.3	12.5	20.4	5.2	5.5	13.0	5.0	6.8	2.5	1.3	0.6	0.9	1.5	3.1	0.5	3.5	5.4	8.4	2.0	1.2	1.4	3.1	6.4	2.9	5.8	5.7	2.4	2.1	2.9	0.9	3.7	5.6	3.9	5.4	9.3	9.3	11.1	2.8	3.3	5.4	2.2	0.8	5.0	3.4	1.2	10.2	6.4	19.9	2.4	3.3	4.9	3.2	6.8	5.1	1.2	5.6	1.8	1.4	0.7	4.2	4.7	7.3	2.8	0.8	2.4	3.0	3.8	3.5	1.6	2.2	5.1	2.3	3.6	3.3	7.5	2.0	2.4	4.7	3.1	2.9	6.5	4.5	3.4	4.8	0.6	0.9	0.6	1.1	0.2	1.9	2.5	2.1	1.3	0.4	1.7	3.1	1.9	0.4	1.5	0.3	1.3	1.3	0.5	6.2	13.0	12.3	8.0	7.2	6.4	14.2	5.9	12.8	12.5	0.0	11.3	1.9	1.4	1.3	7.0	4.5	0.0	0.0	6.8	0.0	0.0	3.2	0.0	1.0	4.8	2.3	2.0	0.0	1.4	1.6	2.3	1.0	4.7	3.4	2.0	15.9	0.0	1.8	1.0	2.6	2.0	2.6	0.0	0.0	1.6	2.9	1.5	3.1	1.8	2.7	9.6	12.9	2.3	9.2	6.5	1.5	2.5	2.2	1.7	1.8
SLAIN2	"FLJ21611, KIAA1458"	ENSG00000109171	"SLAIN motif family member 2"	Q9P270	4	48341322-48426212	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 234.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035824, HPA063599"	Approved		Enhanced	Centrosome,Cytosol		NA	NA		13000	Centrosome	Cytosol	"HPA035824: AB_10602399, HPA063599: AB_2685056"	"unprognostic (6.20e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (5.77e-4)"	"prognostic favorable (7.98e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (6.71e-4)"	"unprognostic (1.57e-1)"	"prognostic favorable (1.50e-4)"	"unprognostic (1.75e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.00e-2)"	14.8	9.3	6.8	11.7	8.6	7.0	12.6	9.2	10.7	18.4	20.7	6.1	11.7	6.9	18.1	12.2	24.0	14.3	12.3	21.3	7.3	5.6	12.8	16.1	14.0	10.6	7.6	7.2	16.4	10.4	17.2	9.4	29.7	8.0	19.0	13.1	14.1	15.2	17.3	49.2	20.1	15.5	30.6	6.2	11.4	13.2	23.6	5.8	23.8	12.1	22.2	16.9	24.9	23.7	7.7	8.5	10.9	8.6	10.7	13.5	4.2	12.5	4.9	9.0	8.8	13.9	17.2	6.3	19.4	24.8	17.4	18.1	4.9	10.6	7.6	12.0	22.2	31.3	8.3	36.7	18.2	30.7	6.2	3.7	13.3	7.3	5.6	15.0	12.1	13.6	14.6	27.0	20.1	23.5	13.1	10.2	6.8	8.4	8.5	17.4	6.4	13.9	10.0	3.8	9.9	7.1	7.9	17.5	4.8	15.2	13.9	6.0	7.6	7.9	5.9	8.3	8.6	7.4	8.7	12.9	19.1	18.1	12.0	19.7	11.6	12.0	6.5	15.0	13.8	13.7	10.9	8.0	9.6	8.8	5.8	9.9	6.1	11.0	13.5	8.5	7.7	9.1	9.8	7.5	10.7	8.6	2.9	7.1	4.2	6.8	8.6	9.2	10.7	7.3	5.6	7.6	7.2	8.0	5.8	50.6	34.2	23.6	40.6	74.9	14.4	68.6	15.3	75.0	27.3	26.2	13.7	24.2	18.3	26.4	122.5	23.3	27.7	0.0	30.2	23.9	23.6	48.5	21.8	28.9	19.9	33.4	24.2	22.1	17.5	234.7	25.3	24.3	18.6	29.7	30.2	19.7	25.2	28.8	34.6	20.7	38.1	32.3	32.3	69.6	47.8	79.9	63.2	29.8	19.0	50.2
SLC18A2	"SVAT, SVMT, VMAT2"	ENSG00000165646	"Solute carrier family 18 member A2"	Q05940	10	117241073-117279430	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"		"Disease mutation, Dystonia, FDA approved drug targets, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 26.3;brain: 28.3;cervix, uterine: 31.2"	"Cell type enriched"	"Detected in some"	22	"granulocytes: 603.6"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	10	"hypothalamus: 9.0;midbrain: 28.3;pons and medulla: 26.5"	"Cell type enriched"	"Detected in some"	13	"basophil: 26.3"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 26.3"	"Cell line enriched"	"Detected in some"	20	"HMC-1: 91.2"	"Region enhanced"	"Detected in many"		"midbrain: 75.4"	"Group enriched"	"Detected in all"	5	"midbrain: 143.8;pons and medulla: 34.7"	HPA073224	Enhanced		Approved	Vesicles,Centrosome		NA	NA			"Vesicles, Centrosome"		"HPA073224: AB_2732222"	"unprognostic (1.49e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.33e-3)"	"unprognostic (9.00e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.06e-3)"	"unprognostic (7.94e-5)"	"unprognostic (2.95e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.57e-2)"	1.7	13.9	1.7	3.1	2.0	2.0	2.0	1.7	1.6	31.2	2.3	0.5	2.2	1.5	11.2	4.9	3.0	1.1	15.9	1.0	1.9	9.0	1.1	3.3	7.6	1.5	28.3	0.2	9.7	3.7	0.5	1.6	2.1	26.5	10.8	3.4	3.1	1.0	4.0	1.1	5.8	2.5	5.4	2.9	0.5	3.5	1.5	0.3	14.1	0.6	3.4	2.9	3.1	5.4	0.0	2.0	26.3	0.0	0.0	0.3	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	4.6	0.0	0.0	0.0	0.2	91.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.1	0.1	0.0	0.1	0.4	0.0	26.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	2.0	0.0	1.1	1.7	2.0	1.7	1.6	1.9	9.0	28.3	0.2	26.5	0.3	8.9	27.6	0.0	0.0	1.6	0.6	0.2	0.0	1.4	4.5	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	4.4	603.6	0.0	0.7	0.0	8.5	11.6	1.8	0.0	0.6	0.6	1.7	0.0	0.0	0.3	0.1	0.0	4.6	0.0	0.7	0.0	0.2	0.2	0.1	2.4	0.0	0.0	0.0	0.0
SMIM18		ENSG00000253457	"Small integral membrane protein 18"	P0DKX4	8	30638600-30646064	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 18.8;pituitary gland: 10.7"	"Cell type enhanced"	"Detected in some"	23	"Bipolar cells: 9.9;Horizontal cells: 4.8;Rod photoreceptor cells: 2.7"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 14.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066648	Supported		Uncertain	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA066648: AB_2685697"	"unprognostic (2.19e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.60e-1)"		"unprognostic (7.29e-2)"	"unprognostic (4.70e-1)"	"unprognostic (8.91e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.25e-1)"	"unprognostic (4.14e-1)"	0.6	3.2	5.2	0.7	6.6	2.7	0.6	18.8	18.7	0.6	0.7	0.4	0.0	0.6	0.7	0.6	0.7	0.7	0.8	0.9	10.9	10.7	2.9	0.7	0.6	0.6	5.7	7.5	0.7	1.8	0.6	10.7	0.6	11.7	0.7	0.8	0.2	0.6	0.6	0.6	0.7	0.7	0.6	4.6	0.7	0.8	0.7	1.4	0.0	0.7	0.0	0.6	0.6	0.0	2.9	4.1	3.0	2.3	0.2	4.3	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.5	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	1.4	0.0	0.0	0.0	3.0	1.9	1.9	3.7	1.3	3.6	2.9	2.3	2.1	0.9	2.9	3.0	4.3	2.1	0.2	2.3	4.1	2.9	0.3	5.2	6.6	18.8	9.7	10.9	10.7	5.7	7.5	11.7	1.4	0.0	0.0	0.0	0.0	0.0	9.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SNAP91	"AP180, CALM, KIAA0656"	ENSG00000065609	"Synaptosome associated protein 91"	O60641	6	83552880-83709691	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 81.9"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 46.7;Cone photoreceptor cells: 58.9;Early spermatids: 16.0;Horizontal cells: 30.2;Rod photoreceptor cells: 59.2;Spermatocytes: 25.0"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	20	"plasmacytoid DC: 6.3"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 6.3"	"Group enriched"	"Detected in some"	11	"GAMG: 6.7;SCLC-21H: 21.5;SH-SY5Y: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009745, HPA029632, HPA029633"	Enhanced		Uncertain	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"CAB009745: AB_2302221, HPA029632: AB_10794614, HPA029633: AB_10794615"	"unprognostic (1.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.55e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.42e-1)"		"unprognostic (2.56e-2)"		"unprognostic (1.17e-1)"	"unprognostic (4.54e-4)"	"unprognostic (6.99e-2)"	"unprognostic (1.75e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.14e-2)"	1.2	8.0	17.8	1.9	25.5	1.1	1.7	44.2	81.9	2.1	1.7	3.4	0.0	1.4	1.7	1.2	1.3	1.8	2.0	1.3	19.2	19.9	1.2	1.1	1.4	3.3	14.3	20.5	3.1	2.4	1.1	9.3	1.6	34.7	3.9	1.7	4.5	1.6	1.7	1.2	1.3	1.7	1.8	7.0	2.2	1.9	10.8	2.9	0.0	2.0	0.0	2.7	1.3	0.2	0.0	6.3	0.0	0.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	6.7	0.3	0.9	0.0	0.0	0.3	1.3	0.5	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.1	0.1	0.2	21.5	13.4	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.1	17.8	25.5	44.2	43.6	19.2	19.9	14.3	20.5	34.7	2.9	0.0	0.0	0.0	0.0	0.0	46.7	0.8	0.0	0.0	0.0	0.0	58.9	1.0	0.0	0.0	16.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	30.2	0.0	0.0	0.0	9.5	0.9	0.0	0.0	0.0	0.0	8.9	0.5	0.0	1.1	0.0	59.2	0.0	0.0	25.0	2.4	0.0	3.7	0.0	0.0	0.0
TBX15	TBX14	ENSG00000092607	"T-box 15"	Q96SF7	1	118883046-118989556	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 23.3;skeletal muscle: 84.9;tongue: 37.5"	"Group enriched"	"Detected in some"	4	"Early spermatids: 6.3;Hepatocytes: 11.3;Melanocytes: 6.8;Smooth muscle cells: 7.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 28.2;ASC TERT1: 12.0;BJ hTERT+ SV40 Large T+ RasG12V: 10.8;fHDF/TERT166: 14.4;HSkMC: 20.3;RH-30: 15.3;U-2197: 14.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA052245, HPA053713"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA052245: AB_2681771, HPA053713: "	"unprognostic (1.94e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.92e-2)"	"unprognostic (3.94e-2)"	"unprognostic (5.72e-3)"	"unprognostic (7.79e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.81e-3)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (5.57e-8)"	"unprognostic (2.63e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.31e-1)"	18.1	0.1	0.2	0.1	0.5	0.1	12.5	0.4	0.8	0.1	0.1	0.2	0.0	0.0	0.1	2.1	1.2	0.1	0.3	1.2	0.5	0.0	0.1	23.3	0.2	1.3	0.2	0.2	0.1	0.1	0.2	0.5	0.1	2.1	0.7	0.0	0.2	2.8	0.1	84.9	3.6	0.1	0.2	0.6	0.0	0.1	0.4	0.4	0.0	1.9	37.5	2.4	0.2	1.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	28.2	12.0	0.0	2.4	3.3	6.4	10.8	0.0	0.0	0.0	1.4	14.4	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.7	0.0	0.0	0.2	0.0	20.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	7.3	0.0	0.0	0.1	1.2	0.0	0.1	0.0	15.3	0.2	1.6	0.7	0.3	0.0	0.8	0.0	0.3	0.3	0.0	0.3	0.0	3.5	2.1	14.3	0.1	0.2	0.1	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.4	0.8	0.5	0.0	0.2	0.2	2.1	0.4	0.0	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	11.3	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.9	0.2	0.1	1.8	0.0	0.0	0.0	0.0
TCEA2	TFIIS	ENSG00000171703	"Transcription elongation factor A2"	Q15560	20	64049836-64072347	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043836	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA043836: AB_2678694"	"unprognostic (6.51e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.91e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.65e-3)"	"unprognostic (9.03e-3)"	"unprognostic (2.49e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.81e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.79e-1)"	14.8	19.5	31.4	7.9	32.8	6.6	9.3	34.7	40.4	18.3	11.7	17.7	11.0	5.6	18.8	10.9	8.4	24.5	13.5	19.1	27.7	30.0	14.8	27.5	10.9	9.2	27.2	32.8	30.3	16.1	18.6	17.9	14.7	26.5	16.9	3.2	14.5	17.9	22.3	30.7	10.4	7.8	11.7	18.3	16.2	10.5	32.0	18.9	8.7	15.0	6.1	5.2	10.9	15.4	9.7	3.0	4.4	2.6	3.6	5.5	1.6	7.6	8.3	13.2	22.4	11.8	7.4	5.4	8.0	8.9	14.1	6.8	4.9	13.6	8.7	18.0	9.2	8.1	20.5	5.2	6.8	2.8	5.4	10.5	3.3	14.5	12.8	17.6	3.6	4.6	11.5	6.1	3.6	4.7	18.9	9.6	10.9	5.7	16.4	4.3	16.6	14.8	17.7	8.5	9.3	20.0	14.5	10.0	22.5	7.1	5.1	13.1	22.1	8.1	5.5	20.0	4.4	15.2	9.1	13.7	25.5	13.5	14.3	4.9	19.1	12.5	4.6	22.7	4.2	5.0	2.4	1.7	4.4	3.6	1.6	1.6	9.7	3.2	2.6	2.1	5.0	5.5	3.4	0.8	3.6	2.6	3.0	5.4	1.6	31.4	32.8	34.7	37.6	27.7	30.0	27.2	32.8	26.5	18.9	0.0	1.9	12.3	28.6	20.0	50.6	26.9	22.9	6.7	7.9	68.0	25.5	21.6	91.2	30.0	85.6	40.8	1.7	0.0	13.9	11.1	39.4	27.1	2.3	35.5	14.9	62.0	18.3	33.7	14.8	118.7	48.1	23.3	59.1	21.6	2.8	84.3	20.7	2.5	46.3	82.3	30.1	25.8	42.9	95.9	31.9	17.7	17.4	13.8	1.7	17.4
TDRKH	TDRD2	ENSG00000182134	"Tudor and KH domain containing"	Q9Y2W6	1	151770107-151791416	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, RNA-mediated gene silencing, Spermatogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 46.5"	"Cell type enhanced"	"Detected in many"	10	"Late spermatids: 48.0;Spermatocytes: 46.8;Spermatogonia: 21.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016419, HPA019625"	Approved		Approved	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA016419: AB_1857870, HPA019625: AB_1857871"	"unprognostic (2.27e-3)"	"unprognostic (2.89e-1)"	"unprognostic (8.60e-2)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.63e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.14e-1)"	2.7	3.5	8.8	4.2	10.9	1.6	4.6	18.0	9.9	2.6	3.3	6.3	7.5	2.5	2.0	6.2	2.1	2.4	2.3	3.6	8.8	8.9	3.1	3.7	4.4	5.4	8.1	7.8	1.4	3.5	46.5	5.5	3.7	15.9	6.2	4.3	2.9	6.4	6.7	4.5	2.5	2.5	3.1	7.6	5.9	3.1	19.3	4.9	8.0	7.3	1.0	5.2	3.7	2.0	3.8	5.3	5.3	7.0	7.3	13.1	4.2	6.3	5.5	4.9	11.4	0.3	0.5	4.8	1.1	0.6	3.4	2.3	3.6	9.2	7.4	10.1	0.4	8.1	3.9	7.2	7.5	5.3	19.2	5.1	7.4	1.6	2.5	2.2	1.4	1.2	0.6	3.0	7.3	3.1	1.0	3.6	14.7	5.7	6.7	1.0	17.2	11.7	2.2	3.8	9.5	9.6	1.4	3.1	15.4	6.0	3.1	7.2	11.8	7.9	6.4	7.4	9.4	13.9	5.6	1.4	1.6	2.9	5.0	6.1	13.8	16.9	8.3	7.4	6.0	2.2	5.3	0.9	1.9	8.8	4.3	13.1	3.8	8.2	8.8	2.0	3.6	6.0	7.5	0.7	7.3	7.0	5.3	9.4	4.2	8.8	10.9	18.0	9.9	8.8	8.9	8.1	7.8	15.9	4.9	3.0	8.8	0.9	1.9	0.2	3.4	2.6	0.0	1.4	2.3	7.0	3.9	2.2	1.7	2.5	17.5	1.0	0.1	0.0	2.2	2.5	0.4	1.7	4.6	0.6	4.4	6.4	0.0	1.3	1.3	48.0	0.3	1.3	1.7	3.6	0.9	1.5	1.8	0.0	2.1	1.3	3.0	12.9	1.2	46.8	21.1	0.1	2.1	1.3	1.0	0.9
TGIF2		ENSG00000118707	"TGFB induced factor homeobox 2"	Q9GZN2	20	36573488-36593950	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Basal keratinocytes: 39.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA053786, HPA064522"			Enhanced	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA053786: AB_2682261, HPA064522: "	"unprognostic (1.42e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.10e-1)"	"unprognostic (7.19e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.14e-2)"	14.0	6.1	2.8	20.0	3.1	4.1	7.8	1.3	3.5	13.7	8.8	4.0	3.5	3.2	23.7	7.9	6.8	18.0	10.2	7.6	2.7	2.5	9.2	13.2	13.7	16.6	4.4	1.6	17.9	33.3	10.5	3.4	9.1	3.9	9.3	3.7	12.1	14.9	5.7	4.1	5.6	8.1	13.7	3.2	20.3	7.0	16.9	2.8	26.7	12.9	6.9	22.1	10.0	7.2	8.2	7.7	14.7	5.4	4.2	7.6	3.8	7.0	1.7	20.3	23.0	3.0	2.7	7.4	4.0	4.7	9.7	7.3	10.4	9.0	19.0	10.7	3.9	4.4	7.3	16.5	10.5	9.5	8.9	5.9	23.8	4.1	13.7	4.6	10.0	5.8	4.3	7.0	2.0	7.6	8.8	9.6	9.2	11.4	11.7	4.7	10.0	17.0	19.2	17.0	10.3	5.1	14.7	24.3	10.3	6.4	4.7	6.1	18.1	1.3	10.8	10.1	17.0	12.9	22.5	6.9	1.5	6.4	0.1	7.6	13.4	5.0	17.9	0.1	12.1	7.6	14.7	5.4	1.7	4.8	4.9	5.2	8.2	4.4	4.9	7.4	6.5	7.6	6.3	2.2	4.2	3.4	7.7	4.2	3.8	2.8	3.1	1.3	3.5	2.7	2.5	4.4	1.6	3.9	2.8	8.9	9.1	6.5	26.2	39.6	0.1	11.2	12.7	5.3	9.1	7.0	2.0	5.2	6.6	16.4	2.0	14.3	0.0	0.0	6.7	1.0	16.9	15.0	16.1	5.9	8.7	0.0	6.3	11.6	7.0	1.9	5.8	8.8	13.5	7.2	2.6	7.2	13.3	6.2	7.1	6.1	1.9	6.5	15.6	2.3	25.6	22.2	7.6	12.8	3.3	13.9
THAP6	MGC30052	ENSG00000174796	"THAP domain containing 6"	Q8TBB0	4	75513946-75550473	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 108.2;Spermatocytes: 56.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA035767	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Centrosome	Nucleoplasm	"HPA035767: AB_10696510"	"unprognostic (9.62e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.89e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.47e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.38e-2)"	15.7	14.9	11.5	18.7	17.6	14.4	18.6	21.2	17.0	18.4	17.0	24.4	16.5	14.9	20.2	23.8	15.5	15.6	13.5	17.2	12.0	11.9	17.8	21.9	13.1	17.9	21.9	14.0	19.3	14.9	19.9	30.9	24.3	17.8	18.3	14.5	17.3	17.0	13.3	20.3	20.8	21.1	18.8	19.2	17.8	13.1	26.5	21.3	18.0	20.4	16.9	15.2	16.5	14.3	10.7	7.1	18.5	8.7	6.8	13.6	6.5	6.9	5.0	11.1	7.7	12.7	12.5	6.3	16.6	8.6	8.7	9.1	6.3	17.4	10.1	8.6	5.4	9.8	7.4	9.9	7.9	10.7	11.5	6.9	7.3	8.2	8.0	17.5	9.8	8.3	10.5	13.8	9.9	15.4	14.0	4.7	12.1	12.6	20.9	9.2	8.1	8.9	6.7	6.3	9.7	5.1	8.7	12.2	7.0	8.1	5.9	8.5	8.8	7.8	10.7	9.2	9.7	11.6	8.2	5.7	14.9	9.9	17.2	8.5	18.7	9.2	9.6	10.4	7.9	12.5	14.6	8.7	12.2	9.8	7.5	13.0	8.9	11.9	9.2	7.1	10.7	13.6	10.4	18.5	6.8	8.0	5.9	13.0	6.5	11.5	17.6	21.2	16.5	12.0	11.9	21.9	14.0	17.8	21.3	11.9	8.3	14.8	14.8	7.3	20.4	15.1	10.2	22.7	9.1	21.0	29.5	8.4	13.3	7.2	108.2	7.9	9.3	0.0	5.6	7.9	10.4	10.1	10.4	8.5	6.5	15.9	12.1	8.6	13.9	18.2	13.0	10.9	6.8	6.4	10.3	14.3	6.5	7.8	10.6	10.2	17.2	0.0	9.9	56.5	15.1	5.9	6.4	10.1	7.4	6.4
TLR10	CD290	ENSG00000174123	"Toll like receptor 10"	Q9BXR5	4	38772239-38782990	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 23.5;brain: 11.3;intestine: 11.2;lymphoid tissue: 31.6"	"Cell type enriched"	"Detected in some"	18	"B-cells: 39.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"memory B-cell: 23.5;naive B-cell: 14.9"	"Lineage enriched"	"Detected in many"	6	"B-cells: 23.5"	"Group enriched"	"Detected in some"	55	"Daudi: 38.2;REH: 12.8;U-698: 13.7"					"Low region specificity"	"Detected in all"			HPA066755			Approved	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA066755: "	"unprognostic (5.41e-5)"	"unprognostic (2.41e-4)"	"unprognostic (1.91e-3)"	"unprognostic (8.22e-4)"	"unprognostic (6.48e-2)"	"unprognostic (9.98e-4)"	"unprognostic (9.31e-2)"	"unprognostic (8.76e-3)"	"unprognostic (4.08e-3)"	"unprognostic (7.26e-2)"	"unprognostic (8.76e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.90e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.88e-2)"	0.8	0.5	4.2	24.5	9.4	0.9	0.6	0.6	3.5	0.6	1.0	2.5	0.0	0.9	0.5	0.3	1.7	0.9	1.0	0.5	3.2	1.8	0.8	0.7	1.2	27.0	5.5	0.5	0.5	0.6	0.1	0.7	0.2	4.8	0.8	1.4	0.0	2.6	0.3	0.5	0.5	11.2	0.3	11.3	24.4	1.8	0.4	7.4	2.7	0.9	0.0	31.6	3.2	0.6	23.5	4.0	0.7	1.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.1	0.2	0.4	0.0	1.5	0.0	23.5	0.0	0.0	3.6	14.9	0.0	0.0	0.7	0.0	1.8	4.0	0.0	0.9	4.2	9.4	0.6	3.5	3.2	1.8	5.5	0.5	4.8	7.4	0.0	1.4	39.2	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.7	0.0	1.2	0.6	2.2	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1
TMEM132C	"DKFZp761O2018, PPP1R152"	ENSG00000181234	"Transmembrane protein 132C"	Q8N3T6	12	128267403-128707915	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 37.5"	"Cell type enhanced"	"Detected in some"	13	"Bipolar cells: 14.3;Cone photoreceptor cells: 5.9;Leydig cells: 8.3;Peritubular cells: 14.2"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 4.6;testis cancer: 4.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"gdT-cell: 5.4"	"Lineage enriched"	"Detected in single"	55	"T-cells: 5.4"	"Group enriched"	"Detected in some"	6	"AF22: 6.1;ASC diff: 8.7;Daudi: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015633, HPA015984"			Approved	Centrosome,Cytosol		NA	NA		110000000	"Centrosome, Cytosol"		"HPA015633: AB_1858089, HPA015984: AB_1858088"	"unprognostic (2.29e-2)"	"unprognostic (5.55e-3)"	"unprognostic (7.34e-2)"	"unprognostic (8.60e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.99e-3)"		"unprognostic (5.48e-2)"		"unprognostic (1.30e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.85e-2)"	"unprognostic (6.29e-2)"	"unprognostic (7.97e-3)"	"unprognostic (2.54e-1)"	"unprognostic (5.71e-2)"	"unprognostic (6.33e-3)"	37.5	4.2	9.6	1.1	7.0	0.8	23.3	5.0	6.6	22.0	2.5	4.2	8.9	1.2	5.9	5.7	4.7	13.4	5.1	3.5	5.0	3.8	1.3	0.8	1.6	2.0	4.9	3.1	7.9	4.1	0.9	0.6	5.1	4.6	3.7	1.3	5.3	2.9	9.1	1.9	2.2	1.4	2.1	3.9	1.1	1.5	2.1	5.4	0.0	1.1	0.9	1.3	3.8	10.5	0.0	0.0	0.0	0.0	0.0	5.4	0.1	0.0	0.0	6.1	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	9.6	7.0	5.0	6.6	5.0	3.8	4.9	3.1	4.6	5.4	0.0	0.0	0.0	0.0	0.3	14.3	0.7	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.3	0.0	1.7	0.0	0.0	0.4	0.1	0.0	14.2	0.0	2.1	0.0	1.9	0.1	0.2	0.0	0.0	0.0	0.0	0.0
TMEM86B	MGC30208	ENSG00000180089	"Transmembrane protein 86B"	Q8N661	19	55226639-55229264	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"liver: 15.1"	"Cell type enhanced"	"Detected in many"	10	"Cholangiocytes: 30.6;Hepatocytes: 28.9"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 10.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA057689	Uncertain		Uncertain	Midbody,Centrosome		Yes	No			Centrosome	Midbody	"HPA057689: AB_2683504"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.76e-5)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.55e-2)"	"prognostic favorable (3.13e-4)"	"unprognostic (1.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (9.97e-6)"	"unprognostic (1.96e-2)"	"unprognostic (6.63e-8)"	"unprognostic (2.28e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.19e-3)"	2.5	2.4	2.8	3.1	4.0	7.8	1.4	4.7	4.2	1.4	7.5	1.4	1.4	5.6	1.5	1.4	1.4	1.8	7.7	2.9	2.2	1.6	2.0	15.1	2.7	5.2	1.4	1.4	1.4	1.4	1.7	2.8	5.2	1.7	1.5	0.4	1.4	1.4	1.4	2.2	3.0	7.7	1.4	1.4	4.3	3.6	2.8	1.4	1.4	2.3	1.4	3.0	1.4	1.4	0.7	1.0	0.6	0.7	0.0	1.6	0.4	4.1	3.9	2.4	3.9	0.4	0.6	3.6	1.5	0.7	1.3	1.8	6.3	2.2	4.8	1.2	1.1	1.3	1.7	0.9	1.0	0.6	0.9	11.2	8.8	2.5	5.9	1.2	4.0	3.7	0.8	1.7	2.1	1.3	1.8	0.5	9.2	6.0	3.5	0.8	2.4	6.4	10.0	0.9	1.9	2.4	6.0	2.8	12.6	1.1	5.1	2.1	3.9	1.8	0.8	4.9	1.3	2.2	8.4	2.8	5.7	3.2	2.5	3.8	2.9	3.4	10.2	4.7	11.1	2.1	0.0	0.7	0.6	1.6	0.1	0.6	0.0	0.5	0.1	0.1	0.7	0.6	1.4	0.1	0.0	0.1	1.0	0.0	0.4	2.8	4.0	4.7	4.2	2.2	1.6	1.4	1.4	1.7	1.4	6.0	2.4	0.8	0.4	3.0	7.6	0.5	30.6	0.0	1.2	0.0	2.0	0.4	0.0	0.9	2.0	1.7	5.2	0.0	0.2	0.3	1.1	1.1	0.0	28.9	0.9	9.5	10.3	0.0	6.2	3.6	0.9	1.7	3.3	1.8	1.9	1.1	0.8	0.0	0.4	0.8	3.6	0.0	0.5	1.6	1.1	1.9	0.2	4.6	1.9	1.7
TNFAIP3	"A20, OTUD7C"	ENSG00000118503	"TNF alpha induced protein 3"	P21580	6	137867188-137883312	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Inflammatory response, Ubl conjugation pathway"	"DNA-binding, Hydrolase, Multifunctional enzyme, Protease, Thiol protease, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 112.4"	"Cell type enhanced"	"Detected in many"	10	"Basal keratinocytes: 688.4;Suprabasal keratinocytes: 651.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 31.8;Karpas-707: 48.1;REH: 41.8;U-266/84: 35.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA002116	Approved		Approved	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"HPA002116: AB_1858162"	"unprognostic (5.50e-3)"	"unprognostic (9.98e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.01e-2)"	"unprognostic (9.47e-2)"	"unprognostic (5.01e-3)"	"unprognostic (4.40e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (6.05e-4)"	"unprognostic (6.06e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.29e-2)"	27.4	6.0	1.5	58.6	1.8	112.4	17.2	0.4	1.5	7.7	15.7	3.2	2.6	5.1	9.7	7.3	12.7	12.1	17.0	11.7	2.1	1.3	6.8	8.1	45.1	38.8	2.1	2.6	37.5	7.2	2.1	3.7	14.5	4.6	13.8	6.3	7.2	8.2	3.5	10.7	20.5	17.2	8.2	3.8	25.9	8.0	9.3	2.1	38.6	5.7	9.2	31.4	23.3	9.5	7.1	18.6	10.0	9.7	7.5	20.5	9.0	8.9	1.4	0.5	0.8	3.0	5.1	2.1	5.1	19.9	1.4	1.8	9.9	2.9	2.0	13.1	5.8	31.8	6.8	0.3	14.7	2.6	14.5	0.5	2.0	5.1	5.8	3.3	2.7	3.6	4.6	2.1	16.8	16.0	1.7	0.8	5.3	4.0	48.1	2.4	0.5	14.7	11.5	0.3	0.6	0.4	41.8	10.4	1.4	4.3	4.3	0.2	0.0	1.0	1.5	4.3	2.1	1.0	3.3	4.0	14.4	1.7	12.9	2.9	15.5	35.9	4.1	5.2	3.4	1.7	5.6	9.7	5.5	14.8	7.1	20.5	6.2	15.1	13.3	10.3	7.1	10.0	7.4	10.0	7.5	3.7	18.6	14.7	9.0	1.5	1.8	0.4	1.5	2.1	1.3	2.1	2.6	4.6	2.1	35.7	83.1	25.1	141.6	688.4	1.0	4.2	30.6	41.5	26.1	0.0	27.5	5.5	1.7	50.3	2.3	27.0	39.0	0.0	23.4	88.6	55.5	117.9	248.4	10.2	45.4	0.0	11.3	45.4	74.2	2.4	6.4	241.1	123.2	82.0	12.5	1.7	27.9	8.2	5.6	2.2	13.3	6.5	87.3	0.9	2.3	651.8	19.3	101.2	8.5	60.3
TRAF5	RNF84	ENSG00000082512	"TNF receptor associated factor 5"	O00463	1	211326615-211374946	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"B-cells: 48.9;Early spermatids: 42.9;Late spermatids: 38.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 22.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008052, CAB010277"	Enhanced		Supported	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"CAB010277: AB_2287961, HPA008052: AB_1858230"	"unprognostic (6.44e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.15e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.44e-3)"	"unprognostic (7.94e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (2.94e-10)"	"unprognostic (3.72e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.71e-2)"	"prognostic favorable (7.29e-5)"	7.5	3.1	3.9	33.6	6.5	3.1	6.1	1.2	4.6	11.1	11.6	3.3	9.9	4.2	24.3	17.4	6.1	17.1	10.4	4.5	3.4	2.3	5.3	1.9	5.4	22.7	1.9	3.1	8.6	19.4	1.7	3.1	4.4	5.3	8.7	8.1	9.6	13.3	17.8	1.6	2.9	15.5	21.4	1.9	16.5	8.6	5.6	1.7	15.9	3.1	4.1	27.4	12.0	6.5	14.7	0.9	5.3	0.3	13.1	11.9	4.8	3.8	2.9	5.2	4.6	4.6	3.3	1.8	5.5	6.6	8.0	7.2	1.4	7.7	11.8	3.2	8.7	4.1	0.7	9.7	0.9	4.0	22.7	3.5	0.6	4.2	0.0	6.6	1.8	8.7	3.9	1.7	4.3	1.3	12.1	5.6	10.4	4.7	5.6	2.2	3.0	5.1	2.1	6.2	6.1	2.4	7.8	7.2	10.9	6.1	2.7	9.2	9.6	4.1	0.2	11.8	20.0	2.9	0.2	3.4	5.2	4.1	1.7	6.1	1.6	2.3	12.6	1.4	0.0	1.9	5.3	0.2	0.3	6.3	0.2	11.9	14.7	7.9	8.4	0.9	13.0	7.2	7.0	0.4	13.1	0.3	0.7	10.8	4.8	3.9	6.5	1.2	4.6	3.4	2.3	1.9	3.1	5.3	1.7	11.9	11.1	48.9	3.5	3.3	1.0	2.0	0.0	13.4	10.3	10.4	0.0	7.1	0.0	0.7	42.9	7.4	1.6	0.0	8.4	1.7	8.6	2.6	14.0	0.0	8.4	0.0	14.3	6.2	3.7	38.6	13.3	7.5	8.5	23.4	10.9	0.8	7.3	8.6	25.8	0.5	0.4	12.9	10.3	3.0	1.1	3.4	1.1	26.3	10.2	1.6
TRIM34	RNF21	ENSG00000258659	"Tripartite motif containing 34"	Q9BYJ4	11	5619764-5644398	"Predicted intracellular proteins"	"Antiviral defense"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"	24	"Ciliated cells: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.5;SK-BR-3: 17.6"									HPA077996			Approved	Nucleoli,Centrosome		NA	NA			Centrosome	Nucleoli	"HPA077996: AB_2686873"	"unprognostic (8.66e-3)"	"unprognostic (9.94e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.88e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.74e-1)"	"unprognostic (9.16e-3)"	"unprognostic (8.16e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.40e-1)"	"unprognostic (6.76e-2)"	15.9	14.6	2.7	12.2	2.9	1.4	7.3	0.9	3.4	9.3	7.9	6.0	8.5	6.6	15.7	10.6	8.7	7.8	5.6	4.1	3.6	2.2	7.1	4.4	7.9	11.7	2.6	3.9	11.4	5.5	4.5	5.5	8.7	4.7	9.5	6.8	7.8	10.2	6.3	2.0	6.2	14.2	5.8	6.2	16.6	6.1	4.6	4.3	12.5	7.0	5.0	14.3	10.0	7.8	12.8	15.9	15.2	15.9	5.9	9.5	7.8	2.3	1.3	0.5	0.2	5.3	8.3	16.5	3.5	10.2	9.1	8.9	1.0	8.1	8.1	1.6	4.7	6.8	3.7	0.3	7.5	4.6	10.6	0.3	4.3	0.4	0.4	2.4	4.7	3.0	8.7	6.5	4.6	1.5	7.1	11.6	7.2	0.2	0.6	4.3	1.0	4.2	2.7	0.0	3.2	0.7	6.3	0.3	0.5	5.4	6.2	0.0	0.0	0.1	17.6	2.6	1.6	3.1	2.3	9.3	2.4	0.5	0.9	1.3	0.9	1.1	3.1	6.8	0.6	1.2	8.7	14.3	3.6	5.6	15.9	6.1	12.6	5.4	6.9	15.9	12.8	6.8	5.7	15.2	5.9	13.5	8.1	9.5	7.8	2.7	2.9	0.9	3.4	3.6	2.2	2.6	3.9	4.7	4.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
TRIM6-TRIM34		ENSG00000258588	"TRIM6-TRIM34 readthrough"		11	5596725-5644398	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in many"	6	"kidney: 30.3;salivary gland: 9.5;testis: 8.0"	"Cell type enriched"	"Detected in single"	9	"Ciliated cells: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"A549: 10.1"									HPA077996			Uncertain	Nucleoli,Centrosome		NA	NA			Centrosome	Nucleoli	"HPA077996: AB_2686873"																		0.9	0.7	0.4	0.6	0.4	0.1	0.9	0.4	0.4	1.4	0.4	0.0	0.7	0.8	1.5	1.6	1.9	0.7	0.2	1.4	0.4	0.3	30.3	0.4	0.7	0.1	0.3	0.0	1.7	2.7	1.1	0.4	1.4	0.3	1.5	0.2	2.2	9.5	1.9	0.4	0.4	0.6	1.9	0.4	1.1	0.4	8.0	0.0	0.0	1.7	0.0	1.5	1.1	0.5	0.5	1.5	1.3	0.8	0.9	0.2	0.2	0.0	10.1	0.0	0.0	0.2	0.8	1.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	1.1	0.0	0.0	0.7	0.6	0.6	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.6	0.2	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.1	0.2	0.2	0.1	0.4	0.0	0.1	1.5	0.5	0.1	0.1	1.3	0.9	0.4	0.3	0.0	0.2	0.4	0.4	0.4	0.4	0.4	0.3	0.3	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TTC30A	"FLJ13946, IFT70A"	ENSG00000197557	"Tetratricopeptide repeat domain 30A"	Q86WT1	2	177612992-177618966	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 24.5"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 29.4;Early spermatids: 31.2;Spermatocytes: 33.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA051714, HPA052100, HPA052487"	Supported		Approved	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"HPA051714: AB_2681583, HPA052100: AB_2681726, HPA052487: AB_2681848"	"unprognostic (7.75e-2)"	"unprognostic (3.83e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.79e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.41e-1)"	"unprognostic (4.67e-3)"	"unprognostic (6.07e-2)"	2.7	4.1	3.8	1.5	7.1	0.4	5.6	2.2	7.1	4.2	3.4	5.9	7.8	2.2	5.0	10.9	2.4	8.4	4.8	4.4	3.7	4.2	6.9	4.6	3.7	1.4	3.6	6.6	5.5	4.4	11.6	8.1	1.9	4.8	3.9	3.3	5.0	8.1	4.0	3.5	1.9	2.5	3.6	3.0	1.7	3.6	24.5	2.1	2.6	9.6	4.6	1.7	3.1	1.7	0.5	1.6	1.9	1.6	0.2	2.7	1.0	5.7	3.3	3.3	0.0	6.7	5.6	2.4	2.8	8.1	5.0	5.3	1.0	4.2	1.3	5.4	4.8	6.8	4.8	2.2	6.1	5.5	0.4	1.8	1.1	1.6	1.4	2.7	1.4	1.3	3.4	4.0	2.8	1.1	4.8	2.3	2.9	0.8	0.5	3.5	2.9	4.4	2.6	1.8	2.0	1.2	2.9	8.8	0.6	6.3	1.5	10.8	7.2	2.5	4.9	3.0	8.1	2.8	1.4	2.1	3.1	1.9	3.4	2.3	2.2	2.1	0.4	7.7	0.1	3.0	0.0	1.3	1.9	0.4	1.6	0.1	0.4	0.1	0.4	1.6	0.5	2.7	1.2	0.7	0.2	1.3	0.6	1.0	1.0	3.8	7.1	2.2	7.1	3.7	4.2	3.6	6.6	4.8	2.1	8.9	1.9	0.0	1.1	0.7	2.2	3.1	2.5	29.4	4.5	7.0	2.0	0.8	1.7	4.1	31.2	1.4	1.7	0.0	3.5	0.7	1.5	1.0	0.0	2.9	0.7	15.9	6.9	4.3	0.3	6.8	2.0	0.2	1.7	0.0	2.5	10.6	2.4	0.0	2.1	3.8	11.3	0.0	0.9	33.6	4.6	0.4	0.2	0.0	2.3	0.3
TTC30B	"fleer, FLJ30990, IFT70B"	ENSG00000196659	"Tetratricopeptide repeat domain 30B"	Q8N4P2	2	177548998-177553014	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Ciliated cells: 42.8;Spermatocytes: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA051714, HPA052100, HPA052487"	Supported		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA051714: AB_2681583, HPA052100: AB_2681726, HPA052487: AB_2681848"	"unprognostic (5.76e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.15e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.27e-2)"	"unprognostic (9.77e-2)"	"unprognostic (9.61e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.65e-1)"	2.4	4.6	4.4	1.9	4.9	0.7	10.5	3.2	5.1	4.8	4.0	7.7	3.8	3.1	4.9	8.9	3.7	13.2	4.5	2.3	3.9	3.8	10.8	4.3	5.5	2.5	3.1	1.5	6.0	5.2	8.0	7.0	3.3	3.4	3.5	3.7	4.5	4.4	4.2	1.2	3.0	3.7	3.1	5.2	3.1	4.7	11.5	2.9	7.7	10.4	1.6	2.8	3.3	2.2	3.2	3.9	6.5	3.4	1.9	2.2	1.6	2.8	4.3	5.7	1.1	5.1	6.0	3.9	1.8	5.3	4.7	5.0	2.4	7.1	1.1	4.7	3.3	5.4	7.0	6.8	7.2	4.5	1.6	3.4	2.0	2.7	2.1	4.3	2.5	3.5	4.9	6.8	4.6	3.5	5.7	3.7	5.4	2.6	1.0	2.8	4.8	5.0	3.9	2.6	3.9	1.1	3.9	4.9	1.2	7.0	3.1	13.9	7.8	2.1	4.9	3.3	8.1	5.0	4.8	3.2	2.6	1.4	3.3	1.5	2.6	2.9	0.3	5.9	1.0	4.3	6.5	3.4	2.8	1.7	3.3	1.1	1.4	1.2	1.8	3.9	3.2	2.2	2.2	2.0	1.9	2.2	2.8	1.0	1.6	4.4	4.9	3.2	5.1	3.9	3.8	3.1	1.5	3.4	2.9	3.0	2.9	0.5	0.4	0.6	2.1	0.8	5.1	42.8	9.1	0.0	2.0	2.1	5.0	3.6	6.2	1.6	2.3	0.0	2.5	1.1	2.1	0.5	1.1	2.4	1.1	4.8	1.2	2.5	1.8	4.0	1.4	1.0	1.7	0.0	2.5	6.6	2.4	0.0	2.1	3.7	11.0	0.0	1.3	23.3	3.4	0.6	0.5	0.5	2.3	0.1
TUBGCP2	"GCP2, SPBC97, Spc97p"	ENSG00000130640	"Tubulin gamma complex associated protein 2"	Q9BSJ2	10	133278630-133312337	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Ciliated cells: 143.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037885	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"HPA037885: AB_10672397"	"unprognostic (3.57e-2)"	"unprognostic (5.53e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.72e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.52e-1)"	"unprognostic (4.24e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.89e-2)"	20.3	26.7	16.7	17.3	25.6	29.4	21.4	28.6	33.4	20.3	19.3	22.5	25.2	19.2	23.2	18.9	19.8	35.1	21.7	18.6	21.9	17.2	24.4	22.2	22.8	27.7	16.3	26.5	28.3	30.9	31.9	23.0	17.0	22.3	20.8	16.0	19.0	26.8	22.3	30.4	24.1	19.7	17.6	16.7	25.6	20.1	33.5	15.4	25.6	23.0	18.3	19.5	19.3	18.2	6.1	14.3	17.3	11.9	12.1	10.4	8.7	18.3	25.5	9.4	9.6	10.1	11.0	12.1	14.4	23.4	17.8	18.0	26.6	12.9	13.9	8.1	16.4	6.5	12.4	12.6	11.8	7.9	13.0	24.1	8.9	12.6	14.6	12.7	19.0	16.4	11.4	10.3	16.5	20.6	18.1	11.7	9.2	10.8	11.3	14.4	25.1	10.4	21.0	8.2	12.0	20.3	8.3	11.0	6.0	11.6	9.6	6.5	12.8	10.3	11.6	11.5	6.0	8.4	9.7	14.1	8.7	7.8	11.4	12.8	11.3	7.7	16.2	34.9	8.6	5.5	5.0	11.9	11.9	7.6	11.2	8.5	6.0	7.6	8.0	14.3	6.1	8.7	9.0	17.3	12.1	11.8	6.5	10.4	8.7	16.7	25.6	28.6	33.4	21.9	17.2	16.3	26.5	22.3	15.4	44.7	36.3	20.8	22.9	12.4	41.4	30.5	22.9	143.2	43.3	38.4	29.5	33.5	19.9	30.5	19.9	21.8	31.4	23.3	32.0	27.4	24.7	25.0	38.2	26.3	41.0	36.5	28.2	28.3	39.5	22.0	31.4	45.0	13.5	75.7	32.6	38.3	28.6	31.7	33.2	44.0	69.1	32.3	15.9	63.2	56.2	12.0	35.6	26.1	32.4	26.7
TUBGCP5	"GCP5, KIAA1899"	ENSG00000275835	"Tubulin gamma complex associated protein 5"	Q96RT8	15	22983192-23039673	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 36.2;Spermatogonia: 33.1"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039366, HPA040366"	Supported		Supported	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"HPA039366: AB_10673243, HPA040366: AB_2676942"	"unprognostic (1.17e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.27e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.79e-1)"	"unprognostic (9.45e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.18e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.53e-3)"	5.1	5.7	5.7	5.1	8.4	5.5	7.3	4.0	10.4	7.9	4.6	6.0	4.6	4.2	7.4	8.7	5.9	4.9	4.7	6.6	7.7		6.3	6.8	5.6	5.5	6.0	11.0	5.0	10.0	10.2	6.3	4.8	12.9	7.5	5.3	5.3	4.0	7.4	14.5	7.3	3.0	9.3	10.0	4.8	5.3	12.9	5.9	5.4	8.6	7.0	6.1	4.6	0.8	5.3	4.0	1.5	3.3	5.4	7.6	2.5	12.2	13.0	15.4	9.0	11.9	7.8	8.9	15.3	16.9	17.0	14.7	9.9	5.8	9.3	6.6	14.0	8.9	12.4	10.1	11.9	14.2	14.4	4.0	16.8	13.1	5.3	4.0	17.0	7.4	12.7	4.5	11.3	10.5	5.5	10.1	16.7	11.8	15.1	10.7	8.0	11.4	7.4	9.1	12.2	11.9	14.1	16.9	1.9	9.8	19.2	5.2	9.0	12.5	8.8	8.0	7.9	14.2	8.0	8.7	11.6	7.6	9.0	22.6	11.9	11.9	25.1	15.3	11.3	10.9	0.2	2.3	0.9	4.5	3.3	4.6	3.7	6.7	7.2	3.6	5.3	6.0	7.6	1.5	5.4	3.3	4.0	5.4	2.5											14.9	15.3	5.1	2.9	3.0	27.8	10.3	5.1	9.4	6.8	5.2	13.7	6.6	5.0	5.5	5.7	5.7	2.2	0.0	4.1	6.0	4.7	1.6	5.8	7.5	6.5	9.5	4.1	6.7	5.9	9.8	10.3	5.8	3.3	2.8	4.6	13.5	5.8	3.4	12.0	5.3	18.4	0.0	6.7	36.2	33.1	2.4	2.9	5.1	4.2	1.6
TWSG1	TSG	ENSG00000128791	"Twisted gastrulation BMP signaling modulator 1"	Q9GZX9	18	9334767-9402420	"Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 91.3;Peritubular cells: 89.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014898	Uncertain		Supported	Centrosome,Cytosol	"Secreted - unknown location"	No	No		6600000	"Centrosome, Cytosol"		"HPA014898: AB_1858467"	"unprognostic (2.55e-1)"	"unprognostic (3.17e-2)"	"unprognostic (7.31e-2)"	"unprognostic (8.95e-3)"	"unprognostic (2.92e-3)"	"unprognostic (1.83e-1)"	"unprognostic (8.29e-2)"	"unprognostic (5.88e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.36e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.32e-2)"	13.0	8.9	8.3	6.9	8.5	2.9	17.3	5.0	6.2	21.9	17.4	9.3	56.2	4.7	33.0	21.5	19.0	14.4	16.4	9.2	8.4	7.1	19.8	4.8	12.6	6.6	11.0	6.1	20.4	4.4	12.7	11.4	10.7	9.1	26.5	10.2	10.6	9.4	34.8	6.1	7.6	8.6	36.0	12.3	9.4	12.0	13.0	8.1	4.3	20.5	8.7	6.8	26.0	17.9	3.3	7.8	7.5	4.1	4.1	7.5	3.1	15.0	5.5	15.8	7.8	31.3	28.3	7.3	28.9	36.0	15.9	22.8	5.8	19.9	2.1	14.7	38.1	10.3	5.3	15.5	11.4	29.3	5.9	4.3	3.9	4.7	2.8	27.8	2.8	8.1	28.7	9.4	13.3	6.4	21.8	24.6	2.1	5.9	4.0	40.6	4.6	3.0	3.4	5.1	8.9	4.5	5.4	16.2	1.3	18.0	20.2	2.1	5.5	22.7	6.3	6.0	6.9	7.1	6.6	20.3	29.2	14.6	27.3	17.9	5.8	5.1	4.1	17.9	3.9	10.2	7.5	4.1	5.8	6.7	2.2	4.4	3.3	3.2	6.8	7.8	2.8	3.8	7.5	2.0	4.1	0.7	7.8	1.4	3.1	8.3	8.5	5.0	6.2	8.4	7.1	11.0	6.1	9.1	8.1	23.8	20.2	4.8	20.9	35.1	4.7	6.5	10.2	6.7	18.2	71.5	0.0	5.0	1.7	8.5	91.3	12.0	2.6	0.0	6.8	11.9	72.5	30.5	5.8	7.4	13.6	3.2	5.8	14.1	6.2	20.4	34.8	9.2	21.9	19.0	7.2	15.6	8.5	10.5	89.5	10.7	4.7	71.1	66.9	21.6	4.9	23.5	3.9	7.5	14.3	15.0
UBE2Q1	"NICE-5, PRO3094, UBE2Q"	ENSG00000160714	"Ubiquitin conjugating enzyme E2 Q1"	Q7Z7E8	1	154548577-154559028	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063368	Approved		Approved	Nucleoplasm,Centrosome		No	No			Nucleoplasm	Centrosome	"HPA063368: AB_2684996"	"unprognostic (3.88e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.44e-3)"	"unprognostic (3.64e-3)"	"unprognostic (5.32e-3)"	"unprognostic (6.10e-3)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (2.92e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (4.84e-7)"	"unprognostic (2.20e-1)"	"unprognostic (4.46e-1)"	"prognostic favorable (1.86e-5)"	"unprognostic (1.04e-2)"	17.3	18.7	26.5	16.2	29.4	24.2	19.4	26.4	29.0	20.0	21.2	18.7	8.2	16.2	18.3	25.4	20.9	21.8	18.2	17.6	24.5	25.8	25.7	27.4	23.0	26.3	22.8	21.0	21.7	27.2	21.4	29.3	24.5	27.2	21.4	25.7	18.5	19.0	19.8	19.1	21.6	21.4	21.9	19.1	26.0	20.5	30.0	22.0	25.1	21.0	14.0	29.9	19.3	18.5	3.2	5.1	8.1	3.1	4.7	6.2	1.6	17.2	14.9	21.1	16.1	21.7	22.4	18.3	17.1	26.0	22.0	17.8	16.7	18.4	21.2	24.6	23.8	18.4	15.0	24.8	19.8	19.0	21.3	15.7	16.8	13.3	16.1	27.4	27.3	27.1	21.5	26.3	17.8	20.7	24.0	28.2	19.7	14.1	26.3	28.1	26.7	16.6	20.1	28.8	41.3	25.4	19.2	14.7	22.3	24.2	18.3	21.5	30.1	17.3	32.6	27.9	37.7	19.9	41.7	19.6	14.3	15.9	16.9	18.2	32.2	23.8	28.1	16.0	19.4	21.5	8.1	2.8	5.6	4.8	3.1	4.3	3.0	4.5	5.9	2.5	3.2	5.0	5.7	4.4	4.7	2.6	5.1	6.2	1.6	26.5	29.4	26.4	29.0	24.5	25.8	22.8	21.0	27.2	22.0	29.8	21.6	22.7	16.5	14.3	38.7	26.9	25.5	34.8	20.5	15.7	3.9	15.3	10.0	13.0	2.7	27.8	23.7	0.0	18.0	14.1	15.8	22.6	10.4	34.2	23.2	57.2	32.3	32.5	41.4	4.3	16.4	19.3	13.5	15.4	30.4	45.6	21.9	11.5	18.0	15.1	19.3	12.9	13.2	30.7	24.4	16.7	16.4	20.8	20.4	22.9
VCPIP1	"DUBA3, FLJ23132, KIAA1850, VCIP135"	ENSG00000175073	"Valosin containing protein interacting protein 1"	Q96JH7	8	66628487-66667217	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023932	Uncertain		Approved	"Plasma membrane,Centrosome"		NA	NA			"Plasma membrane"	Centrosome	"HPA023932: AB_2671373"	"unprognostic (1.12e-1)"	"unprognostic (1.31e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.01e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.23e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.96e-1)"	"unprognostic (5.23e-3)"	"unprognostic (7.28e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.13e-2)"	"unprognostic (8.58e-3)"	9.5	8.7	15.7	12.6	14.5	30.9	8.9	14.4	15.1	7.5	8.4	7.0	3.8	7.0	7.8	8.7	8.1	6.9	7.0	6.7	10.2	9.2	8.3	12.3	10.5	13.6	10.3	13.7	7.8	9.0	14.0	5.9	8.0	12.3	7.0	7.8	6.0	9.0	7.1	14.8	7.3	10.0	6.3	9.6	14.7	8.0	10.8	11.7	11.6	8.0	2.8	13.3	7.9	7.0	2.6	3.4	11.3	8.8	2.8	4.3	1.7	9.0	8.2	4.2	5.6	13.0	9.2	4.1	7.3	7.4	5.6	6.5	4.8	8.5	12.2	2.1	9.7	6.9	8.0	6.8	6.1	8.0	9.0	4.9	13.5	8.1	6.0	7.8	4.5	14.6	9.9	9.0	6.1	11.1	6.9	6.0	6.7	9.1	11.8	8.2	4.4	9.7	7.8	8.0	7.6	5.7	6.3	6.6	6.1	8.1	7.1	2.5	4.8	5.6	8.6	6.3	5.6	8.8	7.5	12.0	7.4	5.5	6.5	4.8	10.5	5.1	13.1	7.3	6.5	5.5	9.2	3.2	6.7	4.3	5.2	3.6	2.0	2.7	3.1	3.4	2.6	2.2	2.9	11.3	2.8	8.8	1.3	3.3	1.7	15.7	14.5	14.4	15.1	10.2	9.2	10.3	13.7	12.3	11.7	17.9	14.6	9.0	8.1	15.0	11.1	16.5	12.7	12.0	11.4	7.0	21.6	8.8	3.3	9.7	4.3	9.9	14.0	23.3	11.7	4.8	12.3	11.3	18.5	20.2	12.4	11.1	5.8	15.4	47.5	4.5	7.5	18.0	10.1	10.8	15.0	11.8	10.8	15.3	14.9	9.9	10.8	6.5	10.8	26.8	14.7	18.1	8.2	26.6	13.3	14.2
ZFAND1	FLJ14007	ENSG00000104231	"Zinc finger AN1-type containing 1"	Q8TCF1	8	81701334-81732903	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 69.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023383	Approved		Approved	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"HPA023383: AB_1859008"	"unprognostic (6.45e-2)"	"unprognostic (1.48e-2)"	"unprognostic (7.74e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.04e-3)"	"unprognostic (8.13e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.35e-2)"	"unprognostic (2.36e-2)"	18.9	17.7	12.5	10.8	23.2	14.8	25.8	24.3	25.9	22.8	19.4	8.6	16.0	16.1	21.6	17.9	19.9	20.8	14.4	14.8	12.7	15.8	19.6	26.6	16.2	13.8	14.8	16.2	35.8	35.1	16.0	31.1	12.6	27.4	23.7	18.7	10.3	23.3	18.1	16.9	13.5	20.2	23.7	16.5	17.5	20.3	10.3	13.2	19.0	42.6	16.1	17.0	26.7	21.3	18.5	20.0	6.4	13.9	17.2	25.1	16.8	19.2	6.1	8.6	7.5	11.8	23.8	8.6	11.5	15.5	10.1	13.2	6.8	15.2	18.9	13.6	8.7	11.3	13.0	9.9	16.5	15.3	15.9	9.9	10.8	10.4	8.0	21.7	13.2	7.2	19.4	39.8	7.0	69.1	17.5	12.6	18.1	16.3	27.1	10.5	12.6	16.3	9.6	2.5	40.4	19.4	11.2	7.3	8.4	12.7	17.8	8.8	5.7	8.3	5.3	18.9	10.3	17.5	9.8	8.0	7.5	11.0	10.7	15.9	10.8	6.6	11.6	8.9	1.2	5.7	6.4	13.9	3.9	11.3	10.2	19.4	18.5	18.5	15.0	20.0	13.4	25.1	18.7	1.4	17.2	11.8	11.6	21.1	16.8	12.5	23.2	24.3	25.9	12.7	15.8	14.8	16.2	27.4	13.2	23.8	31.8	35.2	67.7	85.2	26.9	16.8	43.3	10.7	26.1	24.4	3.9	30.8	87.9	21.1	2.7	39.1	10.5	46.7	43.0	38.4	35.5	55.7	34.6	19.1	26.1	22.3	22.5	24.5	42.4	2.3	36.8	31.1	47.2	22.6	34.4	13.7	30.0	28.1	28.0	54.2	12.7	32.3	63.4	18.2	18.1	68.5	27.3	52.2	30.5	52.1
ZNF12	"GIOT-3, KOX3, ZNF325"	ENSG00000164631	"Zinc finger protein 12"	P17014	7	6688433-6706923	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 9.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA063402			Supported	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA063402: AB_2685005"	"unprognostic (2.68e-1)"	"unprognostic (6.97e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.41e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.89e-3)"	"unprognostic (5.52e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.36e-2)"	"unprognostic (8.46e-3)"	16.7	12.1	12.1	15.6	11.7	8.8	17.0	25.4	13.5	18.9	17.7	9.2	16.0	12.2	17.4	17.9	15.1	15.1	11.9	12.6	10.1	9.7	15.6	13.8	12.2	15.1	10.3	12.8	19.6	13.2	25.2	20.0	20.3	10.3	23.9	13.2	8.6	14.7	16.1	9.5	13.8	18.6	12.5	16.1	18.6	12.9	7.5	13.9	21.1	21.9	7.9	16.0	21.9	29.3	2.1	1.9	9.4	0.9	1.9	3.5	0.4	12.0	5.7	11.4	14.3	11.7	12.0	11.0	7.6	13.8	9.8	10.3	7.8	7.0	9.2	5.3	9.4	22.1	14.5	9.4	7.4	15.0	3.5	7.1	9.2	8.6	7.7	11.0	14.6	10.0	13.1	16.6	7.0	11.4	14.6	7.1	7.4	14.6	8.5	12.9	9.5	5.6	13.5	13.8	3.8	8.8	7.4	16.4	5.6	8.0	12.0	10.5	18.6	8.8	16.1	9.2	15.0	10.2	16.7	7.0	11.1	14.0	8.8	10.0	8.1	5.2	9.4	9.0	9.9	14.6	9.4	0.9	1.1	2.5	0.7	3.5	2.0	2.1	2.8	0.9	2.1	2.7	3.4	0.9	1.9	0.8	1.9	1.7	0.4	12.1	11.7	25.4	13.5	10.1	9.7	10.3	12.8	10.3	13.9	8.9	9.9	13.7	14.1	23.9	26.7	16.2	12.7	9.4	10.3	3.5	15.7	9.8	1.7	7.7	0.4	15.5	6.8	23.3	5.7	7.5	14.2	10.8	11.5	9.0	8.4	35.0	7.5	16.0	11.5	0.8	20.8	7.2	5.0	5.4	11.1	19.5	7.5	7.0	21.2	5.7	19.8	25.8	14.4	12.3	6.0	19.6	7.2	6.4	11.5	14.9
ZNF274	"ZKSCAN19, ZSCAN51"	ENSG00000171606	"Zinc finger protein 274"	Q96GC6	19	58183029-58213562	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 60.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 39.1"					"Low region specificity"	"Detected in all"			HPA028880	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA028880: AB_10601929"	"unprognostic (2.38e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.84e-1)"	"prognostic favorable (6.16e-4)"	"unprognostic (2.73e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (2.91e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.47e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.58e-3)"	9.9	7.6	5.9	8.8	7.0	8.8	15.4	16.6	6.7	7.5	9.9	11.7	14.0	6.3	10.0	12.2	11.7	9.8	14.7	12.0	5.9	4.8	7.3	14.0	12.0	12.8	12.5	5.5	16.8	8.9	20.3	10.9	7.6	9.5	10.4	5.8	14.5	8.6	11.0	11.2	11.4	10.6	10.6	8.7	10.7	8.3	19.3	7.9	6.1	15.3	8.6	10.9	11.2	12.8	16.3	6.7	23.0	8.0	14.0	18.1	8.8	9.0	6.4	10.7	4.4	6.8	10.1	10.4	7.5	4.1	8.2	7.4	3.7	6.7	3.1	4.9	4.6	8.8	2.6	5.0	10.5	11.4	6.4	39.1	14.6	6.3	6.0	11.1	10.4	24.2	8.0	13.5	10.1	19.5	8.5	6.5	5.0	10.9	14.1	6.1	5.9	5.6	9.3	10.2	5.3	6.3	12.7	2.7	13.4	6.2	3.8	7.0	3.1	10.0	4.4	8.4	8.5	10.6	19.7	6.2	4.5	6.7	5.1	8.4	6.4	6.8	10.3	2.0	11.5	9.3	13.7	4.7	23.0	9.3	5.1	14.3	13.8	12.2	13.2	6.7	16.3	18.1	13.0	17.3	14.0	8.0	3.1	15.3	8.8	5.9	7.0	16.6	6.7	5.9	4.8	12.5	5.5	9.5	7.9	14.9	18.7	18.2	36.1	9.3	30.1	14.3	12.7	10.7	10.3	17.4	41.2	9.0	1.7	10.9	14.5	11.3	11.9	0.0	4.9	9.9	6.6	25.3	28.8	6.8	6.8	19.1	6.3	4.3	10.2	8.1	11.2	13.4	6.8	10.0	8.8	20.1	9.3	17.5	11.3	9.0	60.4	19.4	11.8	17.9	12.8	10.7	14.0	25.3	7.6	21.2
ZNF296	ZNF342	ENSG00000170684	"Zinc finger protein 296"	Q8WUU4	19	45071500-45076588	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 29.8;lymphoid tissue: 26.2"	"Cell type enhanced"	"Detected in many"	7	"monocytes: 36.9;Paneth cells: 28.6;Undifferentiated cells: 23.5"	"Cancer enhanced"	"Detected in all"		"testis cancer: 19.5"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 16.6;SK-BR-3: 11.2;U-698: 19.4"	"Low region specificity"	"Detected in many"							"HPA046940, HPA049576"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA046940: AB_2679871, HPA049576: AB_2680821"	"unprognostic (1.32e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.18e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (5.24e-4)"	"unprognostic (3.83e-3)"	"unprognostic (1.67e-2)"	"unprognostic (9.70e-2)"	"unprognostic (9.55e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.67e-5)"	"unprognostic (7.14e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-3)"	1.4	0.8	2.4	22.8	3.4	10.5	7.3	6.6	1.4	3.0	7.1	0.4	3.2	6.4	1.0	1.2	11.3	1.4	4.0	1.4	2.0	1.7	1.4	1.0	3.4	15.9	1.1	0.1	0.6	2.7	0.3	3.5	0.7	0.8	2.4	1.0	0.8	13.8	3.4	0.8	6.2	10.1	0.6	1.3	16.9	5.5	2.6	0.6	4.3	1.7	9.5	26.2	2.0	2.7	29.8	26.7	14.7	6.2	14.7	3.5	2.6	3.0	2.1	0.0	0.4	0.0	0.2	1.8	0.5	0.0	0.2	0.2	3.5	1.2	16.6	1.9	0.1	0.0	5.8	0.8	1.3	0.0	3.5	4.4	4.8	0.9	3.4	0.9	2.7	5.1	0.7	0.6	0.7	0.0	0.1	0.5	0.3	3.5	5.9	0.0	4.6	0.2	4.6	1.9	2.0	4.4	9.3	0.0	10.0	0.4	1.1	3.1	0.3	2.1	11.2	0.1	0.3	2.4	5.5	1.1	0.0	1.7	0.1	0.0	6.1	6.1	19.4	0.1	3.5	0.1	14.7	3.6	5.7	3.0	6.2	3.5	29.8	1.6	3.3	8.8	22.4	0.7	1.7	1.8	14.7	5.8	26.7	1.4	2.6	2.4	3.4	6.6	1.4	2.0	1.7	1.1	0.1	0.8	0.6	0.0	1.1	18.6	12.1	10.8	0.9	0.9	0.0	2.7	1.2	3.5	3.9	0.3	0.0	1.9	0.4	0.0	13.3	0.0	0.8	1.9	1.7	2.8	9.2	0.0	3.0	0.0	5.1	1.3	3.0	0.0	0.0	4.1	3.3	36.9	19.9	0.5	1.0	28.6	1.1	0.3	1.6	0.0	2.0	0.9	10.9	8.8	0.7	10.2	23.5	5.7
ZNF677	MGC48625	ENSG00000197928	"Zinc finger protein 677"	Q86XU0	19	53235381-53254898	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 40.5"	"Group enriched"	"Detected in many"	11	"Early spermatids: 557.4;Late spermatids: 339.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 19.6;SuSa: 17.4"									HPA023106	Approved		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA023106: AB_1859409"	"unprognostic (2.06e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.02e-3)"	"unprognostic (7.73e-2)"	"unprognostic (4.07e-3)"	"unprognostic (7.87e-3)"	"unprognostic (8.16e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.12e-2)"	"unprognostic (8.70e-8)"	"unprognostic (6.57e-3)"	"unprognostic (7.85e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.17e-2)"	9.1	7.3	5.9	4.3	8.3	4.2	9.3	13.0	7.3	7.4	7.0	13.9	1.3	2.9	12.3	5.7	4.6	9.7	6.2	9.4	5.3	4.3	6.3	2.3	6.8	7.3	9.9	4.8	14.3	4.4	9.1	9.9	7.5	6.6	8.9	3.4	7.6	7.4	6.2	3.9	7.5	3.9	8.1	10.5	7.0	5.7	40.5	8.7	6.7	10.1	5.2	5.0	8.2	6.6	17.4	14.5	10.1	2.8	10.3	15.4	4.1	0.2	0.2	11.4	0.4	3.9	6.0	2.0	7.4	5.6	7.7	7.0	0.0	0.4	0.1	5.6	6.4	9.7	0.7	0.0	5.8	2.3	0.2	4.1	0.3	0.5	0.2	9.6	0.1	7.6	10.3	0.0	7.4	0.1	0.2	3.4	0.1	0.1	0.5	5.2	0.2	6.2	0.2	19.6	0.1	2.6	0.1	0.0	0.2	2.2	3.0	0.2	10.8	0.2	2.8	0.1	17.4	0.4	0.3	2.1	12.1	0.2	0.2	4.9	0.3	0.1	0.2	0.2	0.3	0.1	10.1	2.2	6.4	5.1	2.8	7.3	9.6	7.2	5.6	6.1	17.4	15.4	10.0	2.6	10.3	1.8	14.5	4.5	4.1	5.9	8.3	13.0	7.0	5.3	4.3	9.9	4.8	6.6	8.7	23.8	3.2	10.7	23.0	10.2	23.9	15.9	15.3	9.4	17.0	19.2	13.7	10.7	29.9	13.8	557.4	22.4	0.7	23.3	6.0	17.2	15.5	23.9	13.9	0.4	6.7	27.0	0.0	22.7	4.0	339.6	25.3	10.3	13.5	9.0	2.4	20.1	6.5	0.0	16.3	2.2	19.1	19.4	17.6	39.3	35.1	12.8	9.8	10.4	1.9	22.1
ZNF747	MGC2474	ENSG00000169955	"Zinc finger protein 747"	Q9BV97	16	30530367-30535347	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA003203, HPA069173"	Uncertain		Approved	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"HPA003203: AB_1080753, HPA069173: AB_2686097"	"unprognostic (3.82e-2)"	"prognostic favorable (6.53e-4)"	"unprognostic (3.73e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.22e-3)"	"unprognostic (2.45e-2)"	"unprognostic (3.66e-2)"	"prognostic favorable (4.46e-4)"	"unprognostic (1.01e-2)"	"unprognostic (2.60e-3)"	"unprognostic (2.27e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.01e-1)"	12.5	10.5	11.0	8.9	12.4	5.7	10.3	13.1	19.4	14.1	11.3	18.5	6.3	9.6	14.3	10.3	8.9	11.8	10.5	13.2	10.3	8.9	11.4	17.0	8.4	9.3	11.5	8.0	13.2	15.5	23.1	10.4	6.2	10.6	14.6	9.2	13.6	11.2	15.3	14.1	11.0	10.5	11.8	9.4	11.4	10.2	12.4	13.3	18.2	11.8	6.7	9.0	12.8	8.8	8.8	8.1	9.0	4.8	6.6	8.9	4.1	3.8	3.7	1.2	6.1	4.9	4.3	6.2	3.2	4.8	4.6	4.5	2.2	4.9	8.3	2.2	3.8	0.6	5.7	2.8	4.0	2.0	9.8	6.2	7.2	4.0	3.4	5.4	3.3	10.3	4.9	5.1	3.7	5.8	3.0	3.0	10.5	2.0	7.2	3.2	4.2	14.8	4.6	7.2	2.0	2.5	17.7	0.4	7.6	4.0	2.0	8.6	7.6	4.8	3.2	3.5	3.0	6.2	6.6	2.4	5.9	2.7	4.6	0.1	13.7	9.6	4.7	1.2	5.1	6.9	9.0	4.8	6.4	4.5	2.6	5.2	7.4	5.1	5.2	6.0	8.8	8.9	6.6	2.7	6.6	2.4	8.1	3.8	4.1	11.0	12.4	13.1	19.4	10.3	8.9	11.5	8.0	10.6	13.3	3.0	7.5	2.4	3.0	1.3	7.3	5.6	0.0	8.1	2.3	0.0	3.9	1.9	6.6	5.6	1.3	6.3	5.5	0.0	5.0	1.7	4.6	3.4	3.5	7.8	6.1	6.4	7.0	6.2	6.5	0.0	5.5	4.0	0.0	10.8	6.3	5.2	4.6	10.2	9.2	6.4	6.8	12.9	5.2	11.8	2.7	1.0	1.0	4.5	6.0	2.0
ZNF780A	ZNF780	ENSG00000197782	"Zinc finger protein 780A"	O75290	19	40069152-40090938	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Exocrine glandular cells: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003311	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA003311: AB_1080757"	"unprognostic (1.92e-1)"	"unprognostic (9.25e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.53e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.13e-1)"	"unprognostic (9.49e-2)"	"unprognostic (4.91e-2)"	"prognostic favorable (9.30e-4)"	6.9	9.2	11.1	8.6	8.5	4.1	7.7	12.8	10.8	8.7	6.6	5.8	13.9	5.7	8.2	10.8	10.4	7.8	7.8	6.7	7.1	6.1	7.9	11.8	7.0	11.3	10.5	8.9	8.6	11.0	15.8	14.1	7.0	6.8	7.9	6.0	6.8	10.0	11.4	4.5	8.0	9.1	6.0	10.4	12.0	8.2	7.9	9.7	7.8	11.2	5.3	11.3	8.8	7.9	3.9	4.6	8.4	7.7	3.3	5.9	2.5	4.9	9.4	6.2	5.7	5.6	5.2	4.4	5.8	4.7	4.7	7.2	6.1	3.4	4.4	3.8	2.8	4.7	4.2	3.9	3.3	5.3	7.5	5.3	6.9	7.8	5.8	5.0	7.2	5.8	5.3	3.7	4.8	4.0	6.4	4.9	5.0	7.8	7.5	4.0	2.9	2.9	2.4	4.9	4.8	2.9	2.3	10.9	2.6	3.9	10.2	3.8	7.3	8.6	3.3	3.8	5.7	4.1	8.7	3.6	5.8	7.7	5.3	4.6	7.4	6.5	4.4	3.7	5.0	3.9	2.7	5.4	8.4	3.9	4.9	5.1	3.7	4.2	3.5	4.6	3.9	5.9	5.1	4.7	3.3	7.7	3.6	4.5	2.5	11.1	8.5	12.8	10.8	7.1	6.1	10.5	8.9	6.8	9.7	8.9	12.2	4.4	3.5	3.4	5.7	3.7	7.6	8.1	9.1	8.7	2.0	5.0	8.3	11.9	17.3	7.7	7.4	0.0	42.0	6.3	5.5	3.0	16.1	33.6	13.1	4.8	3.4	11.6	25.0	1.1	4.0	17.9	11.8	8.2	7.2	3.5	24.5	8.6	4.9	13.3	6.6	6.5	6.2	5.8	2.5	2.3	4.9	11.5	6.6	2.7
ZNF780B	ZNF779	ENSG00000128000	"Zinc finger protein 780B"	Q9Y6R6	19	40028260-40056209	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 28.1;Cone photoreceptor cells: 31.4;Rod photoreceptor cells: 35.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA003311	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA003311: AB_1080757"	"unprognostic (3.28e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.56e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.83e-3)"	"unprognostic (1.33e-2)"	"unprognostic (4.89e-3)"	"unprognostic (4.71e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.56e-3)"	6.3	8.2	12.4	9.8	18.8	3.3	10.3	22.2	14.0	8.2	8.5	8.2	11.6	5.7	10.8	12.3	5.5	10.0	6.6	12.5	9.4	7.2	9.4	6.7	5.9	9.7	8.1	10.8	16.6	8.1	10.5	24.7	7.1	11.6	9.7	7.6	9.3	7.9	10.5	6.9	7.1	7.6	9.7	7.8	9.2	7.2	5.0	11.4	8.7	14.0	6.4	9.8	9.1	8.2	4.2	5.9	1.5	3.2	2.3	5.1	1.3	2.6	3.5	5.9	4.1	3.6	2.4	0.0	3.1	2.3	3.4	4.5	6.3	2.4	6.6	2.9	3.2	3.4	1.6	4.9	1.9	4.0	5.5	2.5	5.1	6.2	3.9	2.4	7.6	4.3	3.4	1.2	4.7	2.9	2.6	3.2	3.0	5.3	8.9	3.4	1.2	2.5	1.2	5.8	2.3	3.7	3.5	10.4	2.3	2.0	14.5	6.5	6.9	5.4	2.4	1.9	3.7	2.8	3.3	5.8	3.3	8.3	5.8	4.7	6.7	8.6	5.1	3.1	4.0	2.8	0.1	3.2	1.5	2.8	2.8	2.9	2.5	3.4	3.3	2.4	4.2	5.1	4.2	0.6	2.3	1.8	5.9	1.9	1.3	12.4	18.8	22.2	14.0	9.4	7.2	8.1	10.8	11.6	11.4	8.9	8.1	4.2	2.3	1.6	28.1	13.0	10.2	4.0	10.3	8.7	31.4	1.6	3.3	4.4	6.0	5.8	2.6	0.0	8.6	1.2	2.7	2.1	7.0	4.9	3.2	9.5	9.9	9.8	4.8	1.1	3.4	7.2	5.0	5.4	4.3	7.2	4.7	4.5	2.8	2.4	35.0	6.5	3.9	2.7	1.3	2.6	0.6	5.2	4.2	2.2
ZSCAN10	ZNF206	ENSG00000130182	"Zinc finger and SCAN domain containing 10"	Q96SZ4	16	3088890-3099317	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 2.8;testis: 3.9"	"Cell type enhanced"	"Detected in single"	25	"Cytotrophoblasts: 1.5"	"Cancer enriched"	"Detected in single"	207	"testis cancer: 19.5"	"Region enriched"	"Detected in single"	7	"cerebellum: 2.7"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	9	"NTERA-2: 36.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA076826			Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA076826: "	"unprognostic (4.37e-2)"	"unprognostic (5.13e-2)"		"unprognostic (9.15e-2)"	"unprognostic (6.65e-3)"	"unprognostic (6.24e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.24e-2)"		"unprognostic (1.15e-1)"		"unprognostic (1.72e-1)"	"unprognostic (1.85e-11)"	"unprognostic (5.98e-2)"	"unprognostic (2.92e-2)"		"unprognostic (1.79e-2)"	0.2	0.2	0.3	0.2	0.2	1.3	0.2	2.7	1.4	0.2	0.2	0.2	0.2	0.0	0.2	0.3	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.5	0.2	1.3	0.9	0.3	0.2	0.2	0.1	0.2	0.2	0.2	1.1	2.8	0.3	0.2	0.2	0.6	1.2	3.9	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.8	0.7	2.4	0.8	0.6	1.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	36.2	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.0	0.0	2.4	0.8	0.8	0.4	0.6	1.1	0.8	0.2	1.0	0.4	0.8	0.5	0.6	1.3	0.6	0.7	0.7	0.1	0.2	0.3	0.2	2.7	0.3	0.3	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0